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The	   initiation	   of	   the	   hematopoietic	   program	   is	   orchestrated	   by	   key	  
transcription	   factors	   that	   recruit	   chromatin	   regulators	   in	   order	   to	   activate	   or	  
inhibit	   blood	   target	   gene	   expression.	   To	   generate	   a	   complete	   compendium	   of	  
chromatin	   factors	   that	   establish	   the	   genetic	   code	   during	   developmental	  
hematopoiesis,	  we	  conducted	  a	  large-­‐scale	  reverse	  genetic	  screen	  targeting	  425	  
chromatin	  factors	  in	  zebrafish	  and	  identified	  over	  30	  novel	  chromatin	  regulators	  
that	  function	  at	  distinct	  steps	  of	  embryonic	  hematopoiesis.	  	  
In	   vertebrates,	   developmental	   hematopoiesis	   occurs	   in	   two	  waves.	  During	  
the	   first	   and	   primitive	   wave,	   mainly	   erythrocytes	   are	   produced,	   and	   we	  
identified	   at	   least	   15	   chromatin	   factors	   that	   decrease	   or	   increase	   formation	   of	  
scl+,	  gata1+,	  and	  β-­globin	  e3+	  erythroid	  progenitors.	  In	  the	  definitive	  wave,	  HSCs	  
capable	   of	   self-­‐renewal	   and	   differentiation	   into	  multiple	   lineages	   are	   induced,	  
and	   we	   identified	   at	   least	   18	   chromatin	   factors	   that	   decrease	   or	   increase	   the	  
formation	   of	   c-­myb+	   and	   runx1+	   stem	   and	   progenitor	   cells	   in	   the	   aorta	   gonad	  
mesonephros	   (AGM)	   region,	   without	   disruption	   of	   vascular	   development.	   The	  
iv 
majority	   of	   the	   chromatin	   factors	   identified	   from	   the	   screen	   are	   involved	   in	  
histone	  acetylation,	  histone	  methylation,	  and	  nucleosome	  remodeling,	  the	  same	  
modifications	   that	   are	  hypothesized	   to	  have	   the	  most	   functional	   impact	  on	   the	  
transcriptional	   status	   of	   a	   gene.	   Moreover,	   these	   factors	   can	   be	   mapped	   to	  
subunits	   of	   chromatin	   complexes	   that	  modify	   these	  marks,	   such	   as	   HBO/HAT,	  
HDAC/NuRD,	  SET1A/MLL,	  ISWI,	  and	  SWI/SNF.	  	  
One	   of	   the	   strongest	   phenotypes	   identified	   from	   the	   screen	   came	   from	  
knockdown	   of	   chromodomain	   helicase	   DNA	   binding	   domain	   7	   (chd7).	  
Morpholino	   knockdown	   of	   chd7	   resulted	   in	   increased	   primitive	   and	   definitive	  
blood	   production	   from	   the	   induction	   of	   stem	   and	   progenitor	   cells	   to	   the	  
differentiation	   of	  myeloid	   and	   erythroid	   lineages.	   This	   expansion	   of	   the	   blood	  
lineage	   is	   cell	   autonomous	   as	   determined	   by	   blastula	   transplantation	  
experiments.	  	  
Though	   chromatin	   factors	   are	   believed	   to	   function	   broadly	   and	   are	   often	  
expressed	   ubiquitously,	   the	   combined	   results	   of	   the	   screen	   and	   chd7	   analysis	  
show	   that	   individual	   factors	   have	   very	   tissue	   specific	   functions.	   These	   studies	  
implicate	  chromatin	  factors	  as	  playing	  a	  major	  role	  in	  establishing	  the	  programs	  
of	  gene	  expression	  for	  self-­‐renewal	  and	  differentiation	  of	  hematopoietic	  cells.	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   The	  development	  of	  multicellular	  organisms	  from	  a	  single	  cell	  is	  a	  highly	  
regulated	  process	   involving	   the	   formation	   of	   tissue	   specific	   stem	   cells	   that	   are	  
capable	   of	   self-­‐renewal	   and	   progressive	   differentiation	   into	   the	   various	  
specialized	   cell	   types	  of	   an	  organ.	  These	  principles	   are	   illustrated	   in	   the	  blood	  
system,	   where	   self-­‐renewing	   hematopoietic	   stem	   cells	   (HSCs)	   are	   needed	   to	  
maintain	  a	  constant	  pool	  of	  progenitors	  committed	  to	  the	  various	  blood	  lineages	  
in	  order	  to	  replenish	  the	  mature	  blood	  cells	  that	  turn	  over.	  Because	  the	  various	  
cell	   types	   at	   different	   stages	   of	   blood	   differentiation	   have	   been	   largely	  
elucidated,	  hematopoiesis	  has	  been	  widely	  used	  as	  a	  model	  for	  the	  study	  of	  stem	  
cell	  biology	  and	  the	  regulation	  of	  lineage	  commitment	  and	  differentiation.	  One	  of	  
the	  major	  questions	   in	  developmental	  biology	   is	  the	  molecular	  mechanism	  that	  
drives	  this	  process.	  
	  
Hematopoietic	  development	  
The	   ontogeny	   of	   hematopoietic	   cells	   is	   a	   complex	   process	   that	   is	  
spatiotemporally	   regulated.	   Whereas	   the	   specific	   anatomical	   sites	   in	   which	  
hematopoiesis	  occurs	  varies	  between	  species,	   it	   can	  be	  divided	   into	   two	  major	  
waves.	  The	   first	  and	  primitive	  wave	  produces	  mainly	  a	   transient	  population	  of	  
erythroid	  and	  myeloid	  cells.	  The	  definitive	  wave	  generates	  bona	   fide	  HSCs	   that	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will	   sustain	   hematopoiesis	   throughout	   the	   lifetime	   of	   the	   organism.	  
Understanding	   how	   these	   processes	   occur	   provides	   insights	   into	   the	  
mechanisms	  of	  how	  tissues	  develop	  and	  function.	  
	  
Primitive	  hematopoiesis	  
	   The	  primitive	  wave	   is	   characterized	  by	   the	  production	  of	  hematopoietic	  
cells	   with	   limited	   lineage	   potential.	   In	   mice,	   the	   first	   blood	   cells	   in	   the	   early	  
embryo	   arise	   in	   the	   yolk	   sac	   at	   embryonic	   day	   E7.5	   (Sabin	   1920).	   These	   cells	  
originate	   from	   hemangioblasts	   in	   the	   primitive	   streak,	   which	  migrate	   into	   the	  
yolk	   sac	   and	   differentiate	   into	   committed	   endothelial	   and	   hematopoietic	  
progenitors	   (Choi	   et	   al	   1998,	   Fehling	   et	   al	   2003,	   Huber	   et	   al	   2004,	   Ueno	   et	   al	  
2006).	   Primitive	  macrophages	   and	   other	  myeloid	   progenitors	   also	   arise	   in	   the	  
yolk	   sac	   at	   E8.25	   (Palis	   et	   al	   1999,	   Ferkowicz	   et	   al	   2003).	   Primitive	   blood	  
formation	  is	   important	  for	  generating	  erythroid	  cells	  that	  deliver	  oxygen	  to	  the	  
embryo	  proper.	  	  
In	  zebrafish,	  primitive	  hematopoiesis	  occurs	  intraembryonically	  from	  the	  
lateral	   mesoderm.	   Erythroid	   progenitors	   arise	   from	   the	   posterior	   lateral	  
mesoderm	  whereas	  myeloid	  progenitors	  arise	  in	  the	  anterior	  lateral	  mesoderm	  
(Bennett	   et	   al.	   2001,	   Detrich	   et	   al.	   1995,	   Herbomel	   et	   al.	   1999).	   The	   lateral	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mesoderm	   converges	   in	   the	   midline	   of	   the	   trunk	   prior	   to	   the	   onset	   of	   the	  
heartbeat	  at	  24	  hours	  post-­‐fertilization	  (hpf),	  forming	  the	  intermediate	  cell	  mass	  
(ICM)	  region.	  There,	  the	  primitive	  red	  cells	  continue	  to	  mature	  as	  they	  gradually	  
enter	  the	  cirulation.	  	  
Through	   the	   characterization	   of	   various	   zebrafish	   mutants,	   several	  
molecular	  pathways	   that	   regulate	   the	  production	  of	  primitive	  blood	  have	  been	  
identified.	  First,	  proper	  patterning	  and	  specification	  of	  the	  ventral	  mesoderm	  is	  
required	   to	   induce	   primitive	   blood	   formation.	   This	   process	   is	   initiated	   during	  
gastrulation	   with	   cells	   in	   the	   marginal	   zone	   that	   can	   give	   rise	   to	   a	   variety	   of	  
tissues,	   including	   notochord,	   somites,	   pronephros,	   and	   blood.	   Several	   lines	   of	  
evidence	   point	   to	   bone	   morphogenic	   proteins	   (BMPs)	   for	   instructing	   ventral	  
mesoderm,	   among	   others.	   Zebrafish	   mutants	   for	   genes	   in	   the	   BMP	   pathway	  
become	   dorsalized	   while	   overexpression	   of	   bmp4	   ventralizes	   the	   embryo,	  
resulting	   in	   decreased	   or	   increased	   expression	   domains	   of	   hematopoietic	  
markers,	   respectively	   (Amatruda	   and	   Zon	   1999,	   Hammerschmidt	   and	   Mullins	  
2002,	  Neave	  et	  al	  1997).	  In	  addition,	  spadetail	  (spt)	  mutants,	  which	  are	  defective	  
in	  the	  convergence	  of	  paraxial	  mesoderm,	  also	  lose	  gata1+	  erythroid	  cells.	  	  
The	   primitive	   blood	   cells	   are	   then	   believed	   to	   arise	   from	   the	  
hemangioblast,	   a	   common	   precursor	   for	   blood	   and	   endothelial	   cells.	   This	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hypothesis	   is	   supported	   by	   the	   zebrafish	   cloche	   (clo)	   mutant,	   which	   lacks	   all	  
blood	  and	  endothelial	  lineages	  (Stainier	  et	  al	  1995).	  The	  transcription	  factor	  scl	  
is	  believed	  to	  regulate	  these	  cells	  as	  overexpression	  of	  scl	  resulted	  in	  increased	  
vascular	   flk	   and	  erythroid	  gata1	   expression	  and	  can	  rescue	   their	  expression	   in	  
clo	   mutants	   (Gering	   et	   al	   1998,	   Liao	   et	   al	   1998).	   The	   earliest	   hematopoietic	  
markers	  expressed	  are	  gata2	   and	  scl	   in	   the	  bilateral	   stripes	  of	   the	   lateral	  plate	  
mesoderm	  starting	  11	  hpf	   (Crosier	  et	  al	  2002).	   Induction	  of	  gata1	   at	  14	  hpf	   in	  
the	   posterior	   lateral	   mesoderm	   marks	   the	   commitment	   of	   these	   cells	   to	   the	  
erythroid	  fate,	  and	  by	  16	  hpf,	  expression	  of	  embryonic	  globin	  genes	  such	  as	  β-­
globin	   e3	   signals	   the	   beginning	   of	   the	   differentiation	   of	   these	   erythroid	  
progenitors	  down	   the	   red	   cell	   lineage.	   Similarly,	  pu.1+	  macrophages	   arise	   from	  
the	  anterior	  lateral	  mesoderm	  that	  also	  expresses	  scl	  (Lieschke	  et	  al	  2002).	  The	  
entry	   of	   primitive	   blood	   into	   circulation	   completes	   the	   first	   wave	   of	  
hematopoiesis.	  
During	   the	   transition	   from	   primitive	   to	   definitive	   hematopoiesis,	  
additional	   sites	   of	   blood	   formation	   can	  be	   found	   in	   the	   allantois,	   placenta,	   and	  
the	  prospective	  aorta-­‐gonad-­‐mesonephros	  (AGM)	  region	  in	  mice	  by	  E9.0	  (Corbel	  
et	  al	  2007,	  Cumano	  et	  al	  1996,	  Zeigler	  et	  al	  2006).	  These	  blood	  cells	  mainly	  have	  
erythroid-­‐myeloid	  potential,	  but	  under	  the	  right	  conditions,	   lymphoid	  potential	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could	  be	  elicited	   from	  the	  prospective	  AGM	  region	  with	  ability	   for	  multilineage	  
reconstitution	  in	  adult	  mice,	  albeit	  a	  low	  levels	  (Cumano	  et	  al	  1996,	  Cumano	  et	  al	  
2001).	  Additionally,	  populations	  of	  c-­‐Kit+CD34+	  cells	  from	  neonatal	  yolk	  sac	  and	  
AGM	  were	  able	  to	  show	  multilineage	  engraftment	  of	  neonatal	  recipient	  mice	  but	  
not	   adult	   mice	   (Yoder	   et	   al	   1997).	   In	   zebrafish,	   a	   distinct	   population	   of	  
erythromyeloid	  progenitor	  cells	  emerges	   from	  the	  posterior	  blood	   island	   (PBI)	  
of	   24	   hpf	   embryos	   (Bertrand	   et	   al	   2007).	   Overall,	   primitive	   hematopoiesis	   is	  
largely	   restricted	   to	   myeloid	   and	   erythroid	   lineages,	   with	   certain	   populations	  
exhibiting	  more	  definitive	  phenotypes	  as	  the	  embryo	  matures.	  	  
	  
Definitive	  hematopoiesis	  
The	   definitive	  wave	   is	   initiated	   soon	   after	   the	   onset	   of	   circulation.	   It	   is	  
defined	   by	   the	   emergence	   of	   HSCs	   capable	   of	   long-­‐term	   lineage	   reconstitution	  
and	  self-­‐renewal.	  HSCs	  are	  believed	  to	  derive	  from	  the	  endothelium,	  specifically	  
from	   the	   ventral	   wall	   of	   the	   aorta.	   Observations	   in	   various	   species	   show	  
hematopoietic	  clusters	  adhering	  to	  the	  endothelium	  of	  the	  dorsal	  aorta,	  as	  well	  
as	  vitelline	  and	  umbilical	  arteries	  (Jaffredo	  et	  al	  2005).	  Hematopoietic	  cells	  from	  
the	  AGM	  were	   shown	   to	  be	   functional	  HSCs	  by	   their	   ability	   to	   reconstitute	   the	  
adult	   hematopoietic	   system	  of	   irradiated	  mice	   (Medvinsky	   and	  Dzierzak	  1996,	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Muller	  et	  al	  1994).	  Tracing	  experiments	  also	  provide	  evidence	  for	  an	  endothelial	  
origin	   of	   HSCs	   (Zovein	   et	   al	   2008).	   These	   observations	   do	   not	   exclude	   the	  
possibility	   that	  HSCs	   arise	   in	   the	   sub-­‐aortic	  mesenchyme	   and	  migrate	   through	  
the	  endothelial	   layer	   to	   form	  the	  hematopoietic	  clusters	  as	   transplantable	  cells	  
can	  be	  found	  in	  this	  region	  (Bertrand	  et	  al	  2005).	  Recently,	  imaging	  of	  zebrafish	  
and	  mouse	  AGM	   confirmed	   the	   budding	   of	   hematopoietic	   cells	   from	   the	   aortic	  
endothelium	  (Bertrand	  et	  al	  2010,	  Boisset	  et	  al	  2010,	  Kissa	  and	  Herbomel	  2010).	  
In	   zebrafish,	   these	   cells	   bud	   off,	   migrate	   towards	   the	   vein,	   and	   enter	   the	  
circulation	  to	  seed	  additional	  hematopoietic	  sites.	  	  
Several	  transcription	  factors	  regulating	  HSC	  formation,	  self-­‐renewal,	  and	  
differentiation	   have	   been	   found.	   In	   addition	   to	   primitive	   blood,	   SCL	   is	   also	  
required	   for	   definitive	   blood	   formation.	   Knockout	   Scl	   mice	   demonstrated	  
complete	  loss	  of	  stem	  and	  progenitor	  cells	  as	  well	  as	  downstream	  blood	  lineages	  
(Robb	  et	  al	  1995,	  Shivdasani	  et	  al	  1995).	  Expression	  of	  CD41,	  one	  of	  the	  markers	  
expressed	   in	   HSCs,	   is	   also	   lost	   in	   Scl-­‐/-­‐	   mice	   (Mikkola	   et	   al	   2002).	   Runx1	   is	  
required	   for	   the	   induction	   of	   HSCs	   from	   the	   AGM	   and	   differentiation	   of	   adult	  
megakaryocytic	   and	   lymphoid	   populations	   (Li	   et	   al	   2006,	   Okuda	   et	   al	   1996).	  
Although	  the	  endothelium	  is	  not	  affected	  in	  Runx1-­‐/-­‐	  embryos,	  RUNX1	  is	  required	  
for	   the	  emergence	  of	  HSCs	   from	   the	  hemogenic	  endothelium	  (Kissa	  et	  al	  2010,	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Lancrin	  et	  al	  2009,	  North	  et	  al	  1999,	  Yokomizo	  et	  al	  2001).	  C-­‐myb	  is	   important	  
for	   HSC	   self-­‐renewal	   and	   multilineage	   differentiation	   (Lieu	   and	   Reddy	   2009,	  
Mucenski	  et	  al	  1991).	  Several	  other	  factors	  such	  as	  Bmi1,	  cMyc,	  Gfi1,	  Gata2,	  Mll,	  
Evi1,	  and	  Prdm16	  also	  regulate	  HSC	  self-­‐renewal	  and	  function	  (Aguilo	  et	  al	  2011,	  
Chuikov	  et	  al	  2010,	  Hock	  et	  al	  2004,	  Laurenti	  et	  al	  2008,	  Lessard	  and	  Sauvageau	  
2003,	  Macmahon	  et	  al	  2007,	  Park	  et	  al	  2003,	  Rodrigues	  et	  al	  2005,	  Yuasa	  et	  al	  
2005).	  
Studies	  in	  zebrafish	  have	  elucidated	  several	  pathways	  important	  for	  HSC	  
induction	   in	   the	   AGM.	   At	   36	   hpf,	   c-­myb	   expression	   is	   lost	   in	   both	   clo	   and	   spt	  
mutants	   (Thompson	   et	   al	   1998).	   Disruption	   of	   signaling	   pathways	   that	   affect	  
vascular	  development	  also	  affected	  the	   formation	  of	  HSCs.	  The	  plcg1	  mutant	   in	  
the	   vascular	   endothelial	   growth	   factors	   (VEGF)	  pathway	   lose	   ephrinB2	   arterial	  
gene	  expression	  and	  disrupt	  intersomitic	  vessel	  formation,	  which	  coincides	  with	  
the	  loss	  of	  runx1+	  cells	  in	  the	  AGM	  (Gering	  and	  Patient	  2005,	  Lawson	  et	  al	  2003).	  
Overexpression	  of	  vegf	  could	  rescue	  c-­myb+	  cells	  and	  improves	  to	  a	  certain	  extent	  
the	  defects	  in	  flk+	  vascular	  cells	  of	  spt	  mutants	  (Burns	  et	  al	  2009).	  These	  studies	  
suggest	  a	  hierarchical	  pathway	  in	  which	  proper	  formation	  of	  the	  vessel	  followed	  
by	   arterial	   fate	   specification	   is	   required	   for	   HSCs	   to	   emerge	   from	   the	   dorsal	  
aorta.	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Definitive	   hematopoietic	   stem	   and	   progenitor	   cells	   (HSPCs)	   in	   the	   AGM	  
can	   be	   identified	   with	   expression	   of	   runx1,	   c-­myb,	   ikaros,	   lmo2,	   scl,	   and	   cd41	  
along	  the	  ventral	  wall	  of	  the	  dorsal	  aorta	  (Bertrand	  et	  al	  2007,	  Liao	  et	  al.	  1998;	  
Thompson	  et	  al.	  1998;	  Willett	  et	  al.	  2001;	  Kalev-­‐Zylinska	  et	  al.	  2002;	  Kissa	  et	  al.	  
2008;	   Bertrand	   et	   al.	   2008).	   runx1	   overexpression	   causes	   HSC	   expansion	   in	  
embryos	   while	   morpholino	   knockdown	   causes	   defects	   in	   definitive	  
hematopoiesis	  and	  vasculoangiogenesis	  (Burns	  et	  al.	  2005).	  Furthermore,	  c-­myb	  
and	  cd41	  expression	  is	  reduced	  in	  runx1	  morphants	  (Kalev-­‐Zylinska	  et	  al.	  2002,	  
Kissa	  et	  al	  2008).	  Although	  c-­myb	  is	  also	  expressed	  in	  primitive	  erythroid	  cells,	  it	  
is	  not	  required	  for	  their	  development	  (Thompson	  et	  al.	  1998).	  
After	   exiting	   the	   AGM,	   the	   HSCs	   proliferate	   and	   undergo	   further	  
maturation	   at	   different	   anatomical	   sites	   until	   the	   adult	   marrow	   niche	   is	  
established.	   In	   mice,	   the	   HSCs	   are	   believed	   to	   colonize	   the	   fetal	   liver	   first,	  
followed	   by	   the	   spleen	   and	   thymus	   until	   finally	   they	   reach	   the	   bone	   marrow	  
(Dzierzack	  and	  Speck	  2008,	  Morrison	  et	  al	  1995,	  Sánchez	  et	  al	  1996,	  Yokota	  et	  al	  
2006).	   In	   zebrafish,	   the	   AGM	  HSCs	  migrate	   to	   the	   caudal	   hematopoietic	   tissue	  
(CHT)	   and	   then	   to	   the	   kidney	   marrow	   and	   thymus	   after	   between	   3	   to	   5	   dpf	  
(Murayama	   et	   al.	   2006;	   Jin	   et	   al.	   2007;	   Kissa	   et	   al.	   2008).	   Additional	   sites	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harboring	  HSCs	  in	  mice	  include	  the	  umbilical	  artery	  and	  placenta	  (de	  Bruijn	  et	  al	  
2000,	  Geckas	  et	  al	  2005,	  Ottersbach	  et	  al	  2005).	  
Expression	   of	   lineage	   specific	   transcription	   factors	   direct	   the	  
differentiation	  of	  HSCs	  into	  each	  of	  the	  specific	  blood	  lineages.	  GATA1	  is	  required	  
for	   erythroid	   development	   as	   Gata1	   deficient	   cells	   never	   gave	   rise	   to	   red	   cells	  
and	   hemizygous	   knockout	   mice	   die	   during	   mid-­‐gestation	   from	   severe	   anemia	  
(Fujiwara	  et	  al	  1996,	  Pevny	  et	  al	  1991).	  Ikaros	  is	  important	  for	  differentiation	  of	  
HSCs	   down	   the	   lymphoid	   lineage	   (Yoshida	   et	   al	   2006).	   Several	   transcription	  
factors	   are	   important	   for	   myeloid	   lineage	   specification.	   PU.1	   is	   a	   regulator	   of	  
both	  multipotent	   progenitors	   and	  myeloid	   lineages.	   Knockout	  mice	   die	   late	   in	  
gestation,	   failing	   to	   develop	   granulocytic	   and	   monocytic	   lineages	   (Scott	   et	   al	  
1994).	   cMYB	   functions	   in	   multipotent	   progenitors	   as	   well,	   and	   it	   regulates	  
various	  myeloid	  genes	  (Ness	  et	  al	  1993,	  Shapiro	  1995).	  cMyb	  knockout	  mice	  are	  
also	   embryonic	   lethal	   with	   severe	   reductions	   in	   granulocytes	   and	   monocytes	  
(Mucenski	  et	  al	  1991).	  In	  zebrafish,	  the	  developing	  lymphoid	  and	  myeloid	  cells	  in	  
the	   CHT	   can	   be	   identified	   by	   the	   expression	   of	   c-­myb,	   scl,	   runx1,	   and	   ikaros	  
(Murayama	   et	   al.	   2006;	   Zhang	   and	   Rodaway	   2007).	   Differentiating	   definitive	  
erythroid	   cells	   begin	   to	   express	   adult	   globin	   genes,	   and	   thymic	   immigrants	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differentiate	   into	   rag1+	   lymphoid	   cells	   (Murayama	   et	   al.	   2006;	   Jin	   et	   al.	   2007;	  
Kissa	  et	  al.	  2008).	  	  
	  
Regulation	  of	  cell	  fate	  
The	  balance	  of	   the	  various	   transcription	   factors	   is	   important	   for	   lineage	  
determination	   and	   controlling	   multipotency	   versus	   differentiation.	  
Overexpression	   of	   scl	   and	   lmo2	   in	   the	   early	   embryo	   expands	   the	   formation	   of	  
gata1+	   erythroid	   and	   flk+	   vascular	   progenitors	   by	   converting	   non-­‐axial	  
mesoderm	   to	   the	   hematopoietic	   and	   endothelial	   cell	   fates	   (Dooley	   et	   al.	   2005,	  
Gering	  et	  al.	  2003).	  Loss	  of	  gata1	  did	  not	  affect	  the	  expression	  of	  upstream	  genes	  
scl,	  lmo2,	  and	  gata2.	  Instead,	  there	  was	  a	  fate	  switch	  of	  erythroid	  cells	  to	  myeloid	  
cells	  (Galloway	  et	  al	  2005).	  pu.1	  was	  found	  to	  be	  expressed	  in	  cells	  that	  normally	  
develop	   into	   erythroid	   cells,	   and	   subsequent	   increased	   formation	   of	   mpo+	  
granulocytes	  and	   l-­plastin+	  macrophages	  in	  the	  gata1	  morphants	  confirmed	  the	  
differentiation	  of	  these	  precursors	  down	  the	  myeloid	  lineage.	  	  
As	  a	  result,	  proper	  levels	  of	  hematopoietic	  transcription	  factor	  expression	  
are	  required	   for	  specification	  and	  differentiation	  of	   the	  different	  hematopoietic	  
cell	   types.	   The	   activity	   of	   the	   transcription	   factors	   on	   its	   targets,	   however,	   is	  
dependent	  on	  its	  ability	  to	  access	  the	  DNA.	  To	  achieve	  this,	  transcription	  factors	  
 12 
often	  recruit	  additional	   co-­‐factors	   that	   includes	  chromatin	  modifying	   factors	   in	  
order	  to	  effect	  activation	  or	  repression	  of	  their	  target	  genes.	  	  
	  
Chromatin	  regulation	  
	   Because	  DNA	  is	  packaged	  into	  chromatin,	  transcriptional	  complexes	  need	  
to	  be	  able	  to	  alter	  the	  chromatin	  conformation	  in	  order	  to	  activate	  or	  inhibit	  gene	  
expression.	   The	   DNA	   contains	   all	   the	   genetic	   information	   required	   for	  
development,	   and	   it	   is	   compacted	   into	   chromatin	   in	   order	   to	   contain	   3	   billion	  
base	  pairs	  of	  information	  inside	  a	  5-­‐micrometer	  nucleus	  (Avery	  et	  al	  1944).	  The	  
basic	  structure	  of	  chromatin	  is	  the	  nucleosome,	  which	  is	  composed	  of	  147	  base	  
pairs	   of	   DNA	   wrapped	   around	   an	   octamer	   of	   specialized	   histone	   proteins	  
(Kornberg	   and	   Thomas	   1974,	   Luger	   et	   al	   1997).	   Changes	   to	   chromatin	  
conformation	   can	   be	   achieved	   by	   covalent	   modifications	   to	   both	   the	   cytosine	  
bases	   in	   the	   DNA	   and	   histone	   proteins	   (Fisher-­‐Adams	   and	   Grunstein	   1995,	  
Holliday	  and	  Pugh	  1975,	  Lenfant	  et	   al	  1996,	  Megee	  et	  al	  1995,	  Riggs	  1975).	   In	  
addition,	  nucleosomes	  can	  be	  mobilized	  (Varga-­‐Weisz	  and	  Becker	  1998).	  These	  
kinds	  of	  modifications	  that	  do	  not	  alter	  the	  DNA	  sequence	  are	  considered	  part	  of	  
the	  epigenetic	  regulatory	  mechanisms.	  Consequently,	  the	  activation	  of	  a	  gene	  not	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only	  depends	  on	  the	  presence	  of	  transcription	  factors	  but	  also	  on	  the	  chromatin	  
environment.	  
	  
Histone	  modifications	  and	  nucleosome	  remodeling	  
	   Specific	   changes	   in	   chromatin	   conformation	   have	   been	   associated	   with	  
specific	   gene	   functions.	   Condensation	   of	   nucleosomes	   results	   in	   a	   repressive	  
chromatin	   structure	   that	   prevents	   gene	   transcription.	   Conversely,	  
decondensation	   of	   nucleosomes	   facilitates	   gene	   transcription.	   Because	   DNA	   is	  
bound	   to	   histone	   proteins,	   the	   nucleosomes	   themselves	   act	   as	   inhibitors	   of	  
transcription.	   Mobilizing	   nucleosomes	   is	   important	   not	   only	   in	   the	   promoters	  
regions	  for	  transcription	  factor	  binding	  but	  also	  for	  transcriptional	  elongation	  by	  
RNA	   polymerase.	   These	   processes	   are	   greatly	   facilitated	   in	   the	   presence	   of	  
nucleosome	   remodelers	   and	   are	   regulated	   in	   part	   by	   histone	   modifications	  
(Orphanides	  et	  al	  1998).	  	  
	   Histone	  modifications	  are	  an	  essential	  part	  of	   the	  epigenetic	  mechanism	  
that	   regulates	   both	   chromatin	   and	   nonhistone	   protein	   interactions.	   The	  
modification	  of	  N-­‐terminal	  histone	  tails	  have	  been	  characterized	  the	  most.	  These	  
covalent	   modifications	   include	   acetylation,	   methylation,	   phosphorylation,	  
ubiquitylation,	   sumoylation,	   ADP	   ribosylation,	   deimination,	   proline	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isomerization,	   and	  more	   recently	   hydroxylation	   and	   crotonylation	   (Kouzarides	  
2007,	   Tan	   et	   al	   2011).	   All	   these	   modification	   play	   a	   role	   in	   regulating	   gene	  
transcription.	   Histone	   lysine	   acetylation	   is	   generally	   correlated	   with	  
decondensed	   chromatin	   and	   active	   transcription.	   The	   acetylation	   mark	  
facilitates	   binding	   of	   transcriptional	   factors	   to	   chromatin	   (Lee	   et	   al	   1993,	  
Lefebvre	   et	   al	   1998,	   Vettese-­‐Dadey	   et	   al	   1996),	   reducing	   the	   stability	   of	   the	  
histone-­‐DNA	   interaction	   (Hong	   et	   al	   1993,	   Puig	   et	   al	   1998),	   or	   by	   disrupting	  
higher	  order	  histone	  structures	  (Baneres	  et	  al	  1997,	  Garcia-­‐Ramirez	  et	  al	  1995,	  
Tse	   et	   al	   1998).	   Histone	   phosphorylation	   is	   believed	   to	   function	   in	   a	   similar	  
manner	  to	  histone	  acetylation	  by	  changing	  nucleosome	  conformation	  or	  higher	  
order	   structures,	   best	   exemplified	   by	   the	   induction	   of	   global	   levels	   of	   H3S10	  
phosphorylation	   during	   mitosis	   (Chen	   and	   Allfrey	   1987,	   Chen	   et	   al	   1990,	  
Hendzel	   et	   al	   1997).	   Ubiquitin	   is	   a	   relatively	   large	  modification	   that	   can	   alter	  
nucleosome	   conformation,	   yet	   it	   can	   promote	   either	   transcriptional	   initiation	  
and	  elongation	  or	  repression	  (Kim	  et	  al	  2009,	  Pavri	  et	  al	  2006,	  Usachenko	  et	  al	  
1996,	  Varshavsky	  et	  al	  1983,	  Wang	  et	  al	  2004).	  Sumoylation	  occurs	  on	  all	   four	  
histones	   and	  antagonizes	  both	   lysine	  acetylations	   and	  ubiquitylations,	   and	   this	  
modification	  has	  been	  found	  to	  be	  repressive	  in	  yeast	  (Nathan	  et	  al	  2006).	  ADP-­‐
ribosylation	   has	   been	   implicated	   in	   transcription	   via	   the	   association	   with	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enzymes	   that	   catalyze	   it	   with	   the	   transcriptional	   complex	   (Ju	   et	   al	   2006).	  
Deimination	   is	   believed	   to	   antagonize	   the	   activating	   effects	   of	   arginine	  
methylation	  (Cuthbert	  et	  al	  2004).	   Isomerization	  of	  H3P38	   is	   likely	   involved	   in	  
the	   regulation	   of	   a	   nearby	  mark,	   H3K36,	   discussed	   below	   (Nelson	   et	   al	   2006,	  
Chen	  et	  al	  2006).	  One	  of	  the	  newest	  marks	  discovered,	  histone	  crotonylation,	  is	  
associated	  with	  enhancers	  and	  transcriptional	  start	  sites	  (Tan	  et	  al	  2011).	  
Histone	   methylation	   is	   more	   complex,	   reflecting	   different	   states	   of	  
transcription	  depending	  on	  the	  residue	  that	  is	  modified.	  Lysines	  may	  be	  mono-­‐,	  
di-­‐,	  or	  tri-­‐methylated.	  Arginines	  can	  be	  mono-­‐,	  symmetrically	  or	  asymmetrically	  
di-­‐methylated.	   H3K4,	   H3K36,	   and	   H3K79	   are	   implicated	   in	   transcriptional	  
activation.	  H3K4me3	  localizes	  to	  the	  5’	  end	  of	  active	  genes,	  but	  H3K4me1	  and	  –
me2	  are	  associated	  more	  with	  enhancer	  regions	  than	  transcriptional	  start	  sites	  
(Bernstein	  et	  al	  2005,	  Kim	  et	  al	  2005,	  Schübeler	  et	  al	  2004).	  H3K36me3	  is	  found	  
throughout	   the	   body	   of	   active	   genes	   but	   inhibits	   transcription	   initiation	   if	  
methylated	  in	  the	  promoter	  region	  (Keogh	  et	  al	  2005).	  Little	  is	  known	  about	  the	  
function	   of	   H3K79.	   On	   the	   opposite	   end,	   H3K9,	   H3K27,	   and	   H4K20	   are	  
associated	   with	   transcriptional	   repression.	   Both	   H3K9me	   and	   H3K27me	   have	  
well	   known	   roles	   in	   heterchromatin	   formation	   (Cao	  2002,	   Schotta	   et	   al	   2002).	  
Very	   little	   is	   known	   about	   H4K20	   methylation	   except	   that	   it	   is	   also	   found	   in	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heterochromatin	  (Schotta	  et	  al	  2004).	  However,	   these	  repressive	  marks	  can	  be	  
activating	   too	   when	   monomethylated	   (Barski	   et	   al	   2007).	   Like	   lysine	  
methylation,	  arginine	  methylation	  can	  be	  both	  activating	  and	  repressive	  (Lee	  at	  
al	   2005).	   Overall,	   specific	   histone	   marks	   generally	   associated	   with	   either	  
transcription	  activation	  or	   repression,	   but	   as	   in	   the	   case	  of	   lysine	  methylation,	  
their	  function	  can	  be	  highly	  context	  dependent.	  
Interactions	   among	   histone	   modifications	   provide	   another	   layer	   of	  
epigenetic	   regulation.	   Lysines	   can	   be	   acetylated,	   methylated,	   or	   ubiquitinated,	  
thus	   competitive	   antagonism	   can	   occur	   between	   different	   modification	  
pathways.	  Modification	  of	  one	  residue	  can	  be	  dependent	  on	  another	  within	  the	  
same	  or	  different	  histone	  tails.	  For	  example,	  H3K4	  and	  H3K79	  methylations	  are	  
dependent	   on	   H2BK123	   ubiquitination	   (Lee	   et	   al	   2007).	   The	   binding	   of	  
nonhistone	  proteins	  or	  the	  catalytic	  activity	  of	  enzymes	  can	  also	  be	  regulated	  by	  
the	   histone	   marks.	   PHF8	   binding	   to	   H3K4me3	   is	   enhanced	   when	   H3K9	   and	  
H3K14	  are	  also	  acetylated	  (Vermeulen	  et	  al	  2010).	  In	  yeast,	  the	  isomerization	  of	  
H3P38	   regulates	   the	   ability	   of	   Set2	   enzyme	   to	  methylate	   H3K36	   (Nelson	   et	   al	  
2006).	  The	  combined	  effect	  of	  histone	  modifications	  helps	  to	  establish	  chromatin	  
domains	  that	  not	  only	  functions	  to	  regulate	  chromatin	  structure	  but	  also	  allows	  
for	  gene	  specific	  regulation.	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Histone	  modifying	  factors	  
Histone	   modifications	   are	   dynamic,	   with	   modifications	   appearing	   and	  
disappearing	   within	   minutes,	   thus	   identification	   of	   the	   enzymes	   that	   catalyze	  
these	   modifications	   would	   help	   identify	   important	   regulators	   of	   gene	  
transcription.	   Specific	   protein	   domains	   that	   can	   catalyze	   (‘writers’),	   bind	  
(‘readers’),	  and	  remove	  (‘erasers’)	  histone	  modifications	  are	  found	  on	  chromatin	  
modifying	   factors.	   The	   cloning	   and	   identification	   of	   histone	   acetyltransferase	  
Gcn5	  was	   the	   first	   study	   to	   link	  directly	   a	   chromatin	   factor	   to	  gene	   regulation,	  
and	   it	   also	   contains	   a	   conserved	   bromodomain	   that	   is	   now	   known	   to	   bind	  
acetylated	   histone	   tails,	   allowing	   the	   protein	   to	   be	   targeted	   to	   the	   chromatin	  
(Brownell	   et	   al	   1996,	   Owen	   et	   al	   2000).	   Subsequent	   studies	   have	   identified	   a	  
wide	   array	   of	   chromatin	   factor	   families	   that	   can	   recognize	   or	   modify	   histone	  
marks.	  
The	   acetyltransferases,	   which	   have	   the	   ability	   to	   acetylate	   histones,	   have	  
long	  been	  known	  to	  be	  integral	  components	  of	  transcriptional	  complexes.	  There	  
are	   three	  main	   families	  of	  histone	  acetyltransferases	  (HATs),	  GNAT,	  MYST,	  and	  
CBP/P300,	   and	   these	   enzymes	   can	   modify	   multiple	   lysine	   residues	   in	   vitro.	  
Histone	  deacetylases	  (HDACs)	  remove	  the	  acetyl	  mark.	  Like	  HATs,	  they	  also	  do	  
not	   show	   specific	   activities	   towards	   a	   particular	   acetyl	   group	   either,	   but	   are	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often	   associated	   with	   repressive	   chromatin	   complexes	   (Sterner	   and	   Berger	  
2000).	  Many	  HATs	  contain	  bromodomains,	  which	  recognize	  and	  bind	  acetylated	  
histone	  marks.	  	  
In	   contrast	   to	   HATs,	   histone	   lysine	   methyltransferases	   (HKMTs)	   have	  
relatively	   more	   specific	   activity	   towards	   methylating	   histones	   at	   particular	  
residues.	  The	  first	  HKMT	  identified,	  SUV39H1,	  targets	  H3K9	  methylation	  (Rea	  et	  
al	   2000).	  MLL	  and	  SET1	   catalyze	  methylation	  of	  H3K4	   (Wang	  et	   al	   2009).	  The	  
catalytic	  activity	  is	  mediated	  by	  the	  SET	  domain	  of	  these	  proteins.	  The	  removal	  
of	   the	  mark	   is	   accomplished	   by	   lysine-­‐specific	   demethylases	   (LSD1)	   and	   JmjC	  
jumonji	   (JMJ)	   domain	   containing	   demethylases	   (Shi	   et	   al	   2004,	   Tsukada	   et	   al	  
2006).	   The	   LSD1	   family	   demethylates	   H3K4me1	   and	   –me2,	   whereas	   JMJC	  
proteins	   can	   demethylate	   H3K4me3	   and	   H3K36me3.	   These	  methyl	   marks	   are	  
recognized	  by	   chromodomains.	  Kinases	   have	   also	   been	   shown	   to	   have	   specific	  
activity	   towards	   specific	   histone	   residues,	   but	   are	   more	   difficult	   to	   study	   as	  
signaling	   pathways	   need	   to	   be	   activated	   in	   order	   to	   observe	   the	  modifications	  
(Kouzarides	  2007).	  Enzymes	  that	  catalyze	  the	  ubiquitination,	  sumoylation,	  ADP-­‐
ribosylation,	  deimination,	  and	  proline	  isomerization	  of	  histone	  marks	  have	  also	  
been	  identified	  (Cuthbert	  et	  al	  2004,	  Hassa	  et	  al	  2006,	  Nathan	  et	  al	  2006,	  Nowak	  
and	  Corces	  2004,	  Shilatifard	  2006,	  Wang	  et	  al	  2004).	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The	  individual	  chromatin	  factors	  can	  assemble	  into	  multisubunit	  complexes	  
including	   those	   that	   can	   catalyze	   ATP-­‐dependent	   chromatin	   remodeling.	   This	  
class	   of	   remodelers	   is	   important	   to	   displace	   nucleosomes	   to	   allow	   the	  
transcriptional	   machinery	   to	   bind	   to	   the	   DNA.	   For	   example,	   the	   SWI/SNF	  
chromatin	   remodeling	   complex	   was	   found	   to	   facilitate	   GAL4	   and	   TBP	  
transcription	   factor	   bindings	   to	  DNA	   and	   transcription	   initiation	   by	   disrupting	  
nucleosomal	  DNA	  (Imbalzano	  et	  al	  1994,	  Kwon	  et	  al	  1994).	  Mutating	  one	  of	  the	  
SWI/SNF	  subunits	  abolished	  GAL4	  binding	  (Côté	  et	  al	  1994).	  Several	  chromatin	  
remodelling	  complexes	  have	  been	  identified	  thus	  far,	  including	  INO80,	  ISWI,	  and	  
CHD.	  They	  can	  be	  recruited	  by	  transcription	  factors	  to	  facilitate	  their	  binding	  to	  
chromatin	   to	   help	   activate	   or	   repress	   target	   genes.	   RUNX1	  has	   been	   shown	   to	  
interact	  directly	  with	  BRG1	  and	   INI1	  of	   the	  SWI/SNF	  complex	   in	   Jurkat	  cells,	  a	  
human	  T	  lymphoblast	  like	  cell	  line.	  In	  addition,	  they	  colocalize	  to	  the	  promoters	  
of	  RUNX1	  target	  genes	  GMCSF	  and	  IL3.	  siRNA	  knockdown	  of	  RUNX1	  reduced	  the	  
association	  of	  BRG1	  and	  INI1	  at	  these	  promoters,	  indicating	  that	  RUNX1	  recruits	  
components	  of	  the	  SWI/SNF	  complex	  to	  its	  target	  genes.	  These	  promoters	  were	  
associated	  with	  active	  histone	  marks	  H3K4me2	  and	  H4-­‐ac	  but	  not	  the	  repressive	  
mark	  H3K27me2,	  implicating	  that	  association	  of	  RUNX1	  and	  SWI/SNF	  promotes	  
gene	  expression	  (Bakshi	  et	  al	  2010).	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Chromatin	  remodeling	  in	  development.	  
	   Evidence	   is	   accumulating	   that	   chromatin	   remodeling	   have	   essential	  
functions	   in	   development.	   SWI/SNF	   has	   been	   shown	   to	   be	   required	   for	   the	  
development	   of	   all	   organisms	   studied	   so	   far.	   BRG1	   and	   BRM	   are	   the	   catalytic	  
subunits	  of	  SWI/SNF,	  and	  they	  assemble	  with	  various	  BAF	  subunits	  to	  form	  the	  
SWI/SNF	  complex	  (Kasten	  et	  al	  2011).	  Loss	  of	  BRG1	  or	  several	  of	  the	  other	  BAF	  
subunits	   in	  knockout	  mice	  result	   in	  early	   lethality	  during	  the	  peri-­‐implantation	  
stage	  (Ho	  and	  Crabtree	  2010).	  These	  phenotypes	  are	  consistent	  with	  a	  role	   for	  
BAF	  complex	  in	  embryonic	  stem	  (ES)	  cell	  pluripotency	  and	  self-­‐renewal	  (Ho	  et	  al	  
2009).	  The	  SWI/SNF	  complex	  was	  again	  required	  for	  ES	  cells	  to	  exit	  the	  stem	  cell	  
state	   as	   two	   subunits	   BAF57	   or	   BAF155	   were	   required	   in	   Nanog	   repression	  
(Schaniel	  et	  al	  2009).	  SWI/SNF	  was	  required	  again	  at	  multiple	  steps	  during	  the	  
ES	  cell	  differentiation	  into	  neuronal	  progenitors	  then	  into	  neurons	  (Lessard	  et	  al	  
2007).	   In	   BRG1	  deficient	   neuronal	   cells,	   components	   of	   the	  NOTCH	   and	   sonic-­‐
hedgehog	   pathway	   expression	   were	   dysregulated,	   contributing	   to	   the	  
differentiation	  defects.	  Subunit	  switching	  of	  the	  different	  BAF	  subunits	  occurred	  
at	   the	   different	   transition	   stages,	   suggesting	   tissue	   specific	   BAF	   complex	  
formation	  at	  each	  stage	  of	  development	  depending	  on	  the	  BAF	  components	  that	  
are	  present.	  Thus	  chromatin	  factors	  can	  have	  a	  wide	  variety	  of	  possible	  functions	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depending	  on	  the	  developmental	  context.	  	  
	   Depletion	   of	   members	   of	   other	   remodeling	   families	   also	   result	   in	  
developmental	   defects.	   The	   CHD	   family	   is	   composed	   of	   nine	   proteins,	   CHD1-­‐9,	  
that	  contain	   tandem	  chromodomains	  preceding	   the	  ATPase	  domain.	  CHD1	  was	  
believed	   to	   be	   a	   crucial	   factor	   for	   transcription,	   but	   Chd1	   mutant	   Drosophila	  
zygotes	  are	  viable.	  It	  is	  expressed	  broadly	  throughout	  embryogenesis	  and	  in	  the	  
imaginal	  discs,	   but	   the	  mutants	  only	   showed	  defects	   in	  wing	  development	   and	  
gametogenesis	  (McDaniel	  et	  al	  2008).	  How	  such	  tissue	  specific	  defects	  arise	  from	  
a	  broadly	  expressing	  factor	  is	  not	  completely	  understood.	  
	  
CHD7	  in	  development	  
	   	  Of	   all	   the	   CHD	   factors,	   CHD7	   is	   the	  most	   extensively	   studied.	   De	   novo	  
mutations	  of	  CHD7	   in	   humans	   account	   for	  67%	  of	  CHARGE	   syndrome	  patients	  
(Zentner	   et	   al	   2010).	   CHARGE	   stands	   for	   an	   association	   of	  multiple	   anomalies	  
including	  Coloboma	  of	  the	  eyes,	  Heart	  defects,	  Atresia	  of	  the	  choanae,	  Retarded	  
growth	  and	  development,	  and	  Genital	  and	  Ear	  abnormalities	  (Pagon	  et	  al	  1982).	  
Identifying	   the	  mechanism	   of	   CHD7	   function	  will	   help	   elucidate	   its	   role	   in	   the	  




	   The	   birth	   incidence	   for	   CHARGE	   defects	   is	   relatively	   rare,	   about	   1	   in	  
10,000.	   In	   addition	   to	   the	   CHARGE	   syndrome,	   additional	   anomalies	   including	  
hyposmia,	   cleft	   lip/palate,	   and	   tracheoesophageal	   fistula	   can	   be	   found	   in	  
CHARGE	  syndrome	  patients.	  In	  fact,	  many	  features	  of	  CHARGE	  syndrome	  overlap	  
with	  other	  syndromes,	  including	  Treacher	  Collins.	  Treacher	  Collins	  syndrome	  is	  
caused	  by	  a	  mutation	  in	  TCOF1	  that	  affects	  craniofacial	  development	  (Dixon	  et	  al	  
2007).	  Both	  TCOF1	  and	  CHD7	  function	  in	  ribosomal	  biogenesis	  in	  the	  nucleolus,	  
thus	   the	   overlap	   in	   developmental	   defects	   is	   not	   so	   surprising	   (Zentner	   et	   al	  
2010a).	   The	   most	   consistent	   features	   of	   CHARGE	   are	   temporal	   bone	  
abnormalities	  (98%),	  external	  ear	  malformations	  (91%),	  and	  hearing	  loss	  (89%)	  
(Zentner	  et	  al	  2010b).	  
Additionally,	   CHD7	  may	   be	   associated	  with	   T	   cell	   immunodeficiency.	   In	  
one	  study	  of	  a	  cohort	  of	  25	  children	  diagnosed	  with	  CHARGE	  syndrome,	  60%	  of	  
the	   children	   exhibited	   some	   degree	   of	   lymphopenia	   (Jyonouchi	   et	   al	   2009).	  
CHARGE	  syndrome	  patients	  exhibiting	  T-­‐cell	  deficiency	  were	  often	   reported	   to	  
be	   athymic,	   suggesting	   the	  possibility	   that	   the	   immunodeficiency	   is	   not	   due	   to	  
hematopoietic	  defects	  in	  the	  bone	  marrow	  (Gennery	  et	  al	  2008,	  Hoover-­‐Fong	  et	  
al	   2009,	   Inoue	   et	   al	   2010).	   Thus	   the	   overall	   developmental	   defects	   that	   are	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potentially	  caused	  by	  CHD7	  are	  broad.	  
	   Since	  the	  discovery	  that	  CHD7	  was	  a	  causative	  gene	  of	  CHARGE	  (Vissers	  et	  
al	   2004),	   many	   attempts	   were	   made	   to	   uncover	   the	   mechanism	   by	   which	  
haploinsufficiency	  for	  CHD7	  causes	  CHARGE	  syndrome.	  Most	  mutations	  occur	  de	  
novo.	   The	  majority	   of	   the	  mutations	   result	   in	  nonsense	  or	   frameshift	  mutation	  
(72%),	   the	   remaining	   are	   either	   splice	   (13%)	   or	   missense	   (10%).	   These	  
mutations	   appear	   throughout	   the	   body	   of	   the	   gene.	   Consequently,	   CHD7	  
mutations	  are	  thought	  to	  be	  haploinsufficient.	  
	  
Mouse	  models	  of	  CHARGE	  
	   Mouse	  models	  delineate	  an	  important	  function	  for	  Chd7	  in	  ear	  formation.	  
One	   study	   characterized	   nine	   mutant	   alleles	   for	   Chd7	   generated	   by	   ENU	  
mutagenesis	   (Bosman	   et	   al	   2005).	   Similar	   to	   human	   patients,	   mutant	   mice	  
displayed	  semicircular	  canal	  truncations	  of	  the	  inner	  ear.	  Chd7	  was	  found	  to	  be	  
expressed	   in	   the	   canal	   pouches	   of	   the	   vestibular	   system,	   vestibulo-­‐cochlear	  
ganglion,	   the	   cochlea,	   and	   the	   cartilage	   primordium,	   consistent	  with	   the	   inner	  
ear	  defects	  observed	  in	  heterozygous	  mice.	  Chd7	  was	  also	  expressed	  in	  multiple	  
tissues	   such	   as	   the	   tongue,	   facial	   mesenchyme,	   brain	   ventricles,	   olfactory	   and	  
lung	  epithelium.	   Interestingly,	  Chd7	  was	   found	   to	  be	   expressed	  weakly	   in	   yolk	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sac	  vessels	  at	  E12.5.	  The	  Whirligig	  (Whi)	  allele	  contains	  a	  nonsense	  mutation	  in	  
Chd7,	  and	  a	  third	  of	  these	  mice	  had	  palatal	  and	  choanal	  defects	   like	  the	  human	  
patients.	   Additionally,	   some	   of	   the	   heterozygous	   mice	   showed	   defects	   in	  
interventricular	   septum,	   thus	   some	   of	   the	   animals	   showed	   hemorrhaging.	  
Overall,	   Chd7	   was	   expressed	   in	   multiple	   tissues	   that	   are	   affected	   by	   CHARGE	  
syndrome,	   and	   the	   mice	   can	   be	   used	   as	   a	   model	   to	   study	   the	   pathology	   of	  
CHARGE	  given	  the	  overlapping	  defects	  with	  human	  CHARGE	  patients	  (Bosman	  et	  
al	  2005).	  	  
	   Full	  targeted	  knockdown	  was	  achieved	  using	  gene-­‐trapped	  reporter	  mice,	  
Chd7Gt	   (Hurd	   et	   al	   2007).	   Homozygous	   mutants	   were	   lethal	   by	   E11.	  
Heterozygous	  mice	  display	  a	  head	  bobbing	  and	  circling	  behavior	  consistent	  with	  
inner	   ear	   defects.	   Both	   heterozygous	   and	   homozygous	   mice	   showed	  
developmental	   delay,	   suggesting	  Chd7	  was	   important	   for	   the	   proliferation	   and	  
development.	   There	   is	   a	   specific	   requirement	   for	   Chd7	   in	   olfactory	   epithelium	  
proliferation	  and	  differentiation	  partly	  by	  regulating	  pro-­‐neural	  gene	  expression	  
of	   Fgf10,	   Ngn1,	   NeuroD,	   and	   Isl1	   (Hurd	   et	   al	   2010,	   Layman	   et	   al	   2009).	  
Comparison	   between	   Chd7flox/+,	   Chd7Gt/Gt,	   and	   Chd7Gt	   mice	   showed	   dose	  
dependent	   changes	   in	   the	   inner	   ear,	   with	   Chd7Gt/Gt	   mice	   showing	   the	   highest	  
reduction	  in	  neuroblasts	  and	  cell	  proliferation	  (Hurd	  et	  al	  2010).	  Thus	  one	  of	  the	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functions	   of	   CHD7	   in	   development	   appears	   to	   be	   the	   regulation	   of	   cell	  
proliferation.	  
	  
Molecular	  functions	  of	  CHD7	  
CHD7	   is	   a	   member	   of	   the	   chromodomain	   (CHD)	   family	   for	   chromatin	  
remodelers.	   It	   is	   a	   large	   protein	   of	   300	   kDa	   that	   contains	   two	   tandem	  
chromodomains	  in	  its	  N-­‐terminus	  and	  a	  SNF2	  helicase	  domain,	  characteristic	  of	  
CHD	   family	   members	   (Woodage	   et	   al	   2007).	   The	   Drosophila	   ortholog	   kismet	  
functions	   in	   promoting	   RNA	   polymerase	   II	   transcriptional	   elongation	  
downstream	   of	   P-­‐TEFB	   recruitment.	   kismet	   also	   functions	   to	   antagonize	  
heterochromatin	  spreading	  mediated	  by	  Polycomb	  group	  proteins	  (Srinivasan	  et	  
al	  2008).	  Genome-­‐wide	   localization	  studies	  of	  CHD7	   in	  cancer	  cell	   lines	  and	  ES	  
cells	   collectively	   showed	   that	   CHD7	   binds	   to	   enhancer	   regions	   (Schnetz	   et	   al	  
2009,	   Schnetz	   et	   al	   2010).	   These	   binding	   sites	   are	  DNase	   I	   hypersensitive	   and	  
overlap	   with	   P300	   binding.	   A	   direct	   interaction	   was	   even	   detected	   between	  
CHD7	  and	  P300.	  CHD7	  binding	  also	  correlates	  with	  histone	  H3K4me1	  and	  me2	  
marks,	  which	  are	  typically	  found	  in	  enhancer	  regions.	  More	  recently,	  CHD7	  has	  
been	  found	  to	  regulate	  RNA	  biogenesis	  in	  the	  nucleolus	  and	  that	  it	  was	  required	  
for	  neural	  crest	  development	  formation	  from	  ES	  cells	  (Bajpai	  et	  al	  2010,	  Zentner	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et	  al	  2010).	  Knockdown	  of	  Chd7	  in	  Xenopus	  reduced	  neural	  crest	  gene	  expression	  
and	  cell	  migration,	  and	  CHD7	  interacts	  with	  components	  of	  the	  PBAF	  complex	  to	  
regulate	   the	   expression	   of	   neural	   crest	   transcription	   factors.	   In	   ES	   cells,	   there	  
was	   co-­‐localization	   of	   CHD7	  with	   ES	   cell	   pluripotency	   genes	   OCT4,	   SOX2,	   and	  
NANOG	   at	   these	   sites.	   However,	   there	  was	   an	   interesting	   observation	   that	   the	  
most	   highly	   expressed	   embryonic	   stem	   cell	   genes	   were	  modestly	   upregulated	  
when	  CHD7	  was	  depleted,	   though	  such	  a	  small	  change	   in	  expression	  might	  not	  
have	   any	   significant	   impact	   on	   the	   cells.	   There	   has	   also	   been	   only	   one	   other	  
report	   of	   CHD7	   acting	   as	   a	   negative	   regulator,	   which	   is	   its	   recruitment	   by	  
SETDB1	  to	  repress	  PPARγ	  in	  mesenchymal	  stem	  cells	  (Takada	  et	  al	  2007).	  Thus	  




Evidence	   has	   been	   accumulating	   demonstrating	   the	   importance	   of	  
chromatin	  regulating	  various	  developmental	  transitions	  (Ho	  and	  Crabtree	  2010).	  
There	   are	   over	   400	   proteins	   that	   contain	   chromatin	   binding	   or	   chromatin	  
modifying	  domains	  in	  humans,	  and	  how	  they	  function	  together	  to	  achieve	  target	  
and	   tissue	   specifity	   is	   not	  well	   understood.	  As	  discussed	  earlier,	   combinatorial	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assembly	  of	  chromatin	  factor	  complexes	  is	  believed	  to	  be	  part	  of	  the	  mechanism,	  
exemplified	   by	   SWI/SNF	   complex.	   It	   has	   been	   postulated	   that	   the	   specific	  
subunits	  of	  each	  complex	  can	  be	  expressed	  differentially	   in	  different	   tissues	   to	  
achieve	  specifity.	  Although	  they	  may	  be	  interchangeable,	  BRG1	  and	  BRM	  mouse	  
knockouts	  showed	  completely	  different	  phenotypes	  (Bultman	  et	  al	  2000,	  Reyes	  
et	   al	   1998).	   Thus	   the	   function	   of	   chromatin	   regulators	   in	   vivo	   is	   much	   more	  
specific	  and	  may	  be	  more	  dynamic	  than	  previously	  thought.	  	  
	   There	  are	  now	  over	  120	  different	  residues	  and	  at	  least	  10	  different	  kinds	  
of	  post-­‐translational	  modifications	  that	  can	  be	  found	  on	  histone	  proteins	  (Strahl	  
and	  Allis	  2000,	  Tan	  et	  al	  2011,	  Wolffe	  and	  Hayes	  1999).	  To	  study	  the	  role	  of	  all	  
the	   chromatin	   factors	   in	   a	   specific	   developmental	   process	   would	   require	   a	  
significant	  amount	  of	   time	  to	  generate	  knockouts	   for	  all	  400	  chromatin	  factors.	  
The	   zebrafish	  provides	   an	   excellent	  model	   system	   for	   such	   a	   study	   for	   several	  
reasons.	  They	  have	  a	   short	  developmental	   time	  and	  high	   fecundity	  make	   them	  
amenable	   for	   large-­‐scale	   screening.	   Their	   relatively	   small	   size	   allows	   a	   large	  
number	  of	  them	  to	  be	  maintained	  in	  a	  facility.	  The	  embryos	  are	  transparent	  and	  
develop	   ex	   utero,	   facilitating	   visualization	   of	   embryonic	   processes	   under	   a	  
dissecting	  microscope	  or	  by	   in	   situ	   hybridizations	   for	  gene	  expression	  analysis	  
(Patton	   and	   Zon).	   Furthermore,	   targeted	   gene	   knockdowns	   can	   be	   achieved	   in	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zebrafish	   by	   the	   use	   of	  morpholinos,	  which	   are	   chemically	  modified	   antisense	  
oligonucleotides	   that	   inhibit	   translation	   or	   disrupt	   splicing	   (Nasevicius	   and	  
Ekker).	  Most	  importantly,	  the	  molecular	  pathways	  involved	  in	  hematopoiesis	  are	  
well	   conserved	  between	   teleosts	  and	  mammals	   (Davidson	  and	  Zon),	   as	  are	   the	  
chromatin	  factors.	  Thus	  screening	  using	  a	  morpholino-­‐based	  approach	  provides	  
a	  rapid	  way	  to	  assess	  the	  function	  of	  chromatin	  factors	  within	  the	  hematopoietic	  
system.	  
	   	  In	   this	   dissertation,	   we	   have	   attempted	   to	   systematically	   identify	  
chromatin	   factors	   that	   regulate	   developmental	   hematopoiesis	   by	   a	   reverse	  
genetic	  approach.	  We	  curated	  a	   list	  of	  425	  human	  chromatin	  modifying	   factors	  
encompassing	  most	  of	  the	  known	  chromatin	  regulators.	  Then	  we	  annotated	  487	  
zebrafish	   homologs	   corresponding	   to	   these	   chromatin	   factors	   and	   designed	  
morpholinos	  to	  knock	  them	  down.	  We	  conducted	  two	  simultaneous	  screens	  for	  
primitive	   and	   definitive	   blood	   formation.	   In	   the	   primitive	   blood	   screen,	   we	  
scored	  for	  changes	  in	  globin	  gene	  expression.	  In	  the	  definitive	  screen,	  we	  scored	  
for	   changes	   in	   stem	   and	   progenitor	   gene	   expression.	   Knockdown	   of	   many	  
chromatin	   factors	   resulted	   in	   decreased	   or	   increased	   hematopoietic	   gene	  
expression	   in	  both	  primitive	  and	  definitive	   screens.	  We	   identified	  very	   specific	  
hematopoietic	   phenotypes	   for	   smarca1	   and	   chd7,	   and	   found	   that	   different	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chromatin	   factors	   function	   at	   different	   steps	   of	   hematopoiesis.	   Our	   analysis	   of	  
the	   screen	   hits	   indicated	   that	   histone	   methylation	   and	   acetylation	   and	  
nucleosome	   remodeling	  were	   important	   processes	   in	   regulating	  hematopoietic	  
gene	   expression.	   Furthermore,	   we	   found	   that	   multiple	   subunits	   of	   chromatin	  
modifying	   complexes	   were	   represented	   in	   our	   screen	   hit	   list,	   indicating	   the	  
possibility	   that	   theses	   chromatin	   complexes	   regulate	   blood	   development.	  
Follow-­‐up	  work	  of	  chd7	  confirmed	  that	  chromatin	  factors	  identified	  in	  the	  screen	  
can	  have	  very	  tissue	  specific	  functions.	  Knockdown	  of	  chd7	  resulted	  in	  increased	  
primitive	   and	   definitive	   blood	   formation,	   suggesting	   that	   it	   functions	   as	   a	  
repressor	   of	   hematopoiesis.	   Other	   chromatin	   factors,	   for	   example	   unk	   and	  
jmjd2b,	   were	   found	   to	   have	   important	   roles	   in	   both	   hematopoiesis	   and	  
development	  of	  other	  tissues.	  The	  concerted	  action	  of	  both	  transcription	  factors	  
and	   chromatin	   factors	   result	   in	   the	   proper	   specification	   and	   differentiation	   of	  
blood	  lineages,	  as	  illustrated	  in	  the	  movie.	  The	  resource	  that	  we	  have	  established	  

























	   This	   chapter	  was	  written	   in	  preparation	   for	  manuscript	   submission	   to	   the	  
journal	  Nature	  Cell	  Biology	  as	  a	  Resource	  article.	  Dr.	  Zon	  encouraged	  me	  to	  use	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  style	  as	  it	  would	  facilitate	  the	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   I	   have	   performed	   all	   the	   experiments	   described	   in	   this	   chapter.	   This	  
included	  the	  design	  of	  the	  screen,	  curation	  of	  the	  gene	  list,	  bioinformatic	  analysis	  
of	  the	  chromatin	  factors	  in	  zebrafish,	  microinjection	  of	  morpholinos,	  WISH,	  and	  
analysis	   of	   the	   data.	   Katie	   Kathrein	   assisted	   with	   curation	   of	   the	   gene	   list,	  
bioinformatic	   analysis	   of	   the	   chromatin	   factors	   in	   zebrafish,	   microinjection	   of	  
morpholinos,	   and	   data	   analysis.	   Abby	   Barton	   and	   Zachary	   Gitlin	   assisted	  with	  
microinjection	   of	   morpholinos,	   WISH,	   and	   data	   collection.	   Yue-­‐Hua	   Huang	  
assisted	  with	  microinjections	  of	  morpholinos.	  Yi	  Zhou	  collected	  and	  curated	  the	  
preliminary	  list	  of	  human	  chromatin	  factors	  from	  public	  databases	  and	  assisted	  
with	   bioinformatic	   analysis	   of	   the	   chromatin	   factors.	   Anhua	   Song	   assisted	   by	  
Anthony	   DiBiase	   constructed	   the	   chromatin	   factor	   database	   and	   uploaded	  
results	  from	  the	  screen.	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Introduction	  
The	   programs	   of	   gene	   expression	   required	   for	   maintenance	   and	  
differentiation	  of	  a	  cell	   type	  are	  tightly	  regulated	  by	  a	  network	  of	   transcription	  
factors	   and	  associated	   complexes	   that	   include	   chromatin	  modifying	   factors.	  To	  
orchestrate	  the	  correct	  sequence	  of	  events	  required,	  transcription	  factors	  recruit	  
chromatin	   modifying	   factors	   to	   facilitate	   or	   inhibit	   gene	   expression.	   The	  
epigenetic	   information	   consists	   of	   chemical	  modifications	   to	   cytosine	   bases	   in	  
the	   DNA	   and	   histone	   proteins	   that	   fold	   the	   DNA	   into	   nucleosomes,	   and	   the	  
nucleosomes	   themselves	   can	   then	   be	   repositioned,	   dissociated,	   and/or	  
reconstituted	  (Li	  et	  al	  2007).	  All	  these	  chromatin	  alterations	  are	  carried	  out	  by	  a	  
specific	  set	  of	  conserved	  domains	   found	  on	  chromatin	   factors.	  Mouse	  knockout	  
models	   and	   zebrafish	  mutants	   of	   several	   chromatin	   factors	   have	   been	   used	   to	  
investigate	   the	   role	   of	   chromatin	   factors	   in	   vertebrate	   development,	   but	   the	  
majority	  of	  the	  chromatin	  factors	  have	  not	  been	  characterized	  in	  this	  manner.	  	  
Hematopoiesis	  is	  a	  well	  characterized	  process	  encompassing	  the	  formation	  
of	   hematopoietic	   stem	   cells	   (HSCs)	   and	   their	   subsequent	   specialization	   to	  
become	  multilineage	  progenitors	  that	  generate	  terminally	  differentiated	  cells	  of	  
all	  the	  peripheral	  blood	  lineages.	  The	  blood	  program	  is	  initiated	  during	  the	  early	  
stages	   of	   embryonic	   development,	   and	   the	   master	   transcriptional	   regulators	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controlling	  hematopoiesis	  have	  been	  identified.	  Genes	  known	  to	  be	  required	  for	  
stem	  cell	  production,	  survival,	  or	  self-­‐renewal	  of	  HSCs	  include	  Runx1,	  Scl,	  Lmo2,	  
Mll,	   and	   Bmi1.	   Upon	   formation,	   the	   quiescent	   HSCs	   begin	   to	   differentiate	   into	  
lineage	   restricted	   progenitors.	   GATA1,	   PU.1,	   and	   Ikaros	   are	   among	   key	  
transcription	   factors	   required	   for	   commitment	   to	   the	   erythroid,	   myeloid,	   and	  
lymphoid	   lineages,	   respectively	   (Orkin	   and	   Zon	   2008).	   In	   contrast	   to	  
transcriptional	  regulators,	  few	  chromatin	  factors	  have	  been	  studied	  for	  their	  role	  
in	   hematopoiesis,	   but	   several	   have	   been	   identified	   as	   leukemic	   translocation	  
partners,	  underscoring	  the	  importance	  they	  have	  in	  normal	  development	  of	  the	  
tissue	  (Rice	  et	  al	  2007).	  
In	  order	  to	  generate	  a	  comprehensive	  list	  of	  chromatin	  factors	  with	  a	  role	  in	  
hematopoiesis,	  we	  have	  undertaken	  a	   large-­‐scale	   in	  vivo	   reverse	  genetic	  screen	  
targeting	   zebrafish	   homologs	   of	   425	   human	   chromatin	   factors	   to	   identify	  
epigenetic	  regulators	  of	  developmental	  hematopoiesis.	  The	  zebrafish	  provides	  a	  
suitable	   platform	   for	   rapid	   high-­‐throughput	   screening	   to	   assay	   the	   function	   of	  
chromatin	   factors	   in	   blood	   development	   due	   to	   their	   high	   fecundity,	   rapid	  
development,	   conservation	   of	   hematopoiesis,	   and	   ease	   of	   genetic	   knockdowns	  
using	   morpholinos.	   We	   have	   identified	   at	   least	   47	   factors	   that	   affect	  
hematopoietic	  development	  of	  primitive	  and	  definitive	  blood,	   including	  28	  new	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factors	   that	   have	   yet	   to	   be	   associated	   with	   blood	   formation.	   We	   have	   also	  
characterized	  the	  distinct	  stages	  of	  hematopoiesis	  at	  which	  these	  factors	  play	  a	  
role,	   the	   majority	   of	   which	   function	   at	   the	   stem	   and	   progenitor	   level.	  
Furthermore,	  we	  provide	  an	  example	  of	  a	  chromatin	  factor	  combination	  that	  can	  
greatly	   increased	   expression	   of	   stem	   and	   progenitor	   genes	   c-­myb	   and	   runx1,	  
providing	  evidence	  for	  functional	  protein	  complex	  associations	  based	  on	  known	  
protein	   interaction	   data.	   Taken	   together,	   our	   screen	   provides	   a	   valuable	  





	   To	  generate	  a	  complete	  compendium	  of	  factors	  that	  establish	  the	  epigenetic	  
code	  during	  developmental	  hematopoiesis,	  we	  have	  undertaken	   the	   first	   large-­‐
scale	   in	   vivo	   reverse	   genetic	   screen	   targeting	   chromatin	   factors	   (Figure	   2-­‐1A).	  
We	  designed	  antisense	  oligonucleotide	  morpholinos	   to	  knock	  down	  expression	  
of	   487	   zebrafish	   homologs	   of	   425	   human	   chromatin	   factors.	   Our	   gene	   list	  
comprises	   most	   of	   the	   known	   human	   factors	   containing	   chromatin	   binding,	  
modifying,	   or	   remodeling	   domains	   curated	   from	   several	   public	   databases:	  
CREMOFAC,	  SMART	  domain	  by	  NRDB,	  CDD	  at	  NCBI,	  Pfam,	  and	  ChromDB.	  Using	  
comparative	  genomics,	  homologous	  genes	  in	  zebrafish	  were	  retrieved	  by	  BLAST	  
search	  of	  the	  unique	  human	  protein	  sequences	  into	  the	  zebrafish	  genome.	  	  
	   Morpholinos	   for	   each	   chromatin	   factor	   were	   injected	   into	   single	   cell	  
embryos,	   and	   a	   portion	   of	   the	   embryos	   collected	  were	   set	   aside	   as	   uninjected	  
wild-­‐type	   controls.	   Each	  morpholino	  was	   injected	  at	   three	   concentrations.	   In	   a	  
series	   of	   pilot	   experiments	   knocking	   down	   the	   eight	   known	   zebrafish	   DNA	  
methyltransferase	   genes	   with	   ATG	   and	   splicing	   morpholinos,	   we	   have	  
determined	  the	  optimal	  dose	  range	  for	  ATG	  morpholinos	  to	  be	  2,	  4,	  and	  6	  ng	  and	  
for	  splicing	  morpholinos	  to	  be	  4,	  8,	  and	  12	  ng	  (Shimoda	  et	  al	  2005).	  These	  doses	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typically	   give	   a	   range	   of	   phenotypes	   from	   a	   hypomorph	   to	   a	   complete	  
knockdown	   for	   most	   mRNA	   products,	   similar	   to	   an	   allelic	   series.	   For	  
morpholinos	   that	   induced	   severe	   morphological	   effects	   at	   this	   dose	   range,	  
appropriate	  dilutions	  were	  made	  and	  the	  morpholino	  was	  rescreened	  at	  a	  lower	  
dose	  (see	  Methods).	  
	   Post-­‐injection,	  the	  embryos	  were	  grown	  to	  the	  proper	  developmental	  stage	  
and	   collected	   to	   assay	   for	   hematopoietic	   defects	   by	   whole-­‐mount	   in	   situ	  
hybridization	   (WISH).	  We	   conducted	   two	   screens	   simultaneously	   for	   primitive	  
and	   definitive	   blood	   formation.	   For	   the	   primitive	   screen,	   developing	  
erythrocytes	  were	  assayed	  by	  β-­globin	  e3	  expression	  at	  the	  16	  somite	  stage	  (ss),	  
or	  17	  hours	  post-­‐fertilization	  (hpf),	   in	   the	  posterior	   tail	  of	   the	  embryo.	  For	   the	  
definitive	  screen,	   the	  establishment	  of	  hematopoietic	  stem	  and	  progenitor	  cells	  
(HSPCs)	   in	   the	   aorta,	   gonad,	  mesonephros	   (AGM)	   region	  was	   detected	  with	   c-­
myb	  and	  runx1	  expression	  at	  36	  hpf	  (Figure	  2-­‐1B).	  Changes	   in	  gene	  expression	  
were	  evaluated	  by	  comparing	  morphants,	  embryos	  injected	  with	  morpholinos,	  to	  
their	   corresponding	   uninjected	   wild-­‐type	   controls,	   and	   the	   results	   for	   each	  
injection	   were	   determined	   based	   on	   a	   minimum	   of	   65%	   of	   the	   embryos	  
exhibiting	  the	  same	  phenotype.	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Classification	  of	  screen	  results.	  
	   According	   to	   the	   expression	   phenotypes	   observed,	   the	   morphants	   were	  
divided	  into	  three	  major	  categories:	  no	  change,	  decrease,	  or	  increase.	  Due	  to	  the	  
range	   of	   decreased	   staining	   from	   subtle	   reduction	   to	   complete	   absence	   of	  
staining,	   we	   further	   subdivided	   the	   decrease	   category	   into	  mild,	   intermediate,	  
and	   strong	   (Figure	   2-­‐2).	   Morphants	   with	   developmental	   abnormalities	   were	  
listed	  separately	  (Supplementary	  Figure	  2-­‐1).	  Any	  morphant	  showing	  changes	  in	  
blood	   marker	   expression	   were	   considered	   screen	   hits.	   We	   reasoned	   that	  
morphologically	   normal	   morphants	   that	   showed	   the	   strongest	   decrease	   or	  
increase	   in	   blood	   formation	   represented	   genes	   that	   were	   most	   likely	   to	   be	  
specific	  to	  blood	  development.	  The	  25	  and	  47	  morphants	  from	  the	  primitive	  and	  
definitive	  primary	  screen	  hits,	  respectively,	  that	  met	  these	  critieria	  were	  selected	  
for	  further	  analysis.	  
	  
Chromatin	   factors	   regulate	   primitive	   blood	   development	   from	   the	  
mesoderm.	  
	   To	   confirm	   the	   phenotype	   from	   the	   primary	   screen	   and	   characterize	  
additional	  blood	  defects,	  morpholinos	  were	  reinjected	  and	  screened	  for	  changes	  
in	  β-­globin	  e3,	  scl,	  and	  gata1	  expression.	  Of	  the	  25	  primary	  hits,	  knockdown	  of	  13	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chromatin	  factors	  reduced	  β-­globin	  e3	  expression	  while	  depletion	  of	  another	  12	  
factors	  increased	  β-­globin	  e3	  expression	  at	  17	  hpf.	  18	  of	  the	  25	  primary	  hits	  were	  
verified	   in	   which	   knockdown	   of	   7	   factors	   resulted	   in	   a	   strong	   reduction	   of	   β-­
globin	  e3	  expression	  while	  knockdown	  of	  the	  other	  11	  factors	  increased	  β-­globin	  
e3	  expression	  (Supplementary	  Table	  1).	  
	   To	  determine	  the	  earliest	  step	  in	  blood	  development	  that	  is	  affected	  in	  the	  
primitive	  wave	  morphants,	  we	  examined	  scl	  and	  gata1	  expression	  changes	  at	  10-­‐
12	  ss	  (14	  hpf)	  for	  formation	  of	  mesodermal	  precursor	  and	  erythroid	  progenitors,	  
respectively	   (Figure	   2-­‐3).	   15	   morphants	   showed	   changes	   in	   scl	   and	   gata1	  
expression	  consistent	  with	  the	  changes	  in	  β-­globin	  e3,	  such	  as	  smarca1	  and	  cicl,	  
suggesting	  that	  most	  of	  the	  factors	  categorized	  in	  the	  strong	  decrease	  or	  increase	  
categories	  play	  a	  role	  in	  the	  formation	  of	  mesodermal	  precursors	  competent	  to	  
make	   blood.	   The	   remaining	   3,	   chrac1,	   actr2b,	   and	   hdac9b,	   had	   normal	   scl	  
expression	  but	   reduced	  gata1	   and	  β-­globin	  e3	   expression,	   indicating	   that	   these	  
factors	   function	   at	   the	   next	   step	   in	   regulating	   the	   formation	   of	   erythroid	  
progenitors	  from	  the	  mesoderm.	  Most	  of	  the	  factors	  represent	  novel	  regulators	  
of	  erythroid	  development	  since	  only	  Zfat,	  HDAC9,	   and	  ASH2L	  have	  been	  shown	  
previously	  to	  be	  required	  for	  globin	  gene	  expression	  or	  erythroid	  development	  
(Kim	  et	  al	  2007,	  Muralidhar	  et	  al	  2011,	  Tsunoda	  et	  al	  2010).	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Chromatin	  factors	  regulate	  the	  induction	  of	  HSPCs.	  
	   As	  in	  the	  primitive	  screen,	  we	  re-­‐screened	  47	  definitive	  primary	  screen	  hits	  
to	   confirm	  and	  characterize	  additional	  HSPC	  phenotypes.	   Injection	  of	  41	  and	  6	  
morpholinos	   resulted	   in	   decreased	   and	   increased	   c-­myb	   and	   runx1	   staining,	  
respectively,	  in	  the	  AGM	  at	  36	  hpf.	  Of	  the	  29	  morpholinos	  that	  were	  validated,	  24	  
were	   strongly	   reduced	   and	   5	   increased	   c-­myb	   and	   runx1	   expression	  
(Supplementary	  Table	  2).	  
Previous	   work	   has	   shown	   that	   proper	   vessel	   development	   and	  
establishment	   of	   artery	   identity	   are	   important	   for	   AGM	   stem	   cell	   induction	  
(Burns	   et	   al	   2009,	   Lawson	   et	   al	   2003).	   Thus	   the	   expression	   of	   the	   vascular	  
marker	   flk	   and	   the	  arterial	   identity	  marker	  ephrinB2	  were	  analyzed	   for	   the	  29	  
verified	  hits.	  22	  morphants,	  the	  majority	  of	  those	  examined,	  showed	  normal	  flk	  
and	  ephrinB2	  expression,	   indicating	  that	   the	  chromatin	   factors	   identified	   in	  the	  
strong	   decrease	   and	   increase	   categories	   function	   in	   the	   specification	   or	  
maintenance	   of	  HSPCs	   from	   the	   hemogenic	   endothelium	   (Figure	   2-­‐4).	   Some	  of	  
these	   factors	   have	   been	   shown	   to	   regulate	  HSC	   self-­‐renewal,	   like	   Prdm16	   and	  
HDACs	  (MacMahon	  et	  al	  2007,	  Chuikov	  et	  al	  2010,	  Aguilo	  et	  al	  2011,	  Young	  et	  al	  
2004).	  This	   indicates	   the	  possibility	   that	  other	   factors	   in	   this	   same	  phenotypic	  
category	   represent	  potential	   new	  candidates	   required	   for	  HSC	  maintenance,	   of	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which	  few	  are	  known.	  	  
The	  remaining	  7	  chromatin	  factors	  were	  found	  to	  function	  at	  earlier	  stages	  
of	   HSPC	   specification	   based	   on	   their	   vascular	   defects.	   There	   were	   4	   factors,	  
hdac4l,	   mier1b,	   phf21a,	   and	   suv39h1,	   with	   normal	   flk	   but	   ephrinB2	   expression	  
was	  reduced,	  suggesting	  that	  they	  function	  at	  an	  earlier	  step	  in	  the	  establishment	  
of	  aorta	  identity	  required	  for	  proper	  HSPC	  formation.	  SUV39H1	  has	  been	  shown	  
to	  be	  recruited	  by	  multiple	  hematopoietic	   transcription	  factors,	  such	  as	  RUNX1	  
and	  PU.1,	  to	  repress	  target	  genes,	  and	  our	  results	  indicate	  that	  it	  is	  also	  required	  
at	   the	   earlier	   hemogenic	   endothelium	   stage	   as	   well	   (Chakraborty	   et	   al	   2003,	  
Stopka	   et	   al	   2005).	   Finally,	   3	  morphants,	  mier1,	   jhdm1bb,	   and	   rbbp7,	   lost	   both	  
intersomitic	   flk	   and	   arterial	   ephrinB2	   expression,	   hence	   the	   loss	   of	   HSPCs	   in	  
these	  morphants	  is	  likely	  due	  to	  the	  absence	  of	  a	  hemogenic	  endothelium.	  These	  
results	   are	   consistent	   with	   data	   showing	   an	   interaction	   between	   RBBP7	   and	  
TAL1/SCL	   via	   the	   LSD1	   histone	   demethylase	   complex,	   and	   scl	   is	   required	   for	  
both	  endothelial	  and	  blood	  formation,	  hence	  the	  loss	  of	  HSPCs	  in	  the	  morphants	  
may	   be	   related	   to	   loss	   of	   scl	   function	   in	   the	   absence	   of	   rbbp7	   (Hu	   et	   al	   2009,	  
Patterson	   et	   al	   2005).	   Of	   the	   47	   factors	   that	   we	   characterized,	   this	   class	   of	  
morphants	   was	   surprisingly	   rare	   given	   how	   broadly	   chromatin	   factors	   are	  
believed	   to	   function.	   This	   suggests	   that	   the	   chromatin	   factors	   identified	   in	   our	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screen	   have	   very	   specific	   effects	   on	   the	   formation	   of	   HSPCs.	   Overall,	   our	  
definitive	   chromatin	   factor	   screen	   identified	   many	   new	   potential	   regulators	  
specifically	  involved	  in	  the	  development	  of	  HSPCs	  from	  the	  AGM.	  
	  
ISWI	  chromatin	  remodeling	  is	  essential	  for	  hematopoiesis.	  
One	  of	  the	  most	  striking	  phenotypes	  we	  observed	  came	  from	  knockdown	  of	  
smarca1	  in	  the	  primitive	  screen.	  smarca1,	  or	  snf2l,	  is	  the	  catalytic	  subunit	  of	  ISWI	  
complex	  and	  had	  the	  most	  reduction	  in	  β-­globin	  e3	  expression	  of	  all	  the	  factors	  
examined	  in	  the	  primitive	  blood	  analysis.	  We	  found	  that	  high	  levels	  of	  smarca1	  
knockdown	  abolished	  all	  scl	  expression	  at	  10	  ss	  (14	  hpf),	  consistent	  with	  the	  loss	  
of	   gata1+	   and	   β-­globin	   e3+	   cells	   in	   these	   morphants.	   The	   loss	   of	   primitive	   scl	  
expression	  would	   also	   impair	   definitive	   blood	   formation	   since	   these	   early	   scl+	  
cells	   have	   been	   shown	   to	   contribute	   to	   definitive	   hematopoiesis	   as	   well	  
(Supplementary	  Figure	  2-­‐2A)	  (Dooley	  et	  al	  2005).	  Because	  loss	  of	  smarca1	  also	  
impairs	   embryonic	   development,	  we	   injected	   smarca1	   at	   lower	   doses	   to	   allow	  
embryos	  to	  develop	  to	  36	  hpf	  and	  were	  able	  to	  confirm	  loss	  of	  c-­myb	  and	  runx1	  
expression	   in	   the	   AGM	   (Supplementary	   Figure	   2-­‐2B).	   These	   results	   are	  
consistent	   with	   a	   study	   in	   which	   depletion	   of	   SMARCA5	   (SNF2H),	   the	   other	  
catalytic	   subunit	   that	   forms	   distinct	   ISWI	   complexes	   from	   SNF2L,	   prevents	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erythroid	  differentiation	  of	  CD34+	  human	  hematopoietic	  progenitors	  and	  results	  
in	  embryonic	  lethality	  by	  E7.5	  (Stopka	  and	  Skoultchi	  2003).	  In	  addition,	  2	  other	  
genes	  associated	  with	   ISWI	   chromatin	   remodeling,	  chrac1	   and	  rsf1b,	  were	  also	  
identified	   as	   a	   primitive	   screen	   in	   the	   same	   category	   as	   smarca1,	   suggesting	   a	  
possible	   interaction	   between	   the	   3	   factors	   as	   part	   of	   the	   ISWI	   chromatin	  
remodeling	  complex	  in	  primitive	  blood.	  Taken	  together,	  our	  study	  suggests	  that	  
zebrafish	   smarca1	   is	   the	   functional	   homolog	   of	   SMARCA5	   in	   mice,	   and	   it	   is	  
essential	  for	  hematopoietic	  development.	  
	  
Chromatin	  factor	  complex	  subunits	  are	  conserved.	  
	   Given	   that	   chromatin	   factors	  often	   function	   in	  multisubunit	   complexes,	  we	  
hypothesized	   that	   we	   could	   identify	   chromatin	   complexes	   important	   for	  
hematopoietic	   development	   by	   mapping	   known	   protein	   interactions	   between	  
the	  different	  chromatin	  factors	  found	  in	  our	  screen	  hits.	  We	  used	  the	  18	  and	  29	  
strongest	   hits	   from	   the	   primitive	   and	   definitive	   screens,	   respectively,	   as	   the	  
center	  of	  a	  “hub”	  and	  added	  additional	  subunits	  that	  were	  also	  found	  as	  hits	   in	  
other	   phenotypic	   categories	   of	   our	   screen	   (Figure	   2-­‐5).	   The	   results	   confirmed	  
that	  multiple	  subunits	  of	  the	  same	  complex	  are	  represented	  in	  our	  gene	  list.	  The	  
definitive	   chromatin	   factor	   hits	   encompass	   a	   wide	   range	   of	   chromatin	   factor	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complexes,	   BAF/PBAF,	   SET1,	   NuRD/SIN3A/HDAC,	   NuA4/HAT,	   P300/CBP,	   and	  
PRC1/PRC2.	  In	  contrast,	  a	  smaller	  number	  of	  complexes	  was	  represented	  in	  the	  
primitive	   list,	   most	   of	   them	   overlapping	   with	   the	   ones	   identified	   from	   the	  
definitive	  list	  such	  as	  BAF/PBAF	  and	  SET1.	  A	  different	  HAT1	  complex	  HBO1	  was	  
present	  in	  the	  primitive	  list,	  but	  it	  still	  functions	  in	  acetylation.	  Moreover,	  fewer	  
of	   the	   subunits	   in	   the	   primitive	   complexes	   were	   also	   identified	   as	   hits	   in	   the	  
primitive	   screen.	   This	   comparison	   suggests	   that	   primitive	   hematopoiesis	  
employs	  only	  a	  subset	  of	  the	  chromatin	  factor	  complexes	  used	  during	  definitive	  
hematopoiesis.	   This	   may	   reflect	   an	   increased	   complexity	   in	   the	   regulation	   of	  
definitive	  stem	  cells	  given	  their	  ability	  to	  self-­‐renew	  and	  generate	  all	   the	  blood	  
lineages.	  
We	  tested	  whether	  knockdown	  of	  multiple	  subunits	  reportedly	  in	  the	  same	  
complex	  could	  enhance	  the	  hematopoietic	  phenotype	  when	  combined.	  CHD7	  and	  
ARID2	   have	   been	   shown	   to	   participate	   in	   the	   PBAF	   chromatin	   remodeling	  
complex	   in	   human	   neural	   crest	   stem	   cells,	   and	   both	   chd7	   and	   arid4b	   were	  
definitive	   screen	  hits	   that	   increased	  HSPC	   formation	   (Bajpai	   et	   al	   2010).	  arid2	  
and	   arid4b	   belong	   to	   the	   same	   family	   of	   AT-­‐rich	   interacting	   domain	   (ARID)	  
containing	  factors,	  thus	  we	  tested	  whether	  knockdown	  of	  both	  chd7	  and	  arid4b	  
could	   enhance	   the	   individual	   morphant	   phenotypes.	   Indeed,	   there	   was	   a	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dramatic	   increase	   of	   c-­myb+	   and	   runx1+	   cells	   in	   the	   AGM	   at	   the	   expense	   of	   flk	  
expression	   in	   the	   double	   morphants	   (Supplementary	   Figure	   2-­‐3).	   Given	   the	  
staining	  patterns	  with	  normal	  flk	  in	  the	  head,	  it	  is	  likely	  that	  all	  the	  vascular	  cells	  
in	   the	   tail	   competent	   to	   produce	   blood	   have	   been	   induced	   to	   express	  
hematopoietic	  genes.	  Although	  we	  cannot	  exclude	  the	  possibility	   that	  chd7	  and	  
arid4b	   function	   in	   parallel,	   our	   results	   suggest	   the	   possibility	   that	   chromatin	  
factors	   identified	   in	   our	   screen	   reported	   to	   function	   in	   the	   same	   complex	   in	  
mammalian	   systems	   synergize	   to	   enhance	   the	   blood	   phenotype	   in	   our	  
morphants,	  providing	  in	  vivo	  evidence	  for	  the	  role	  of	  these	  chromatin	  complexes	  
in	  regulating	  distinct	  steps	  of	  hematopoietic	  development.	  
	  
Other	   categories	   of	   screen	   hits	   with	   milder	   phenotypes	   also	   function	   in	  
blood	  development.	  	  
In	   addition	   to	   the	   chromatin	   factors	   with	   strong	   decrease	   or	   increase	  
phenotypes,	   primitive	   screen	   hits	   with	   milder	   reductions	   in	   β-­globin	   e3	  
expression	   were	   also	   found	   to	   function	   at	   different	   stages	   of	   erythroid	  
differentiation.	   We	   characterized	   the	   7	   chromatin	   factors	   from	   the	   primitive	  
screen	   that	   were	   not	   verified	   because	   they	   showed	   only	   an	   intermediate	  
decrease	   in	   β-­globin	   e3	   expression	   upon	   reinjection,	   and	   we	   observed	   that	   6	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morphants	  had	  normal	  scl	  but	  reduced	  gata1	  expression.	  These	  results	  suggests	  
that	   the	  6	  chromatin	   factors	   likely	   function	  at	   the	  erythroid	  specification	  stage.	  
CHD4	   and	  CBX8,	   2	   of	   the	   6	   factors,	   have	   already	  been	   shown	   to	   be	   associated	  
with	   the	   FOG1/GATA1	   transcriptional	   complex	   and	   the	   TIF1-­‐γ	   elongation	  
complex,	  respectively,	   that	  are	  known	  key	  regulators	  of	  erythroid	  development	  
(Bai	   et	   al	   2010,	   Hong	   et	   al	   2005).	   The	   last	   one	   of	   the	   7	   factors	   tested,	   kat5,	  
showed	  only	  a	  decrease	  in	  β-­globin	  e3	  without	  loss	  of	  scl	  and	  gata1	  expression,	  
indicating	   that	   it	  plays	  a	  role	   in	  erythroid	  cell	  differentiation.	   In	  comparison	   to	  
the	  18	  strong	  hits,	  the	  remaining	  chromatin	  factors	  likely	  function	  at	  later	  stages	  
of	  erythropoiesis	  after	  induction	  of	  the	  scl+	  mesoderm.	  
Given	   that	  most	  of	   the	   strongest	  definitive	  hits	  did	  not	   show	  any	  vascular	  
defects,	   morphants	   in	   other	   categories	   with	   milder	   reductions	   in	   c-­myb	   and	  
runx1	  expression	  would	  have	  normal	  vasculature	  as	  well.	  As	  predicted,	  of	  the	  11	  
morphants	  tested	  in	  the	  intermediate	  decrease	  category,	  we	  did	  not	  observe	  any	  
defects	   in	   flk	   and	   ephrinB2	   expression.	   Collectively,	  we	   have	   identified	   a	   large	  





Hematopoietic	   stem	   cells	   undergo	   proliferation	   and	   differentiation	   under	  
the	  control	  of	   cell-­‐specific	   transcription	   factors	  whose	   function	   is	   facilitated	  by	  
chromatin	  factors.	  These	  factors	  establish	  an	  epigenetic	  landscape	  that	  controls	  
self-­‐renewal	   at	   the	   same	   time	   as	   providing	   lineage	   priming	   to	   drive	  
differentiation.	   In	   an	   effort	   to	   better	   understand	   the	   epigenetic	   regulation	   of	  
blood	  stem	  cells,	  we	  undertook	  a	  genetic	  approach	  to	  define	  the	  function	  of	  most	  
of	   the	   chromatin	   factors	   in	   the	   zebrafish	   genome.	   A	   library	   of	   zebrafish	   genes	  
homologous	  425	  human	  chromatin	  factors	  were	  identified,	  and	  these	  genes	  were	  
targeted	   by	   morpholinos	   to	   suppress	   gene	   expression.	   Our	   library	   contains	  
canonical	   ‘readers,’	   ‘writers,’	   and	   ‘erasers’	   of	   chromatin	   as	   well	   as	   less	  
characterized	   domain	   families.	   The	   large	   numbers	   of	   zebrafish	   embryos	  
produced	  allowed	  the	  screening	  of	  such	  a	  large	  number	  of	  genes.	  We	  identified	  a	  
cohort	  of	  18	  factors	  that	  directly	  regulate	  primitive	  hematopoiesis	  and	  29	  factors	  
that	  are	  essential	  for	  definitive	  hematopoiesis,	  and	  they	  include	  both	  known	  and	  
novel	  regulators	  of	  hematopoiesis.	  
In	   our	   investigation	   of	   the	   primitive	  wave	   of	   hematopoiesis,	   we	   analyzed	  
expression	   of	   the	   embryonic	   globin	   gene,	   β-­e3,	   upon	   chromatin	   factor	  
knockdown.	   From	   this	   work,	   we	   identified	   7	   genes	   that	   resulted	   in	   nearly	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complete	   loss	   of	   globin	   staining	   and	   11	   that	   caused	   an	   increase.	   Only	   3	   genes	  
from	   either	   category	   have	   defined	   roles	   in	   hematopoiesis.	   Most	   of	   these	  
chromatin	   factors	  regulate	   the	   formation	  of	  hematopoietic	  precursors	   from	  the	  
mesoderm	   since	   15	   of	   the	   18	   factors	   showed	   changes	   in	   both	   scl	   and	   gata1	  
expression	  consistent	  with	  the	  β-­globin	  e3	  phenotype.	  All	  other	  primitive	  screen	  
hits	   likely	   function	   at	   later	   stages	   of	   erythroid	   progenitor	   specification	   and	  
differentiation	  given	  that	  only	  gata1+	  and/or	  β-­globin	  e3+	  cells	  were	  affected.	  In	  a	  
recent	  study	  investigating	  the	  histone	  modifications	  on	  differentiating	  erythroid	  
cells	  in	  mouse	  fetal	  liver,	  five	  histone	  marks	  were	  induced	  during	  this	  transition,	  
H3K4me2,	  H3K4me3,	  H3K9Ac,	  H4K16Ac,	  and	  H3K79me2	  (Wong	  et	  al	  2011).	  Our	  
strongest	   primitive	   hits	   is	   composed	   of	   chromatin	   factors	   involved	   in	  
methylation	  and	  acetylation	  of	  histones,	  including	  H3K4	  methylation,	  consistent	  
with	  the	  mouse	  findings.	  These	  data	  support	  the	  current	  model	  that	  methylation	  
and	  acetylation	  marks	  have	  the	  most	  functional	  impact	  on	  transcription.	  
For	  our	  study	  of	  definitive	  hematopoiesis,	  we	  examined	  expression	  of	  HSPC	  
markers	  c-­myb	   and	  runx1	  after	  knockdown	  of	   chromatin	   factors.	  We	   identified	  
24	   genes	   that	   greatly	   reduced	   and	   5	   that	   increased	   the	   number	   of	   c-­myb+	  and	  
runx1+	  cells	  in	  the	  AGM.	  A	  number	  of	  these	  genes	  have	  been	  shown	  previously	  to	  
regulate	  HSC	  function,	   including	  prdm16,	  p300,	  crebbp,	   jhdm1b,	  and	  hdacs.	  Still,	  
 48 
over	  half	  of	  the	  gene	  list	  represents	  putative	  novel	  chromatin	  factors	  important	  
for	   HSPC	   regulation	   and	   includes	   includes	   interesting	   factors	   such	   as	   the	  
nucleosome	  remodeler	  nap1l4	  and	  components	  of	  the	  SET1	  chromatin	  complex,	  
cxxc1l	   and	   setd1ba,	   which	   has	   been	   shown	   to	   interact	   with	   MLL	   complexes.	  
Although	  a	  similar	  study	  characterizing	  changes	  in	  histone	  marks	  during	  various	  
stages	  of	  definitive	  HSC	  formation	  has	  not	  been	  done,	  we	  predict	   that	   they	  will	  
include	  histone	  modifications	   such	  as	  methylation	  of	  H3K4,	  H3K9,	   and	  H3K36,	  
and	   acetylation	   as	   well	   based	   on	   the	   chromatin	   factors	   identified	   from	   the	  
screen.	  	  
	   Interestingly,	   disruption	   of	   both	   positive	   and	   negative	   regulators	   of	  
chromatin	   frequently	   resulted	   in	   the	   same	   reduced	   marker	   expression	  
phenotype	  in	  our	  screen.	  For	  example,	  knockdown	  of	  p300,	  which	  functions	  in	  a	  
complex	   to	   acetylate	   histones,	   and	   hdac6,	   which	   deacetylates	   histones,	   each	  
resulted	  in	  loss	  of	  c-­myb+	  and	  runx1+	  cells	  in	  the	  AGM.	  While	  these	  genes	  encode	  
proteins	  that	   likely	  serve	  opposing	  roles	  in	  regulation	  of	  their	  respective	  target	  
genes,	  their	  functions	  are	  both	  required	  for	  proper	  HSC	  specification.	  These	  data	  
are	   in	   concordance	   with	   more	   recent	   discoveries	   that	   transcription	   factors	  
recruit	   both	   positive	   and	   negative	   regulators	   to	   activate	   and	   repress	   target	  
genes,	  respectively,	  which	  has	  been	  shown	  for	  GATA1	  (Blobel	  et	  al	  1998,	  Hong	  et	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al	  2005,	  Kadam	  and	  Emerson	  2003,	  Rodriguez	  et	  al	  2005).	  
Another	   interesting	   observation	   from	   our	   screen	   is	   that	   two	   factors	   with	  
similar	  functions,	  namely	  p300	  and	  crebbp,	  showed	  opposing	  phenotypes.	  P300	  
and	   CBP	   are	   homologous	   proteins	   that	   share	   a	   bromodomain	   and	   histone	  
acetyltransferase	  domain	  (Ogryzko	  et	  al	  1996,	  Bannister	  and	  Kouzarides	  1996).	  
They	   interact	   with	   a	   wide	   variety	   of	   transcription	   factors,	   regulate	   different	  
cellular	   functions,	   and	   are	   targets	   of	   leukemic	   chromosomal	   translocations	  
(Blobel	  2000,	  Rice	  et	  al	  2007).	  Mouse	  knockouts	  of	  P300	  and	  Cbp	  exhibit	  similar	  
phenotypes	  (Yao	  et	  al	  1998).	  Despite	  their	  largely	  overlapping	  roles,	  evidence	  of	  
differential	   regulation	   has	   been	   accumulating	   (Kalkhoven	   2004).	   In	   HSCs,	   Cbp	  
plays	   an	   important	   role	   in	   HSC	   self-­‐renewal	   whereas	   P300	   regulates	   HSC	  
differentiation,	   and	   these	   results	   are	   supported	   by	   recent	   ChIP-­‐seq	   results	  
indentifying	   distinct	   binding	   sites	   between	   the	   two	   factors	   (Ramos	   et	   al	   2010,	  
Rebel	  et	  al	  2002).	  Taken	  together,	  our	  results	  suggest	  that	  the	  effect	  chromatin	  
factors	  have	   in	  vivo	   cannot	  be	  predicted	  based	  solely	  on	  their	  domain	   function,	  
thus	  future	  studies	  of	  chromatin	  factors	  in	  the	  context	  of	  development	  would	  be	  
important	  for	  our	  understanding	  of	  chromatin	  regulation	  and	  gene	  expression.	  
Of	   the	   47	   genes	   that	   we	   characterized	   for	   primitive	   and	   definitive	   blood	  
formation,	   the	   majority	   could	   be	   mapped	   to	   known	   chromatin	   modifying	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complexes:	   histone	   methylation/demethylation	   (SET1A/MLL	   and	   PRC	  
complexes,	  Jmj	  proteins),	  histone	  acetylation/deacetylation	  (HDAC/NuRD/Sin3A	  
and	   NuA4	   complexes),	   and	   nucleosome	   remodeling	   (SWI/SNF	   and	   ISWI	  
complexes).	   For	   other	   chromatin	   factors	   that	   could	   not	   be	  mapped	   because	   of	  
the	   lack	   of	   protein	   interaction	   data,	   it	   is	   still	   possible	   that	   they	   may	   also	   be	  
associated	   with	   these	   complexes.	   Based	   on	   genome-­‐wide	   histone	   mark	   and	  
nucleosome	   localization	  studies,	   these	  modifications	  are	  highly	   correlated	  with	  
the	   transcriptional	   status	   of	   a	   gene	   (Mikkelsen	   et	   al	   2007,	   Schones	   et	   al	   2008,	  
Schübeler	   et	   al	   2004).	   Though	   this	   does	   not	   exclude	   the	   possibility	   that	   other	  
marks	  such	  as	  histone	  phosphorylation	  may	  be	  important	  for	  the	  development	  of	  
other	   tissues,	   our	   findings	   provide	   in	   vivo	   evidence	   that	   these	   chromatin	  
modifications	  have	  the	  most	  important	  functional	  impact	  on	  hematopoiesis.	  
Although	   a	   number	   of	   chromatin	   factors	   identified	   in	   both	   primitive	   and	  
definitive	   blood	   screens	   have	   no	   known	   function	   in	   hematopoiesis,	   new	  
hypotheses	   regarding	   the	   subunit	   composition	   of	   the	   chromatin	   factor	  
complexes	  can	  be	  generated.	  One	  of	  the	  most	  striking	  results	  from	  our	  primitive	  
screen	  was	  the	  knockdown	  of	  smarca1,	  which	  nearly	  abolishes	  all	  scl,	  gata1,	  and	  
β-­globin	  e3	   expression	   in	   the	  embryo.	  chrac1	   and	  rsf1b,	  other	  components	   that	  
form	   the	   ISWI	   complex,	  were	  also	   identified	   in	   the	   screen	   though	  according	   to	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mammalian	  data,	  they	  normally	  complex	  with	  the	  other	  homolog,	  smaraca5.	  Our	  
data	   suggest	   that	   ISWI	   chromatin	   remodeling	   is	   important	   for	   primitive	   and	  
definitive	   hematopoiesis	   and	   that	   the	   complex	   involves	   smarca1,	   chrac1,	   and	  
rsf1b.	   In	   combining	   our	   screen	   results	   with	   currently	   available	   protein	  
interaction	   data,	   an	   epigenetic	   network	   regulating	   the	   different	   stages	   of	  
embryonic	  hematopoiesis	  could	  be	  generated.	  
	   The	  mechanism	  by	  which	  ubiquitously	  expressed	  chromatin	  factor	  subunits	  
have	   tissue	   specific	   function	   is	   not	   known.	   Moreover,	   members	   of	   the	   same	  
chromatin	   domain	   family	   could	   compensate	   for	   each	   other,	   yet	   individual	  
knockdown	  of	  many	  of	  these	  factors	  still	  resulted	  in	  a	  hematopoietic	  phenotype,	  
suggesting	  that	  their	  functions	  are	  not	  entirely	  redundant.	  A	  study	  in	  neural	  stem	  
cells	   identified	   changes	   in	   BAF	   subunit	   composition	   as	   they	   transitioned	   to	   a	  
more	  committed	  neuronal	  lineage	  (Lessard	  et	  al	  2007).	  Our	  screen	  results	  would	  
indicate	   a	   similar	   model	   given	   that	   the	   predicted	   chromatin	   complexes	  
important	  for	  primitive	  blood	  overlapped	  with	  those	  for	  definitive	  blood,	  but	  the	  
screen	  hits	   that	  mapped	   to	   these	  complexes	  were	  not	  all	   the	  same.	  This	  model	  
for	   combinatorial	   assembly	   is	   one	   type	   of	   mechanism	   that	   would	   allow	  
chromatin	   factors	   in	   vertebrates	   to	   achieve	   stage	   specific	   and	   tissue	   specific	  
epigenetic	  regulation.	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   In	   addition	   to	   validating	   the	   remainder	   of	   our	   gene	   list,	   new	   studies	  
focusing	  on	  the	  interaction	  between	  hematopoietic	  transcription	  factors	  and	  our	  
chromatin	  factor	  list	  would	  provide	  a	  more	  complete	  transcriptional	  network	  of	  
gene	  regulation	  in	  blood	  development.	  To	  facilitate	  these	  and	  other	  studies,	  we	  
have	  generated	  a	  searchable	  database	  in	  which	  the	  screen	  data	  can	  be	  accessed	  
as	   a	   resource.	   All	   information	   about	   experimental	   design,	   methods,	   screen	  
results,	   and	  characterization	  data	  presented	  here	  are	   included	   in	   the	  database.	  
Most	   importantly,	   the	   database	   provides	   a	   collection	   of	  morpholino	   sequences	  
that	   result	   in	  an	  embryonic	  phenotype.	  These	  effects	   can	  be	  deduced	  based	  on	  
the	  morphological	  defects	  or	  abnormal	  staining	  pattern	  of	  the	  blood	  markers	  in	  
the	  embryo.	  For	  example,	  we	  observed	  morphants	  with	  abnormal	  patterning	  of	  
globin	  expressing	  cells	   in	  morphants	  such	  as	  sirt1,	  dbf4,	   and	  setd6	   that	  may	  be	  
related	   to	   cell	  migration	   defects	   in	   the	  mesoderm.	   Live	   images	   for	  morphants	  
with	  interesting	  phenotypes	  can	  also	  be	  found	  in	  the	  database.	  
	   Overall,	   we	   have	   identified	   a	   set	   of	   genes	   involved	   in	   the	   regulation	   of	  
developmental	   hematopoiesis,	   including	   specification	   of	   HSCs	   and	   primitive	  
erythropoiesis.	  Through	  our	  verification	  of	  morphant	  phenotypes,	  we	  have	  also	  
found	  a	  subset	  of	  chromatin	   factors	  that	  regulate	  mesoderm,	  artery,	  and	  vessel	  
formation,	   with	   implications	   for	   the	   role	   of	   these	   factors	   outside	   of	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hematopoiesis.	   These	   data	   provide	   a	   resource	   for	   the	   identification	   and	  
characterization	   of	   novel	   regulators	   in	   blood	   development	   as	   well	   as	   for	   the	  
assembly	   of	   chromatin	   factor	   complex	   associations	   in	   blood.	   The	   epigenetic	  
changes	  can	  only	  be	  achieved	  by	  a	  network	  of	  chromatin	  factor	  complexes	  that	  
can	  recognize,	   interpret,	  and	  catalyze	  additional	  modifications	  on	  chromatin.	  In	  
combination	   with	   other	   genetic	   and	   biochemical	   studies,	   our	   screen	   helps	   to	  
unravel	  the	  epigenetic	  code	  that	  establishes	  the	  programs	  of	  gene	  expression	  for	  
self-­‐renewal	  and	  differentiation	  in	  hematopoietic	  cells.	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Materials	  and	  Methods	  
Zebrafish	  maintenance	  and	  microinjection	  
Zebrafish	   (Danio	   rerio)	   Tüebingen	   strain	   were	   bred	   and	   maintained	  
according	  to	  Animal	  Research	  guidelines	  at	  Children’s	  Hospital	  Boston.	  Embryos	  
were	   developed	   at	   25°C	   and	   staged	   according	   to	   hours	   post-­‐fertilization	   and	  
morphological	  features	  (Kimmel	  et	  al	  1995).	  Microinjection	  of	  morpholinos	  were	  
performed	  at	  the	  1-­‐2	  cell	  stage.	  Injection	  volumes	  were	  measured	  using	  a	  stage	  
micrometer	  to	  a	  diameter	  of	  ~91	  μm	  (0.4	  nl)	  and	  injected	  one	  to	  three	  times	  into	  
the	  same	  embryo	  to	  achieve	  a	  3	  dose	  range.	  	  
	  
Morpholino	  design	  and	  synthesis	  
Due	   to	   the	   occurrence	   of	   a	   whole	   genome	   duplication	   event	   in	   zebrafish	  
evolution,	  there	  are	  several	  human	  genes	  that	  have	  two	  homologous	  sequences	  
that	  can	  be	  found	  in	  the	  zebrafish	  genome.	  For	  these	  genes,	  we	  have	  designated	  
with	  a	  and	  b	  suffix	  according	  to	  standard	  zebrafish	  nomenclature	  guidelines.	  
	   For	  each	  zebrafish	  homolog,	  the	  sequences	  were	  analyzed	  to	  identify	  the	  
most	   suitable	   target	   sites	   for	  morpholino	   knockdown.	   Translation	   blocking,	   or	  
ATG,	   morpholinos	   were	   designed	   if	   the	   transcriptional	   start	   site	   was	   well	  
annotated.	   Otherwise,	   splice	   blocking	   morpholinos	   were	   designed	   in	   which	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exons	  were	  prioritized	  based	  on	  the	  proximity	  to	  the	  5’	  end	  of	  the	  gene	  and	  their	  
non-­‐divisibility	   by	   3,	   increasing	   the	   likelihood	   of	   a	   frameshift	   mutation	   after	  
exon	   excision.	   All	   splicing	   morpholinos	   targeted	   exons	   prior	   to	   or	   within	   the	  
chromatin	   domain	   of	   interest.	   Once	   the	   target	   site	   was	   selected,	   morpholino	  
oligos	  were	  designed	  and	  synthesized	  (Gene-­‐Tools).	  
	  
Whole-­mount	  in	  situ	  hybridization	  and	  imaging	  
	   WISH	  on	  zebrafish	  embryos	  fixed	  in	  4%	  paraformaldehyde	  were	  performed	  
as	  described	  previously	  using	  the	  Biolane	  HTI	  in	  situ	  robot	  (Intavis)	  (Thisse	  and	  
Thisse	   2008).	   Probes	   used	   were	   c-­myb	   (Thompson	   et	   al	   1998),	   runx1	   (Kalev-­‐
Zylinska	  et	  al	  2002),	  gata1	  (Liao	  et	  al	  1998),	  scl	  (Gering	  et	  al	  1998),	  β-­globin	  e3	  
(Brownlie	   et	   al	   2003),	   flk	   (Thompson	   et	   al	   1998),	  and	   ephrinB2	   (Lawson	   et	   al	  
2002).	   Stained	   embryos	  were	   imaged	   using	   a	  Nikon	   stereoscope	  with	   a	  Nikon	  
Coolpix	   4500	   camera	   or	   Zeiss	   Axiocam	   camera.	   Embryos	  mounted	   in	   glycerol	  
were	  imaged	  on	  a	  Nikon	  E600	  compound	  microscope.	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Figure	  2-­2.	  Summary	  of	  screen	  results.	  	  (A)	  Primitive	  screen	  results.	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Figure	  2-­2.	  Continued.	  (B)	   Definitive	   screen	   results.	   Blue	   downward	   arrows	   represent	   reduced	  expression	   of	   the	   marker,	   with	   three	   arrows	   representing	   the	   strongest	  reduction.	  Red	  upward	  arrows	  represent	  increase	  in	  marker	  expression.	  	  	  	  
 60 
	  	  	  	  	  	  	  





Figure	   2-­3.	   Chromatin	   factors	   regulate	   distinct	   steps	   of	   primitive	  
hematopoiesis.	   Blue	   downward	   arrows	   mean	   decreased	   expression.	   Red	  upward	   arrows	   mean	   increased	   expression.	   n.c.	   means	   no	   change	   in	   marker	  expression.	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Figure	   2-­4.	   Chromatin	   factors	   regulate	   HSPC	   induction.	   Blue	   downward	  arrows	   mean	   decreased	   expression.	   Red	   upward	   arrows	   mean	   increased	  expression.	  n.c.	  means	  no	  change	  in	  marker	  expression.	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  The	  chromatin	  factor	  chd7	  is	  a	  cell	  autonomous	  regulator	  of	  hematopoiesis	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 64 
Attributions	  	  
I	   performed	   all	   the	   experiments	  described	   in	   this	   chapter.	   CHD7	  ChIP-­‐seq	  
data	   was	   obtained	   from	   the	   Bernstein	   lab	   (Ram	   et	   al	   2011).	   Anthony	   Dibiase	  
helped	   generate	   peak	   files	   used	   for	   MEME	  motif	   and	   GREAT	   analysis.	   Jian	   Xu	  
generated	   the	   Flag-­‐cMYB	   K562	   cell	   line	   that	   was	   used	   for	   co-­‐
immunoprecipitation	   experiments	   (Orkin	   lab).	   Andrew	   Woo	   performed	   gel	  
filtration	   of	   K562	   protein	   extracts	   (Cantor	   lab).	   Full	   length	   human	   CHD7	  







	  	  	  	  	  	  
 65 
Introduction	  
Gene	   regulation	   involves	   the	   changing	   of	   chromatin	   structure	   to	   control	  
access	   of	   cellular	   factors	   to	   DNA.	   The	   different	   mechanisms	   that	   regulate	  
chromatin	   structure	   include	   DNA	   methylation,	   histone	   modifications,	   and	  
nucleosome	   remodeling,	   and	   these	   modifications	   are	   catalyzed	   by	   specific	  
protein	   domains	   of	   chromatin	   modifying	   factors.	   For	   example,	   histone	   lysine	  
methylation	   can	  be	   catalyzed	  by	  SET	  domain	   containing	   enzymes	   such	  as	  MLL	  
while	  histone	  lysine	  acetylation	  is	  catalyzed	  by	  HAT	  domain	  containing	  enzymes	  
such	   as	   MOF	   (Li	   et	   al	   2007).	   These	   modifications	   are	   then	   recognized	   by	  
additional	   factors	   containing	   specific	   modules	   like	   PHD	   and	   bromodomain	  
domains	   that	   can	   bind	   the	   methylation	   and	   acetylation	   marks,	   respectively.	  
These	  modifications	  can	  act	  combinatorially	  to	  regulate	  gene	  transcription.	  	  
Unlike	  histone	  lysine	  acetylation	  which	  almost	  always	  correlates	  with	  active	  
transcription,	  lysine	  methylation	  can	  be	  either	  activating	  or	  inhibitory	  depending	  
on	  the	  histone	  residue	  that	  is	  modified.	  H3K4	  methylation	  correlates	  with	  active	  
transcription	  whereas	  methylated	  H3K27	  is	  a	  repressive	  mark.	  Thus	  chromatin	  
factors	  that	  recognize	  these	  methylation	  marks	  would	  be	  important	  subunits	  of	  
transcriptional	  complexes	  to	  help	  ‘read’	  the	  chromatin	  state	  of	  a	  gene	  locus.	  One	  
such	  group	  of	  chromatin	  factors	  is	  the	  chromodomain	  (CHD)	  family	  of	  proteins.	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In	  vertebrates,	  there	  are	  nine	  factors	  that	  belong	  to	  the	  CHD	  family,	  and	  they	  
are	   characterized	   by	   tandem	   chromodomains,	   which	   bind	   methylated	   histone	  
tails,	  followed	  by	  a	  catalytic	  Snf2	  helicase	  domain.	  The	  family	  is	  subdivided	  into	  
three	  groups,	  CHD1-­‐2,	  CHD3-­‐5,	  and	  CHD6-­‐9,	  and	  most	  of	  them	  have	  been	  shown	  
to	  play	  important	  roles	  in	  transcriptional	  regulation.	  CHD1	  regulates	  embryonic	  
stem	  (ES)	  cell	  pluripotency	  genes	  (Gaspar-­‐Maia	  et	  al	  2009).	  CHD3	  and	  CHD4	  are	  
subunits	   of	   the	   repressive	   NuRD	   chromatin	   remodeling	   complex	   (Xue	   et	   al	  
1998).	  CHD5	  is	  a	  tumor	  suppressor	  that	  regulates	  p53	  target	  genes	  (Bagchi	  et	  al	  
2007).	  CHD8	  regulates	  cell	  cycle	  and	  β-­‐catenin	  target	  genes	  (Rodriguez-­‐Paredes	  
et	  al	  2009,	  Thompson	  et	  al	  2008).	  	  
Among	   the	   nine	   CHD	   proteins,	   CHD7	   is	   of	   particular	   interest.	   De	   novo	  
mutations	   of	   CHD7	   are	   found	   in	   67%	  of	   CHARGE	   (Coloboma	   of	   the	   eye,	  Heart	  
malformations,	  Atresia	  of	  the	  choanae,	  Retardation	  of	  growth,	  Genital	  hypoplasia	  
and	   Ear	   abnormalities	   and	   deafness)	   syndrome	   patients	   (Zentner	   et	   al	   2010).	  
Several	   studies	   have	   been	   conducted	   to	   study	   the	   function	   of	   CHD7	   during	  
development	   to	   help	   understand	   the	   pathological	   basis	   of	   CHARGE	   syndrome.	  
Chd7	   mutant	   mice	   display	   many	   features	   of	   CHARGE	   syndrome,	   including	  
postnatal	   growth	   retardation,	   inner	   ear	  malformations,	   genital	   hypoplasia,	   and	  
olfactory	   defects	   (Bosman	   et	   al	   2005,	   Bergman	   et	   al	   2010,	   Hurd	   et	   al	   2010).	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Genome-­‐wide	   localization	   studies	   revealed	   CHD7	   binding	   predominantly	   at	  
enhancer	  sites	  (Schnetz	  et	  al	  2009,	  Schnetz	  et	  al	  2010).	  Biochemical	  purification	  
of	   CHD7	   revealed	   associations	   with	   PBAF	   complex	   to	   regulate	   human	   neural	  
crest	   stem	   cells	   development	   (Bajpai	   et	   al	   2010).	   Taken	   together,	   CHD7	   has	  
broad	  functions	  throughout	  development,	  though	  much	  remains	  unknown	  about	  
its	  precise	  mechanism	  of	  action.	  
In	   our	   reverse	   genetic	   chromatin	  modifying	   factor	   screen	   in	   zebrafish,	  we	  
identified	   chd7	   as	   a	   novel	   and	  potent	   regulator	   of	   hematopoiesis.	  During	   early	  
embryonic	   development	   in	   vertebrates,	   two	   waves	   of	   hematopoiesis	   establish	  
blood	   formation	   in	   the	   embryo.	   The	   first	   and	   primitive	  wave	   produces	  mainly	  
red	  cells	  whereas	   the	  definitive	  wave	  produces	  all	   the	  hematopoietic	  cell	   types	  
required	  to	  sustain	  the	  organism	  for	  the	  remainder	  of	   its	   life,	  most	  importantly	  
the	  hematopoietic	  stem	  cell	  (HSC).	  Knockdown	  of	  chd7	  increased	  both	  primitive	  
and	   definitive	   blood	   formation,	   suggesting	   that	   chd7	   acts	   as	   a	   repressor	   of	  
hematopoiesis.	   Blastula	   transplantation	   experiments	   demonstrated	   that	   this	  
effect	  is	  cell	  autonomous.	  To	  identify	  gene	  targets	  of	  CHD7,	  ChIP-­‐seq	  performed	  
in	  K562	  human	  erythroleukemia	  cells	  revealed	  an	  underlying	  MYB	  motif,	  and	  gel	  
filtration	  analysis	  showed	  co-­‐elution	  of	  CHD7	  and	  MYB,	  suggesting	  an	  interaction	  























Knockdown	  of	  chd7	  results	  in	  increased	  HSPC	  formation.	  
	   For	  the	  chromatin	  factor	  knockdown	  screen	  described	  in	  detail	  in	  Chapter	  2,	  
a	  morpholino	  targeting	  exon	  4	  of	  chd7	  was	  used.	  chd7	  is	  a	  large	  gene	  composed	  
of	  40	  exons	  encoding	  a	  transcript	  nearly	  10kb	  in	  size,	  and	  exon	  4	  lies	  just	  before	  
the	   sequences	   that	   encode	   the	   chromodomains	   (Figure	  3-­‐1A).	  The	  morpholino	  
was	   injected	   into	   1-­‐cell	   stage	   zebrafish	   embryos,	   and	   the	   injected	   embryos,	   or	  
morphants,	   and	   uninjected	   controls	  were	   subsequently	   collected	   at	   36hpf	   and	  
stained	   for	   the	   combination	   of	   hematopoietic	   stem	   and	   progenitor	   cell	   (HSPC)	  
markers	   c-­myb	   and	   runx1	   by	   whole-­‐mount	   in	   situ	   hybridization	   (WISH).	   The	  
stainings	   showed	   an	   expansion	   of	   HSPC	   markers	   in	   the	   aorta	   gonado	  
mesonephros	  (AGM)	  region	  in	  the	  morphants	  compared	  to	  uninjected	  wild-­‐type	  
control	   embryos,	   suggesting	   chd7	   functions	   as	   a	   repressor.	   To	   verify	   the	  
phenotype,	  knockdown	  of	  chd7	   using	  a	   second	  morpholino	   targeting	  exon	  3	  of	  
the	  gene	  resulted	  in	  the	  same	  phenotype.	  By	  qPCR,	  the	  morphants	  have	  a	  1.5-­‐2	  
fold	   increase	   in	   c-­myb	   and	   runx1	   expression	   (Figure	   3-­‐1D).	   Injection	   of	   both	  
morpholinos	   resulted	   in	   the	   most	   robust	   phenotype,	   thus	   all	   subsequent	  
experiments	   were	   performed	   with	   co-­‐injections	   of	   exon	   3	   and	   4	   morpholinos	  
(Figure	  3-­‐1C).	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To	   determine	   whether	   the	   splice	   blocking	   activities	   of	   the	   morpholinos	  
would	   result	   in	   a	   knockdown	   of	   chd7,	   RT-­‐PCR	   was	   performed	   to	   test	   for	   the	  
presence	   of	   splice	   variants	   in	   the	  morphants	   (Figure	   3-­‐1B).	   The	   PCR	   products	  
were	   subsequently	   cloned,	   and	   sequencing	   revealed	   that	   exon	   3	   splicing	  
morpholino	  results	  in	  the	  deletion	  of	  276	  bp	  of	  that	  exon	  whereas	  exon	  4	  splicing	  
morpholino	   resulted	   in	   a	   31	   bp	   insertion	   at	   the	   end	   of	   exon	   4.	   Both	   splicing	  
defects	   resulted	   in	   a	   frameshift	   that	   introduced	   stop	   codons	   immediately	  
following	   the	   splice	   junctions,	   indicating	   that	   Chd7	   should	   be	   truncated	   after	  
amino	  acid	  656,	  deleting	  all	  annotated	  functional	  domains	  of	  this	  protein.	  
	   The	   increase	   in	   c-­myb	   and	   runx1	   expression	   in	   chd7	   morphants	   reflects	  
increased	   hematopoietic	   cell	   production.	   chd7	   morpholinos	  were	   injected	   into	  
Tg(c-­myb:GFP)	   embryos,	   and	   confocal	   imaging	   of	   transgenic	   embryos	   revealed	  
an	   increase	   in	   GFP-­‐positive	   cells	   both	   in	   the	   AGM	   and	   in	   the	   caudal	  
hematopoietic	   tissue	   (CHT).	   (Figure	  3-­‐1E).	  Quantification	   revealed	   a	  near	  50%	  
increase	  of	  GFP-­‐positive	  cells	  in	  the	  morphants.	  Given	  that	  c-­myb	  is	  expressed	  in	  
various	  cell	  types,	  including	  the	  spinal	  cord	  and	  pronephric	  cells,	  the	  experiment	  
was	   repeated	   in	  Tg(cd41:GFP)	   embryos	  with	   similar	   results	   (data	   not	   shown).	  
Conversely,	  overexpression	  of	   full	   length	  human	  CHD7	  by	  mRNA	   injection	   into	  
the	  single-­‐cell	  of	  Tg(c-­myb:GFP)	  and	  Tg(lmo2:dsRed)	  double	  transgenic	  embryos	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suppressed	   the	   formation	   of	   GFP	   positive	   cells	   in	   the	   AGM	   (Figure	   3-­‐1F).	   In	  
summary,	  knockdown	  of	  chd7	  results	  not	  only	  in	  increased	  hematopoietic	  gene	  
expression	  but	  also	  in	  hematopoietic	  cell	  expansion.	  
	  
Loss	  of	  chd7	  enhances	  all	  stages	  embryonic	  hematopoiesis.	  
	   Given	   that	   knockdown	   of	   chd7	   leads	   to	   increased	   formation	   of	   HSPCs,	  we	  
examined	  whether	  other	  hematopoietic	  cell	   types	  were	  also	  expanded	  over	  the	  
course	  of	  embryonic	  development.	  The	  first	  and	  primitive	  wave	  begins	  with	  the	  
formation	  of	  scl+	  mesodermal	  precursors	  that	  differentiate	  into	  gata1+	  erythroid	  
progenitor	   cells	   which	   subsequently	   begin	   to	   express	   β-­globin	   e3	   as	   they	  
differentiate	  into	  red	  cells.	  All	  these	  cell	  types	  were	  expanded	  in	  chd7	  morphants	  
(Figure	  3-­‐2A).	  The	  primitive	  myeloid	  lineage	  was	  also	  expanded	  as	  can	  be	  seen	  
by	   the	   increase	   in	   the	   number	   of	   pu.1+	   and	   mpo+	   cells.	   Given	   that	   scl	   was	  
expanded	  as	  early	  as	  5	  ss	  (12	  hpf),	  we	  examined	  mesodermal	  markers	  eve1	  and	  
brachyury	   but	   did	   not	   observe	   an	   expansion	   of	   the	   mesoderm	   during	  
gastrulation	   at	   6	   hpf.	   Consequently,	   chd7	   not	   only	   functions	   in	   hematopoietic	  
cells	   but	   also	   in	   early	   mesodermal	   precursors	   competent	   to	   undergo	  
hematopoiesis.	  
	   Enhanced	  blood	  formation	  in	  chd7	  morphants	  extends	  beyond	  the	  formation	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of	   HSPCs	   in	   the	   AGM	   during	   the	   definitive	   wave	   (Figure	   3-­‐2B).	   At	   5	   dpf,	  
hematopoiesis	   has	   shifted	   to	   the	   CHT	   in	   the	   tail,	   the	   equivalent	   of	   fetal	  
placenta/liver	  hematopoiesis	  in	  mammals.	  HSPC	  and	  myeloid	  marker	  c-­myb	  was	  
upregulated	   in	   chd7	   morphants,	   as	   well	   as	   larval	   erythroidβ-­globin	   e1	  
expression.	   Increased	   number	   of	   circulating	   thrombocytes	   could	   be	   seen	   in	  
Tg(cd41:GFP)	   morphant	   embryos.	   The	   lymphoid	   marker	   rag1	   was	   expressed	  
normally,	   although	  at	   times	   the	   size	  of	   the	   thymus	   can	  be	   smaller	   than	   that	   of	  
wild-­‐type	  embryos.	  Patients	  with	  CHARGE	  syndrome	  have	  been	  described	  with	  a	  
defective	  thymus,	  suggesting	  that	  CHD7	  is	  involved	  in	  thymic	  development,	  and	  
thus,	  the	  rag1	  phenotype	  may	  be	  due	  to	  impaired	  formation	  of	  the	  thymus	  and	  
not	  due	  to	  defects	  in	  the	  hematopoietic	  lineage.	  	  
	  
chd7	  acts	  cell	  autonomously	  to	  regulate	  stem	  cell	  formation.	  
	   Because	   morpholino	   knockdown	   occurs	   throughout	   the	   entire	   embryo,	  
other	  mesodermal	  tissues	  were	  examined	  for	  changes	  in	  gene	  expression	  in	  chd7	  
morphants.	  myoD	  expression	  in	  the	  developing	  somites	  and	  flk	  in	  the	  developing	  
vasculature	  appeared	  normal.	  nkx2.5	   is	   reduced	   in	   cardiomyocytes.	  Like	  blood,	  
pronephric	  ducts	  expressing	  pax2a	  was	  increased	  in	  chd7	  morphants	  (Figure	  3-­‐
3A).	  Overall,	  chd7	  morphants	  appeared	  normal	  with	  a	  normal	  beating	  heart,	  and	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thus	  these	  changes	  in	  gene	  expression	  do	  not	  seem	  to	  have	  significant	  functional	  
effects	  on	  tissue	  development	  at	  these	  early	  embryonic	  stages.	  
Blastula	   transplantation	   experiments	   were	   performed	   to	   test	   the	   cell	  
autonomy	  of	  the	  expansion	  of	  HSPCs.	  Tg(c-­myb:GFP)	  embryos	  were	  first	  injected	  
with	  a	  standard	  control	  or	  chd7	  morpholino.	  Dextran	  blue	  was	  included	  to	  trace	  
the	   donor	   cells.	   Once	   embryos	   reached	   the	   blastula	   stage	   (3-­‐4hpf),	  
approximately	   30	   to	   40	   pluripotent	   blastula	   cells	   were	   transplanted	   into	  
Tg(lmo2:dsRed)	  embryos	  at	  the	  equivalent	  stage	  and	  examined	  for	  the	  ability	  to	  
form	  GFP	  positive	  c-­myb	   cells	   located	  within	   the	  red	   fluorescent	  vasculature	  of	  
the	  hosts	  at	  36	  hpf	   (Figure	  3-­‐3B).	   In	   three	  sets	  of	   transplantation	  experiments,	  
there	   were	   more	   chimeric	   embryos	   transplanted	   with	   chd7	   morphant	   cells	  
compared	  to	  controls	  (Figure	  3-­‐3C).	  Consequently,	  although	  knockdown	  of	  chd7	  
affects	   multiple	   tissues,	   the	   expansion	   of	   blood	   in	   the	   morphants	   is	   a	   cell	  
autonomous	  event.	  
	  
chd7	  is	  expressed	  ubiquitously	  during	  development.	  
To	  understand	  how	  chd7	  can	  have	  such	  a	  specific	  hematopoietic	  effect,	  we	  
examined	   its	   gene	   expression	   pattern.	   Given	   the	   large	   size	   of	   the	   gene,	   three	  
different	  probes	  encompassing	  the	  5’,	  middle,	  and	  3’	  end	  of	  the	  gene	  were	  made.	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The	   expression	   pattern	   detected	   by	   all	   three	   probes	   were	   identical.	   chd7	   is	  
maternally	   deposited	   and	   remains	   ubiquitously	   expressed	   until	   2	   dpf,	   when	  
expression	  becomes	  restricted	  to	  the	  head	  and	  brain	  (Fiure	  4).	  
	  
Knockdown	  of	  chd7	  does	  not	  increase	  cell	  proliferation	  or	  cell	  death	  in	  the	  
early	  embryo.	  
	   To	   determine	   whether	   the	   hematopoietic	   cell	   expansion	   is	   the	   result	   of	  
increased	   cell	   proliferation	   or	   reduced	   apoptosis,	   phospho-­‐histone	   H3	   (pH3)	  
staining	   and	   terminal	   deoxynucleotidyl	   transferase	   dUTP	   nick	   end	   labeling	  
(TUNEL)	  assay	  was	  performed.	  As	  before,	  chd7	  morpholino	  was	  injected	  into	  1-­‐
cell	   stage	   embryos	   and	   collected	   at	   different	   timepoints	   ranging	   from	  
somitogenesis	   to	   36	   hpf.	   Mitotic	   cells	   were	   detected	   using	   an	   anti-­‐phospho	  
histone	   H3	   antibody,	   and	   apoptotic	   cells	   were	   assayed	   by	   TUNEL	   staining	   for	  
fragmentation	  of	  DNA.	  No	  significant	  differences	  were	  observed	  for	  both	  assays	  
in	  the	  hematopoietic	  regions	  between	  wild-­‐type	  uninjected	  and	  chd7	  morphant	  
embryos	  at	  different	  stages	  (Figure	  3-­‐5A,B).	  However,	  at	  5	  dpf,	  an	  increase	  in	  cell	  
proliferation	  was	  observed	  in	  the	  CHT	  by	  BrdU	  incorporation	  (Figure	  3-­‐5C).	  It	  is	  
possible	  that	  cell	  proliferation	  is	  enhanced	  during	  the	  earlier	  stages,	  but	  that	  the	  
pH3	  antibody	  is	  not	  sensitive	  enough	  to	  detect	  it.	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CHD7	  is	  a	  potential	  regulator	  of	  cMYB.	  
	   To	  search	  for	  target	  genes	  that	  could	  cause	  the	  blood	  expansion	  phenotype	  
observed	   in	   zebrafish	   chd7	   morphants,	   CHD7	   ChIP-­‐seq	   data	   from	   human	  
erythroleukemic	  K562	   cells	  was	   analyzed.	  The	  data	  was	  obtained	   from	  a	   large	  
scale	   ChIP-­‐seq	   study	   of	   human	   chromatin	   regulators	   in	   K562	   and	   ES	   cells	  
published	  previously	  (Ram	  et	  al	  2011).	  Using	  a	  significance	  cutoff	  of	  10-­‐9,	  8,348	  
peaks	   were	   identified.	   Using	   the	   Genomic	   Regions	   Enrichment	   of	   Annotations	  
Tool,	  the	  majority	  of	  CHD7	  binding	  sites	  were	  distal	  to	  the	  transcriptional	  start	  
site,	   consistent	  with	  previous	   studies	   (Schnetz	   et	   al	   2009,	   Schnetz	   et	   al	   2010).	  
Binding	   peaks	   were	   found	   at	   the	   promoters	   of	   several	   hematopoietic	   genes	  
including	  SCL,	  LMO2,	  NFE2,	  HBB,	  and	  RUNX1.	  Peaks	  were	  also	  found	  at	  the	  MYC	  
locus	   as	   well	   as	   119	   MYC	   target	   genes,	   an	   important	   regulator	   of	   cell	  
proliferation.	  	  
In	   a	   motif	   search	   of	   CHD7	   binding	   sites	   using	   Multiple	   Em	   for	   Motif	  
Elicitation	  (MEME)	  analysis,	  an	  underlying	  MYB	  motif	  was	   identified	  (Figure	  3-­‐
6A).	  Western	  blot	  of	  K562	  nuclear	  extracts	  after	  gel	  filtration	  showed	  co-­‐elution	  
of	   CHD7	   and	  MYB	   in	   the	   same	   protein	   fraction	   corresponding	   to	   a	   size	   of	   1.4	  
MDa,	   a	   size	  much	   larger	   than	   either	   MYB	   (75kDa)	   or	   CHD7	   (~300kDa)	   alone	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(Figure	   3-­‐6B).	   However,	   no	   direct	   interaction	   between	   MYB	   and	   CHD7	   was	  
detected	  by	   co-­‐immunoprecipitation.	   It	   remains	  possible	   that	   they	  may	   still	   be	  
present	  in	  the	  same	  complex.	  	  
To	   test	   for	  genetic	   interaction	  between	  chd7	   and	  c-­myb,	  chd7	  morpholinos	  
were	   injected	   into	   cmybt25127	   mutant	   zebrafish	   embryos.	   The	   mutant	   allele	  
contains	   a	   missense	   mutation	   in	   the	   DNA	   binding	   domain	   of	   c-­myb,	   and	   the	  
mutants	  progressively	   lose	  all	  definitive	  hematopoietic	   lineages	  starting	  from	  2	  
dpf	   (Soza-­‐Reid	   et	   al	   2010).	   Embryos	   were	   grown	   to	   36	   hpf	   and	   collected	   for	  
WISH	   to	   examine	   the	   patterns	   of	   c-­myb	   and	   runx1	   expression.	   None	   of	   the	  
genotyped	   embryos	   in	   the	   initial	   experiment	   were	   homozygous	   mutant	   for	   c-­




	   In	   this	   study,	   chd7	   was	   found	   to	   be	   a	   potent	   repressor	   of	   embryonic	  
hematopoietic	   cell	   development.	   Knockdown	   of	   chd7	   resulted	   in	   increased	  
primitive	  and	  definitive	  hematopoiesis	  from	  the	  earliest	  stage	  of	  scl+	  mesodermal	  
precursor	  formation	  at	  12	  hpf	  up	  to	  the	  formation	  of	  definitive	  blood	  lineages	  at	  
5	  dpf.	  Given	  the	  early	  hematopoietic	  phenotype,	  chd7	  likely	  functions	  at	  the	  stem	  
and	  progenitor	  level.	  Gene	  expression	  of	  Chd7	  from	  sorted	  blood	  populations	  in	  
mice	   show	   high	   expression	   of	   Chd7	   in	   various	   cell	   types	   such	   as	   granulocytes	  
and	  neutrophils	  in	  the	  myeloid	  lineage	  and	  natural	  killer,	  T,	  and	  B	  cells	  from	  the	  
lymphoid	   lineages,	   suggesting	   that	  CHD7	  may	  also	   regulate	   later	   stages	  of	  HSC	  
differentiation	  (Beerman	  et	  al	  2010).	  
It	  is	  not	  surprising	  that	  knockdown	  of	  chd7	  affects	  multiple	  tissues	  given	  its	  
ubiquitous	  expression	  during	  embryonic	  development	  and	   the	  range	  of	  defects	  
exhibited	   by	   knockout	  mice	   and	   human	   CHARGE	   syndrome	   patients.	   Although	  
embryos	  injected	  with	  chd7	  exon	  3	  and	  4	  splice	  blocking	  morpholinos	  appeared	  
relatively	   normal,	   contrary	   to	   the	   embryonic	   lethal	   phenotype	   of	   knockout	  
mouse	  embryos,	  this	  is	  likely	  due	  to	  preservation	  of	  maternal	  transcript	  required	  
during	   the	   earliest	   stages	   of	   embryonic	   development.	   Indeed,	   translation	  
blocking	   morpholinos	   targeted	   against	   chd7	   mRNA	   in	   zebrafish	   embryos	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resulted	   in	   general	   malformations	   such	   as	   defective	   retinal	   differentiation,	  
reduced	   number	   of	  motor	   neurons,	   loss	   of	   bone	  mineralization,	   and	   improper	  
vascular	  segmentation	  (Patten	  et	  al	  2012).	  It	  is	  also	  possible	  that	  the	  remaining	  
656	  amino	  acids	  in	  the	  N-­‐terminus	  after	  morpholino	  induced	  splice	  blocking	  may	  
have	  residual	  activity,	  although	  no	  annotated	  domains	  exist	  within	  that	  region	  to	  
allow	   prediction	   of	   possible	   functions	   it	   may	   have.	   Whole	   mount	  
immunohistochemistry	   for	   Chd7	   using	   the	   available	   mouse	   CHD7	   antibody	   to	  
help	   verify	   the	   knockdown	   is	   ongoing.	   Nevertheless,	   the	   exon	   3	   and	   4	   splice	  
blocking	   morpholinos	   worked	   to	   elucidate	   the	   role	   that	   chd7	   has	   in	  
hematopoiesis,	  and	  it	  is	  cell	  autonomous.	  
There	  are	  multiple	  ways	  by	  which	  the	  blood	  expansion	  phenotype	  caused	  by	  
loss	  of	  chd7	  might	  have	  occurred.	  Although	  increased	  cell	  proliferation	  was	  the	  
most	   likely	  mechanism,	   no	   increase	   in	  mitosis	   was	   observed	   by	   pH3	   staining.	  
However,	  CHD7	  binding	  to	  MYC	  and	  MYC	  target	  genes	  were	  found	  in	  K562	  cells,	  
suggesting	   that	   CHD7	   may	   be	   involved	   in	   regulating	   cell	   proliferation.	   BrDU	  
remains	   to	   be	   tested	   at	   the	   earlier	   stages	   to	   verify	   this	   phenotype.	   Another	  
possible	  mechanism	  would	  be	  a	   fate	  change	   from	  other	   tissues	   to	  blood.	  Given	  
the	   lack	   of	   mesoderm	   expansion	   during	   gastrulation	   and	   the	   preservation	   of	  
other	   posterior	  mesodermal	   tissues	   tested	   (somites,	   vasculature,	   pronephros),	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this	   is	   not	   likely	   the	   case.	   An	   interesting	   alternative	   would	   be	   enhanced	   self-­‐
renewal	  of	  the	  HSPCs.	  However,	  this	  hypothesis	  would	  require	  the	  use	  of	  other	  
systems	  such	  as	  Chd7	  conditional	  knockout	  mice	  in	  which	  established	  assays	  are	  
available	  to	  answer	  this	  question.	  Thus	  chd7	  may	  not	  only	  regulate	  proliferation	  
of	  hematopoietic	  cells	  but	  also	  the	  self-­‐renewal	  of	  HSPCs.	  
The	   identification	   of	   the	  MYB	  motif	   from	   CHD7	   ChIP-­‐seq	   binding	   sites	   in	  
K562	   cells	   hinted	   towards	   a	   potential	   interaction	   that	   could	   account	   for	   the	  
hematopoietic	   expansion	   phenotype	   observed	   in	   chd7	   morphants.	  
Overexpression	   of	   c-­‐Myb	   in	   ES	   cells	   has	   been	   shown	   to	   increase	   multilineage	  
colony	   formation	   and	   self-­‐renewal	   in	   culture	  whereas	   conditional	   knockout	   of	  
the	   gene	   in	   mouse	   bone	   marrow	   resulted	   in	   defective	   self-­‐renewal	   and	  
multilineage	  differentiation	  of	  adult	  HSCs	  (Dai	  et	  al	  2006,	  Lieu	  and	  Reddy	  2009).	  
Although	  CHD7	   is	   generally	   associated	  with	   active	   transcription,	   the	   results	   in	  
zebrafish	   suggest	   a	  model	   in	  which	  Chd7	   limits	   the	  ability	  of	  c-­myb	   to	   activate	  
the	   hematopoietic	   program,	   and	   thus,	   knockdown	   of	   chd7	   leads	   to	   enhanced	  
hematopoiesis.	   Although	   no	   direct	   interaction	   was	   observed	   by	   co-­‐
immunoprecipiation	   in	   K562	   cells,	   the	   co-­‐elution	   of	   both	   proteins	   by	   gel	  
filtration	  is	  consistent	  with	  CHD7	  and	  MYB	  being	  present	  in	  the	  sample	  complex.	  
A	  protein	  pull-­‐down	  with	  CHD7	  may	  be	   able	   to	   identify	  MYB	  as	   an	   interacting	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protein	  and	  provide	  additional	  clues	  about	  the	  mechanism	  of	  CHD7	  function.	  
No	  specific	  hematopoietic	  defects	  have	  been	  identified	  in	  CHARGE	  patients	  
with	  confirmed	  mutations	  in	  CHD7.	  A	  small	  number	  of	  patients	  have	  been	  shown	  
to	  exhibit	  T	  cell	  deficiencies,	  but	  they	  also	  exhibit	  thymic	  aplasia,	  hence	  the	  T	  cell	  
deficiency	   is	   probably	   non-­‐cell	   autonomous.	   Bone	   marrow	   analysis	   would	   be	  
required	   to	   determine	   whether	   there	   are	   any	   changes	   in	   hematopoiesis	   of	   in	  
CHARGE	  syndrome	  patients.	  
Future	  studies	  addressing	  the	  mechanism	  of	  how	  CHD7	  functions	  in	  HSPCs	  
and	   multilineage	   differentiation	   are	   important	   for	   our	   understanding	   of	  
hematopoiesis.	  Very	  few	  genes	  are	  known	  to	  regulate	  self-­‐renewal	  of	  stem	  cells,	  
and	   the	   studies	   presented	   here	   implicate	  CHD7	   as	   a	   strong	   candidate.	   It	   is	   an	  
integral	  regulator	  of	  the	  hematopoietic	  program	  because	  all	  cell	  types	  within	  the	  
hematopoietic	   lineage	   examined	   have	   been	   affected,	  which	  may	   be	   useful	   as	   a	  
therapeutic	  target.	  
	  
[Note	   added	   in	   proof.	   Recently,	   a	   direct	   interaction	   between	   CHD7	   and	   the	  
transactivation	   domain	   of	   RUNX1	   was	   reported.	   Conditional	   deletion	   of	   Chd7	  
using	  Vav-­‐Cre	  did	  not	  cause	  any	  lineage	  specific	  defects,	  but	  Chd7	  deficient	  bone	  
marrow	   cells	   had	   a	   competitive	   advantage	   in	   T	   cell	   reconstitution.	   Runx1	   is	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required	  for	  the	  emergence	  of	  HSCs,	  thus	  these	  results	  are	  consistent	  with	  those	  
in	   the	   zebrafish.	   This	   presents	   another	   potential	   mechanism	   for	   the	   blood	  
expansion	   observed	   in	   chd7	   morphants,	   namely	   loss	   of	   Chd7	   releases	   the	  





Materials	  and	  Methods	  
Zebrafish	  maintenance	  and	  microinjection.	  
Zebrafish	   (Danio	   rerio)	   Tüebingen	   strain	   were	   bred	   and	   maintained	  
according	   to	   Animal	   Research	   guidelines	   at	   Children’s	   Hospital	   Boston.	   Other	  
lines	  used	  were	  Tg(c-­myb:EGFP)	  (North	  et	  al	  2007),	  Tg(cd41:EGFP)	  (Traver	  et	  al	  
2003),	  Tg(lmo2:dsRed)	  (North	  et	  al	  2007),	  and	  Tg(kdrl:RFP)	  (Huang	  et	  al	  2005).	  
Embryos	  were	  developed	  at	  25˚C	  or	  28.5˚C	  and	  staged	  according	   to	  hours	  post	  
fertilization	  (hpf)	  and	  morphological	  features	  (Kimmel	  et	  al	  1995).	  Morpholinos	  
were	   injected	   into	  the	  yolk,	  and	  mRNA	  was	   injected	   into	  the	  cell	  of	  1-­‐cell	  stage	  
embryos.	   Injection	   volumes	   were	   measured	   using	   a	   stage	   micrometer	   to	   a	  
droplet	  size	  of	  1	  nl	  (~124	  μm	  in	  diameter).	  
	  
Morpholino	  design	  and	  synthesis.	  
The	   FASTA	   sequence	   for	   the	   predicted	   chd7	   gene	   in	   zebrafish	   was	  
downloaded	   from	   NCBI	   (XM_692864)	   and	   input	   into	   UCSC	   zebrafish	   genome	  
browser	  to	  extract	  exon	  intron	  structure	  of	  the	  gene.	  25	  bps	  of	  exon	  and	  intron	  
sequence	  was	  copied	  from	  exons	  3	  and	  4	  exon-­‐intron	  junctions	  and	  submitted	  to	  
Gene-­‐Tools	  for	  morpholino	  oligo	  design	  and	  synthesis.	  Morpholinos	  were	  diluted	  
in	  nuclease	   free	  water	  and	  concentrations	  measured	   in	  0.1	  N	  hydrochloric	  acid	  
 83 
on	   a	   Nanodrop	   following	   instructions	   provided	   by	   Gene-­‐Tools.	   Morpholinos	  
were	  heated	  briefly	  at	  65˚C	  for	  five	  minutes	  prior	  to	  embryo	  injections	  to	  disrupt	  
any	  secondary	  structures.	  Morpholino	  sequences	  were:	  	  
chd7	  exon	  3:	  ACTCGTTTATACTCTACACGTACCT	  	  
chd7	  exon	  4:	  TTACAAGCAAGTTTACCTGAACACC.	  
	  
Whole-­mount	  in	  situ	  hybridization	  and	  imaging	  
WISH	  on	  zebrafish	  embryos	  fixed	  in	  4%	  paraformaldehyde	  was	  performed	  
as	   described	   previously	   (Thisse	   and	   Thisse	   2008).	   Digoxigenin	   (DIG)-­‐labeled	  
antisense	   RNAs	   were	   transcribed	   from	   linearized	   plasmid	   templates	   or	   PCR	  
products	   with	   T7	   or	   SP6	   RNA	   polymerase	   according	   to	   the	   manufacturer’s	  
protocol	  (Roche).	  Antisense	  riboprobes	  used	  were	  c-­myb,	  runx1	  (Kalev-­‐Zylinska	  
et	   al	   2002),	   gata1,	   scl	   (Liao	   et	   al	   1998),	   β-­globin	   e3	   (Brownlie	   et	   al	   2003),	   β-­
globin	  e1,	  flk	  (Thompson	  et	  al	  1998),	  ephrinB2	  (Lawson	  et	  al	  2002),	  myoD,	  pax2a,	  
nkx2.5,	  pu.1	  (Lieschke	  et	  al	  2002),	  and	  mpo	  (Bennett	  et	  al	  2001).	  	  
Probes	   to	   detect	   chd7	   embryonic	   expression	  were	   generated	   from	   partial	  
clones	   EDR1052-­‐99603877	   (chd7	   N-­‐terminus),	   EXELIXIS4269886	   (chd7	  
Internal),	   and	   EDR1052-­‐98884484	   (chd7	   C-­‐terminus)	   (Open	   Biosystems).	  
Primers	  used	  were:	  	  
 84 
chd7-­N-­SP6(F)	  	  	  5’-­‐TAATTTAGGTGACACTATAGAAGAAGCTTGGCTGCACAGCAG-­‐3’	  
chd7-­N-­T7(R)	  	  	  	  	  	  	  5’-­‐TATAATACGACTCACTATAGGGCCACCCATCACTTGCTGCTG-­‐3’	  
chd7-­I-­SP6(F)	  	  	  	  	  5’-­‐TAATTTAGGTGACACTATAGAAGGCAGACTGGCTTGCTGACT-­‐3’	  
chd7-­I-­T7(R)	  	  	  	  	  	  	  5’-­‐TATAATACGACTCACTATAGGGATAGGCTGTGATGAGGCGGC-­‐3’	  
chd7-­C-­SP6(F)	   	   	   	   5’-­‐AATTTAGGTGACACTATAGAAGTCCGGATTCCCGGGATCTG-­‐3’	  
chd7-­C-­T7(R)	  	  	  	  	  	  5’-­‐	  TATAATACGACTCACTATAGGGGGACCAGCGCGCACATCTTA-­‐3’	  
Stained	   embryos	   were	   imaged	   using	   a	   Nikon	   stereoscope	   with	   a	   Nikon	  
Coolpix	   4500	   camera	   or	   Zeiss	   camera.	   Embryos	   mounted	   in	   glycerol	   were	  
imaged	   on	   a	   Nikon	   E600	   compound	   microscope.	   Confocal	   imaging	   was	  
performed	  on	  a	  Zeiss	  spinning	  disk	  confocal	  microscope	  using	  Volocity	  software	  
for	  image	  acquisition.	  
	  
RT-­	  and	  qPCR	  
	   Pools	   of	   20-­‐50	   embryos	   were	   collected	   in	   500μl	   of	   TRIzol,	   and	   RNA	  
extracts	  were	   prepared	   according	   to	   the	  manufacturer’s	   protocol	   (Invitrogen).	  
cDNA	  was	  prepared	  using	  the	  SuperScript	  III	  First	  Strand	  synthesis	  kit	  according	  
to	   the	   manufacturer’s	   protocol	   (Invitrogen).	   Primers	   used	   for	   RT-­‐PCR	   were:	  
chd7ex2	   forward:	   5’-­‐GGGCACCTACTCACCAATCA-­‐3’,	   chd7ex4	   reverse:	   5’-­‐
GCCTCTTTCTTGGTGCTGTT-­‐3’,	  chd7ex3	   forward:	  5’-­‐TCCCAAGACACCCAAAGAAC-­‐
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3’,	   chd7ex5	   reverse:	   5’-­‐GCCTCTTTCTTGGTGCTGTT-­‐3’,	   ef1α	   forward:	   5’-­‐
ATCTACAAATGCGGTGGAAT-­‐3’,	  and	  ef1α	  reverse:	  5’-­‐ATACCAGCCTCAAACTCACC-­‐
3’.	  	  
qPCR	   was	   performed	   using	   SsoFast	   EvaGreen	   Supermix	   on	   the	   BioRad	  
C1000	   CFX-­‐384	   real-­‐time	   PCR	  machine	   (BioRad).	   qPCR	   primers	   used	  were:	   c-­
myb	   forward:	   5’-­‐CCGACAGAAGCCGGATGA-­‐3’,	   c-­myb	   reverse:	   5’-­‐
TGGCACTTCGCCTCAACTG-­‐3’,	   runx1	   forward:	   5’-­‐CGTCTTCACAAACCCTCCTCAA-­‐
3’,	  runx1	  reverse:	  5’-­‐GCTTTACTGCTTCATCCGGCT-­‐3’.	  ΔΔCt	  values	  were	  calculated	  
using	  ef1α	  as	  the	  control	  gene.	  
	  
Phospho-­histone	  H3,	  TUNEL,	  and	  BrdU	  assays	  
	   The	   phospho-­‐histone	  H3	   and	   TUNEL	   assays	  were	   performed	   as	   described	  
previously	   (Shepard	   et	   al	   2005),	   followed	   by	   staining	   with	  
diaminobenzidine/H2O2	   (Invitrogen).	   For	   BrdU	   incorporation	   assays,	   live	  
embryos	  were	  soaked	  for	  20	  minutes	  in	  10mM	  BrdU/15%	  DMSO/E3	  medium	  on	  
ice.	  The	  solution	  was	  rinsed	  off	  three	  times	  with	  E3	  and	  embryos	  were	  allowed	  
to	  develop	  for	  another	  15	  minutes	  prior	  to	   fixation	  with	  4%	  paraformaldehyde	  
(PFA)	   overnight	   at	   4°C.	   Embryos	   were	   subsequently	   dehydrated	   in	   methanol,	  
rehydrated	   in	  PBT,	   treated	  with	  proteinase	  K,	   and	   re-­‐fixed	  with	  4%	  PFA.	  After	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removal	   of	   PFA,	   embryos	  were	   rinsed	  with	  water	   and	   treated	  with	  2N	  HCl	   for	  
one	   hour	   before	   starting	   immunohistochemistry	   staining	   of	   whole	   embryos	  
using	  mouse	  anti-­‐BrdU	  and	  anti-­‐mouse	  IgG-­‐Alexa546	  antibodies.	  
	  
Blastula	  transplantation	  
	   Blastula	   transplantation	   was	   performed	   as	   described	   previously	   using	   an	  
analog	  microinjector	  to	  transfer	  cells	  in	  2%	  methylcellulose	  (Kemp	  et	  al	  2009).	  	  
	  
Co-­immunoprecipitation.	  
	   Nuclear	   extracts	   were	   prepared	   from	   K562	   cells	   expressing	   Flag-­‐MYB.	  
Immunoprecipitation	   was	   performed	   with	   anti-­‐MYB	   (Millipore),	   anti-­‐CHD7	  













Figure	  3-­1.	  chd7	  regulates	  c-­myb+	  and	  runx1+	  expression.	  	  (A)	  Gene	  structure	  of	  zebrafish	  chd7	  with	  magnified	  view	  of	  exons	  2-­‐6	   in	  wild-­‐type	  uninjected	   controls	   and	  chd7	  morpholino	   injected	  embryos.	  Exon	  3	  and	  4	  splicing	  morpholinos	  induce	  a	  276	  bp	  deletion	  and	  31	  bp	  insertion,	  respectively,	  both	  resulting	  in	  the	  introduction	  of	  downstream	  stop	  codons.	  	  (B)	   RT-­‐PCR	   of	   wild-­‐type	   control	   and	   chd7	   morphants	   show	   a	   smaller	   spliced	  product	  in	  the	  morphants.	  	  (C)	  WISH	  of	  wild-­‐type	  and	  chd7	  morphant	  embryos	  for	  combined	  expression	  of	  








Figure	  3-­1.	  Continued.	  (D)	  Quantification	   of	   c-­myb	   and	   runx1	   by	   qPCR.	   Knockdown	   of	   chd7	   results	   in	  1.5-­‐2	   fold	   increase	   in	   c-­myb	   and	   runx1	   expression.	   EF1α	   was	   used	   as	   control	  gene.	  	  (E)	  Tg(c-­myb:EGFP)	  morphants	   show	   increase	   in	  GFP+	   cells	   in	   the	  AGM	  region.	  White	  dotted	  lines	  mark	  the	  position	  of	  the	  aorta.	  	  (F)	  Overexpression	  of	  human	  CHD7	  by	  mRNA	  injection	  suppresses	  formation	  of	  








Figure	  3-­3.	  chd7	  regulates	  gene	  expression	  in	  multiple	  tissues	  but	  acts	  cell	  
autonomously	  in	  blood.	  	  (A)	   Gene	   expression	   of	   non-­‐hematopoietic	   mesodermal	   tissues	   in	   chd7	  morphants.	   The	   heart	   domain	  marked	   by	  nkx2.5	   was	   reduced,	   but	   pronephric	  ducts	   showed	   increased	   pax2a	   expression	   in	   chd7	   morphants.	   Somites	   and	  vasculature	   were	   relatively	   unaffected.	   Black	   arrowhead	   points	   to	   pronephric	  ducts.	  	  (B)	   Blastula	   transplantation	   experiments	   demonstrate	   cell	   autonomy	   of	   chd7.	  Control	  or	  chd7	  morpholino	  was	  injected	  in	  Tg(c-­myb:EGFP)	  donor	  embryos,	  and	  blastula	   cells	   were	   subsequently	   transplanted	   into	   Tg(lmo2:dsRed)	   hosts.	  Chimeric	  embryos	  were	  scored	  for	  the	  number	  of	  GFP+	  cells	  in	  the	  AGM	  and	  CHT.	  Results	   of	   1	   of	   3	   experiments	   are	   shown.	   White	   arrowheads	   point	   to	   GFP+	  hematopoietic	  cells.	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Figure	  3-­4.	  chd7	  is	  expressed	  ubiquitously	  during	  embryonic	  development.	  













Figure	  3-­5.	  No	  major	  changes	  in	  cell	  proliferation	  or	  apoptosis	  during	  early	  
stages	  of	  hematopoiesis	  in	  chd7	  morphants.	  	  (A)	  Representative	  images	  of	  pH3	  and	  TUNEL	  stained	  embryos	  in	  wild-­‐type	  and	  


















































	   The	  unk	  studies	  were	  performed	  in	  collaboration	  with	  Jernej	  Murn	  from	  
the	  laboratory	  of	  Yang	  Shi.	  I	  designed	  morpholino	  sequences	  to	  knockdown	  unk	  
in	  zebrafish	  embryos,	  injected	  morpholinos,	  performed	  acridine	  orange	  staining,	  
whole-­‐mount	  immunohistochemistry	  stainings,	  and	  confocal	  imaging.	  Katie	  
Kathrein	  assisted	  with	  embryo	  injections,	  acridine	  orange	  stainings,	  and	  
performed	  the	  unk	  mRNA	  rescue	  experiment.	  
	  
	  
	   The	  jmjd2b	  studies	  were	  performed	  in	  collaboration	  with	  Partha	  Das	  from	  
the	  laboratory	  of	  Dr.	  Stuart	  Orkin.	  I	  designed	  jmjd2b	  morpholinos,	  performed	  
injections,	  and	  WISH.	  Katie	  Kathrein	  assisted	  with	  embryo	  injections.	  Cong	  Xu	  








	   Regulating	  the	  structure	  of	  chromatin	  is	  essential	  to	  compact	  1.7	  meters	  
of	  DNA	  into	  a	  5	  micrometer	  nucleus	  inside	  a	  mammalian	  cell.	  This	  is	  achieved	  by	  
wrapping	  DNA	  around	  specialized	  histone	  proteins	  to	  form	  nucleosomes,	  which	  
can	   subsequently	   be	   compacted	   into	   higher	   order	   structures.	   In	   addition,	  
chromatin	   must	   remain	   malleable	   enough	   to	   allow	   the	   cell	   to	   change	   its	  
conformation	  in	  order	  to	  adjust	  gene	  expression	  programs	  in	  response	  to	  diverse	  
stimuli	  (Bernstein	  et	  al	  2007).	  
	   Many	   different	   types	   of	   chemical	   modifications	   executed	   by	   specific	  
protein	   domains	   of	   chromatin	   modifiers	   can	   be	   used	   to	   alter	   the	   structure	   of	  
chromatin.	   These	   include	   cytosine	   methylation	   on	   the	   DNA	   and	   lysine	   and	  
arginine	   methylation,	   lysine	   acetylation,	   serine	   phosphorylation,	   and	   lysine	  
ubiquitination	   on	   the	   histone	   proteins	   (Li	   et	   al	   2007).	   The	   majority	   of	   the	  
enzymes	  that	  catalyze	  these	  modifications	  have	  been	  identified.	  
	   The	   radical	   S-­‐adenosylmethionine	   (SAM)	   domain	   was	   identified	  
computationally	   a	   decade	   ago	   and	   subsequently	  mapped	   to	   over	  600	  proteins.	  
The	  proteins	  of	   this	   large	  superfamily	  catalyze	  diverse	  chemical	  reactions	  via	  a	  
conserved	   domain	   of	   cysteine	   residues	   (CxxxCxxC)	   that	   harbor	   an	   iron	   cluster	  
[4Fe-­‐4S]1+,	   a	   strong	   reducing	   agent,	   that	   is	   used	   to	   generate	   a	   radical,	   5'-­‐
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deoxyadenoxyl,	   by	   cleavage	   of	   SAM	   (Sofia	   et	   al	   2001).	   This	   reaction	   has	   been	  
implicated	  in	  DNA	  repair	  and	  demethylation	  (Chandor-­‐Proust	  et	  al	  2008,	  Okada	  
et	  al	  2010).	  Elp3,	  an	  important	  catalytic	  subunit	  of	  the	  transcriptional	  elongation	  
complex,	  also	  contains	  a	  radical	  SAM	  domain	  (Wittschieben	  et	  al	  1999).	  Because	  
of	   the	  diverse	   and	   large	  number	  of	  proteins	   found	   in	   this	   family,	  many	   radical	  
SAM	  domain	  containing	  factors	  have	  not	  been	  well	  characterized.	  Of	  the	  radical	  
SAM	   factors	   included	   in	   our	   chromatin	   factor	   screen,	   we	   identified	   a	   putative	  
role	   for	   unkempt	   (unk)	   in	   the	   induction	   of	   definitive	   hematopoietic	   stem	   cells	  
(HSCs)	  since	  unk	  morphants	  lose	  c-­myb	  and	  runx1	  expression	  in	  the	  aorta	  gonad	  
mesonephros	  (AGM)	  region	  at	  36	  hours	  post	  fertilization	  (hpf).	  Furthermore,	  we	  
discovered	  that	  unk	  is	  essential	  for	  proper	  nervous	  system	  development	  as	  early	  
degeneration	  of	  the	  entire	  neuroectodermal	  tissue	  occurs	  in	  the	  absence	  of	  unk.	  
	   Although	  the	  occurrence	  of	  histone	  methylation	  marks	  have	  been	  known	  
for	  a	  long	  time,	  histone	  demethylating	  enzymes,Lsd1	  and	  Jumonji	  (JmjC)	  domain-­‐
containing	  proteins	  have	  only	  been	  identified	  recently	  (Shi	  et	  al	  2004,	  Tsukada	  et	  
al	  2006).	  Ample	  evidence	  has	  accumulated	  about	  the	  importance	  of	  these	  factors	  
in	   development	   (Takeuchi	   et	   al	   2006).	   In	   our	   chromatin	   factor	   screen,	   we	  
discovered	  that	  one	  of	  the	  less	  characterized	  Jumonji	  proteins,	  jmjd2b,	  not	  only	  is	  
a	  regulator	  of	  hematopoietic	  stem	  and	  progenitor	  cells	  but	  may	  also	  be	  one	  of	  the	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Knockdown	  of	  unk	  results	  in	  widespread	  neural	  degeneration.	  
	   To	   characterize	   the	   neural	   defects	   observed	   in	   unk	   morphants,	   we	   co-­‐
injected	  unk	  morpholino	  with	  acridine	  orange	  to	  determine	  the	  degree	  of	  neural	  
degeneration	   observed	   in	   the	   morphants	   at	   28	   hours	   post-­‐fertilization	   (hpf).	  
Wild-­‐type	  uninjected	   embryos	   from	   the	   same	   clutch	  were	  used	   as	   controls.	   As	  
expected,	   unk	   injected	   embryos	   showed	   a	   dramatic	   increase	   in	   green	  
fluorescence,	  indicating	  cell	  death.	  They	  showed	  increased	  apoptosis	  throughout	  
the	   entire	   central	   nervous	   system	   (CNS)	   including	   forebrain,	   midbrain,	  
hindbrain,	   and	   the	   spinal	   cord	   (Figure	   4-­‐1A).	   This	   defect	   is	   specific	   to	   the	  
depletion	  of	  unk	  and	  not	  due	  to	  general	  toxicity	  from	  the	  morpholino	  because	  the	  
morphants	   can	   be	   rescued	   with	   co-­‐injection	   of	   mouse	   Unk	   mRNA	   (data	   not	  
shown).	  	  
	   unk	   expression	   is	   not	   initiated	   until	   after	   gastrulation.	   Once	   expressed,	  
unk	   is	  ubiquitious,	  but	  after	  24	  hpf,	   its	  expression	  becomes	  highly	  restricted	  to	  
the	  head	  and	  nervous	  system,	  consistent	  with	  the	  expression	  seen	  in	  Drosophila	  
(Thisse	   et	   al	   2004,	   Mohler	   et	   al	   1992).	   Whole-­‐mount	   immunohistochemistry	  
using	  mouse	  UNK	  antibody	  detected	  Unk	  protein	  expression	  beginning	  after	  the	  
onset	  of	  definitive	  neural	   formation	   in	   the	  brain	  at	  24	  hpf,	  marking	  only	  a	   few	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neurons	   if	   any.	   By	   28	   hpf,	   the	   number	   of	   Unk+	   neurons	   have	   increased	  
dramatically,	   scattered	   throughout	   the	   head	   region	   and	   the	   spinal	   cord.	   This	  
expression	  pattern	  was	  abolished	  in	  unk	  morphants	  (Figure	  4-­‐1B).	  
	   Both	   the	   apoptosis	   and	   loss	   of	   Unk+	   cells	   in	   the	   morphants	   suggested	  
severe	   defects	   in	   the	   formation	   of	   the	   CNS.	   In	   vertebrate	   development,	   the	  
nervous	  system	  forms	  from	  neurons	  and	  radial	  glial	  cells,	  which	  are	  considered	  
the	  neural	  stem	  cells	  since	  they	  are	  able	  to	  generate	  more	  neuronal	  and	  glial	  cell	  
types	  (Barresi	  et	  al	  2010).	  gfap	  is	  one	  of	  the	  genes	  expressed	  by	  radial	  glial	  cells,	  
and	   confocal	   imaging	  of	  unk	   injected	  Tg(gfap:EGFP)	   embryos	   revealed	   that	   the	  
neural	   tube	   was	   severely	   underdeveloped	   with	   significant	   loss	   of	   gfap	  
expression	  (Figure	  4-­‐1C).	  Taken	  together,	  these	  data	  suggest	  that	  unk	  expression	  
is	   required	   for	  maintenance	   and	   differentiation	   of	   neural	   stem	   and	   progenitor	  
cells.	  
	  
jmjd2b	  is	  required	  for	  zygotic	  transcription	  in	  zebrafish.	  
	   Full	   knockdown	   of	   jmjd2b	   never	   resulted	   in	   live	   embryos	   the	   following	  
day	   (data	   not	   shown).	   To	   determine	  when	   death	   occurred,	   the	   embryos	  were	  
observed	   intermittently	   after	   morpholino	   injection.	   Embryonic	   development	  
proceeded	  normally	  until	  ~4	  hpf	  during	  the	  onset	  of	  the	  mid-­‐blastula	  transition	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stage	  (MBT)	  in	  which	  zygotic	  transcription	  is	  initiated.	  jmjd2b	  morphants	  did	  not	  
develop	   beyond	   this	   point	  when	   an	   otherwise	   normal	   embryo	  would	   undergo	  
epiboly	  as	  blastula	  cells	  begin	   to	  migrate	  and	  envelop	  the	  yolk.	  The	  morphants	  
subsequently	  underwent	  a	  yolk	  burst	  phenotype	  characteristic	  of	  embryos	  that	  
fail	  to	  undergo	  epiboly	  (Figure	  4-­‐2A).	  
	   No	   embryonic	   transcripts	   for	   the	   zebrafish	   equivalent	   of	   early	  
mammalian	   trophectoderm	   (krt4),	   primitive	   endoderm	   (gata6,	   slc26a),	  
endoderm	   (sox17),	   and	   mesoderm	   (brachyury)	   were	   detected	   after	   the	   MBT	  
stage	  in	  jmjd2b	  morphants,	  suggesting	  zygotic	  transcription	  was	  not	  initiated	  or	  
severely	  delayed	   (Figure	  4-­‐2B).	  Co-­‐injection	  of	   jmjd2b	  morpholino	  with	  mouse	  
mRNA	   ameliorated	   the	   phenotype,	   suggesting	   that	   the	   defects	  were	   caused	   by	  
depletion	  of	  jmjd2b	  transcripts	  (Figure	  4-­‐2C).	  To	  test	  the	  hypothesis	  that	  the	  lack	  
of	   embryonic	   gene	   expression	   is	   due	   to	   failure	   to	   activate	   zygotic	   gene	  
transcription,	  we	   knocked	   down	   jmjd2b	   in	  Tg(ubiquitin:EGFP)	   embryos	   and	   as	  







	   In	   addition	   to	   having	   a	   role	   in	   hematopoiesis,	   we	   identified	   distinct	  
functions	  of	  unk	  and	  jmjd2b	  in	  other	  tissues	  during	  zebrafish	  development.	  unk	  is	  
required	  for	  maintenance	  and	  differentiation	  of	  the	  developing	  neuroepithelium.	  
Regardless	  of	   functional	  class,	  only	  9	  mutants	  in	  zebrafish	  have	  been	  described	  
that	  share	  a	  similar	  neural	  degeneration	  phenotype	  observed	  in	  unk	  morphants	  
(Abdelilah	   et	   al	   1996,	   Furutani-­‐Seiki	   et	   al	   1996).	   Recently,	   UNK	  was	   found	   to	  
play	   a	   role	   in	   the	   ubiquitination	   of	   BAF60b	   subunit	   of	   the	   BAF	   chromatin	  
remodeling	   complex	   in	   response	   to	   Rac	   activation,	   and	   the	   BAF	   complex	   has	  
been	  shown	  to	  be	  essential	  for	  neural	  development	  in	  mice	  (Lessard	  et	  al	  2007,	  
Lorès	   et	   al	   2010).	   Collectively,	   the	   data	   implicate	  unk	   as	   a	   critical	   regulator	   of	  
early	  neural	  development.	  	  
	   The	  evidence	  presented	  here	  for	   jmjd2b's	  requirement	  to	  initiate	  zygotic	  
transcription	   in	   blastula	   cells	   has	   never	   been	   described	   before.	   Our	   current	  
understanding	   of	   the	   genetic	   regulation	   of	  MBT	   is	   limited.	   By	   gene	   expression	  
analysis,	   factors	   involved	   in	   transcription,	   cell	   cycle,	   and	  embryonic	  patterning	  
are	  among	  the	  first	  zygotic	  genes	  to	  be	  activated	  while	  miR-­430	  targets	  maternal	  
mRNA	   for	   degradation	   	   (Giraldez	   et	   al	   2006,	   O'Boyle	   et	   al	   2007).	   It	   is	   unclear	  
whether	  depletion	  of	   any	  of	   these	   zygotic	   transcripts	  would	   result	   in	   a	   similar	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phenotype.	   Finally,	   loss	   of	   either	  mapkapk2	   or	   nanog	   results	   in	   a	   yolk	   burst	  
phenotype	   due	   to	   defects	   in	   yolk	   syncytial	   layer,	   the	   driver	   of	   morphogenic	  
movements	   during	   epiboly,	   which	   might	   be	   the	   case	   in	   jmjd2b	   morphants	  
(Holloway	  et	  al	  2009,	  Xu	  et	  al	  2012).	  Thus,	  further	  characterization	  of	  jmjd2b	  in	  
zebrafish	   would	   provide	   important	   clues	   to	   the	   mechanism	   of	   zygotic	   gene	  
activation.	  	  
	   Evidence	   of	   the	   tissue	   specific	   roles	   of	   chromatin	   factors	   has	   been	  
accumulating,	  but	  the	  mechanisms	  by	  which	  they	  achieve	  this	  function	  remains	  
unclear.	   Differential	   combinatorial	   assembly	   of	   chromatin	   complexes	   is	   one	  
elucidated	  mechanism	  (Lessard	  et	  al	  2007).	  Whether	  this	  is	  the	  only	  mechanism	  
by	  which	  tissue	  specificity	  is	  achieved	  remains	  to	  be	  determined.	  Further	  studies	  
on	   the	   function	  of	   individual	  chromatin	   factors	  such	  as	  unk	  or	   jmjd2b	  will	  help	  








Materials	  and	  Methods	  
Zebrafish	  maintenance	  and	  microinjection.	  
Zebrafish	  (Danio	  rerio)	  were	  bred	  and	  maintained	  according	  to	  Animal	  Research	  
guidelines	  at	  Children’s	  Hospital	  Boston.	  Embryos	  were	  developed	  at	  28.5°C	  and	  
staged	  according	  to	  hours	  post	  fertilization	  and	  morphological	  features	  (Kimmel	  
et	   al	   1995).	   Wild-­‐type	   Tüebingen,	   Tg(ubiquitin:EGFP),	   and	   Tg(gfap:EGFP)	   fish	  
were	   used	   (Mosimann	   et	   al	   2011,	   Bernardos	   and	   Raymond	   2006).	  
Microinjections	   were	   performed	   into	   the	   cell	   at	   the	   1-­‐cell	   stage.	   For	   mRNA	  
rescue	  experiments,	  200ng	  of	  mRNA	  was	   co-­‐injected	  with	   the	  morpholino.	  For	  




Morpholinos	  targeting	  the	  ATG	  start	  codon	  of	  unk	  and	  jmjd2b	  were	  synthesized	  




Whole-­mount	  in	  situ	  hybridization	  and	  immunohistonchemistry.	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WISH	  on	  zebrafish	  embryos	   fixed	   in	  4%	  paraformaldehyde	  were	  performed	  as	  
described	   previously	   (Thisse	   and	   Thisse	   2008).	   Immunohistochemistry	   was	  
performed	  as	  described	  previously	  (Shepard	  et	  al	  2005).	  Stained	  embryos	  were	  
imaged	   using	   a	   Nikon	   stereoscope	   with	   a	   Nikon	   Coolpix	   4500	   camera.	  
Fluorescent	   images	   were	   imaged	   on	   a	   Zeiss	   stereoscope	   with	   Zeiss	   Axiocam	  
camera	   or	   by	   confocal	   imaging	   on	   a	   Zeiss	   spinning	   disk	   confocal	   microscope	  


































Figure	  4-­1.	  unk	  is	  essential	  for	  central	  nervous	  system	  development.	  


















Figure	  4-­2.	  jmjd2b	  is	  required	  for	  zygotic	  transcription.	  	  (A)	   jmjd2b	  morphants	  begin	  to	  die	  by	  10	  hpf	  and	  exhibit	  yolk	  burst	  phenotype.	  Co-­‐injection	  of	  jmjd2b	  mRNA	  allowed	  embryos	  to	  survive	  to	  10	  hpf.	  	  (B)	   Zebrafish	   markers	   for	   enveloping	   layer	   (EVL)	   (krt4),	   yolk	   syncytial	   layer	  (YSL)	   (gata6,	   slc26a),	   endoderm	   (sox17),	   and	  mesoderm	   (brachyury)	  were	   not	  detected	  in	  jmjd2b	  morphant	  embryos	  by	  WISH.	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Figure	  4-­2.	  Continued.	  (C)	  Embryonic	  expression	  of	  krt4	  can	  be	  rescued	  with	  mRNA	  injection.	  	  (D)	  Loss	  of	   jmjd2b	   in	  Tg(ubiquitin:EGFP)	   leads	  to	  lack	  of	  GFP	  exprsesion	  during	  gastrulation.	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Attributions	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   this	   chapter.	   Gaël	  McGill	  
provided	  technical	  assistance.	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Introduction	  
The	  ontogeny	  of	  hematopoiesis	  in	  vertebrates	  is	  a	  highly	  dynamic	  process	  
involving	   multiple	   sites	   of	   blood	   formation	   and	   movement	   of	   these	   cells	   at	  
different	  stages	  of	  embryonic	  development.	  At	  least	  two	  waves	  of	  hematopoiesis	  
occur	  during	  development.	  The	   first	  and	  primitive	  wave	  produces	  erythrocytes	  
and	  macrophages	   in	   the	   posterior	   and	   anterior	   lateral	  mesoderm	   in	   zebrafish	  
(Detrich	   et	   al	   1995,	   Herbomel	   1999).	   This	   is	   equivalent	   to	   mouse	   yolk	   sac	  
hematopoiesis	   (Palis	   et	   al	   1999).	   Primitive	   blood	   enters	   the	   circulation	   at	   24	  
hours	  post-­‐fertilization	  (hpf),	  soon	  after	  the	  onset	  of	  the	  heartbeat.	  At	  the	  same	  
time,	  a	  transient	  population	  of	  erythroid	  myeloid	  progenitors	  (EMPs)	  is	  induced	  
in	   the	   posterior	   blood	   island	   in	   the	   tail	   (Bertrand	   et	   al	   2007).	  Meanwhile,	   the	  
aorta	   gonad	   mesonephros	   (AGM)	   becomes	   competent	   to	   give	   rise	   to	  
hematopoietic	   stem	   cells	   (HSCs),	   which	   are	   capable	   of	   self-­‐renewal	   and	  
differentiation	  into	  all	  hematopoietic	  lineages.	  The	  definitive	  wave	  is	  defined	  by	  
the	  formation	  of	  HSCs.	  They	  develop	  from	  the	  ventral	  wall	  of	  the	  dorsal	  aorta	  in	  
the	   AGM	   region	   by	   36	   hpf	   and	   enter	   the	   circulation	   through	   the	   caudal	   vein,	  
migrating	  to	  the	  caudal	  hematopoietic	  tissue	  (CHT)	  in	  the	  tail	  and	  subsequently	  
to	  the	  kidney,	  the	  zebrafish	  adult	  hematopoietic	  organ	  (Jin	  et	  al	  2007,	  Kissa	  and	  
Herbomel	  2010,	  Kissa	  et	   al	  2007,	  Murayama	  et	   al	  2006,	  Thompson	  et	   al	  1998,	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Zhang	  and	  Rodaway	  2007).	  Similarly,	  in	  mammals,	  the	  HSCs	  transition	  from	  the	  
AGM	  to	  the	  fetal	  liver,	  and	  finally	  to	  the	  adult	  bone	  marrow	  (Boisset	  et	  al	  2010,	  
Dzierzak	  and	  Speck	  2008).	  
	   Depicting	   the	   process	   of	   hematopoietic	   development	   using	   traditional	  
diagrams	   is	   difficult	   given	   the	   spatiotemporal	   regulation	   of	   HSCs.	   To	   improve	  
visualization	   of	   HSC	   development,	   a	   three-­‐dimensional	   (3D)	   animation	   was	  
created	   based	   on	   our	   current	   understanding	   of	   this	   process	   in	   zebrafish	   using	  
Autodesk	   Maya.	   Maya	   is	   a	   3D	   software	   that	   can	   be	   used	   for	   creating	   3D	  
animations,	   visual	   effects,	   game	   development,	   and	   post	   production	   projects.	  
Multiple	   programs	   are	   embedded	   within	   Maya,	   including	   3D	   modeling,	   3D	  
animation,	   dynamics	   and	   effects,	   rendering	   and	   imaging,	   and	  Maya	   Embedded	  
Language	  (MEL),	  Maya’s	  own	  scripting	  program.	  The	  program	  is	  highly	  versatile	  
and	  can	  be	  used	  for	  many	  different	  kinds	  of	  purposes,	  including	  animation	  of	  3D	  
protein	  structures.	  	  	  
Once	   created,	   the	   zebrafish	   animation	   can	   be	   updated	   rapidly	   upon	   the	  
release	  of	  new	  discoveries	  using	   the	  scene	   files	   that	  have	  been	  created	   for	   this	  
animation.	   Actual	   experimental	   data	   such	   as	   confocal	   images	   can	   also	   be	  
incorporated	   into	   the	  movie	   to	  present	  new	  models	  of	  HSC	  regulation.	  Overall,	  
this	   movie	   provides	   a	   clear	   and	   simple	   illustration	   of	   the	   process	   of	   HSC	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development	  that	  can	  be	  presented	  to	  investigators	  within	  or	  outside	  the	  blood	  





	   Six	   scenes	   were	   created	   for	   the	   animation	   (Figure	   2).	   The	   first	   scene	  
involves	   creating	   a	  model	   of	   a	   36	   hpf	   embryo,	   the	   timepoint	   when	   HSCs	   first	  
appear	  in	  the	  AGM.	  The	  embryo	  was	  created	  with	  multiple	  objects,	  specifically	  a	  
Polygon	   cube	   for	   the	   embryo	   proper,	   the	   eyes,	   neural	   tube,	   and	   otoliths,	   the	  
major	  features	  observed	  at	  this	  timepoint.	  A	  Polygon	  sphere	  was	  used	  to	  create	  
the	  yolk	  sac.	  Using	  reference	   images	  of	  zebrafish	  embryos,	  each	  polygon	  object	  
was	   extruded	   to	   match	   the	   shape	   of	   the	   embryo,	   and	   Subdivision	   lines	   were	  
increased	  at	  the	  end	  to	  smooth	  the	  mesh	  (Figure	  5-­‐1A).	  Finally,	  the	  embryo,	  the	  
eyes,	  the	  neural	  tube,	  otoliths,	  and	  yolk	  sac	  objects	  were	  then	  grouped	  together	  
to	  generate	  the	   final	  model	   for	   the	  embryo.	  The	  same	  modeling	  procedure	  was	  
used	  to	  create	  a	  5	  day	  embryo	  for	  the	  final	  scene.	  
	   The	   second,	   third,	   and	   fourth	   scenes	   involve	   closeups	   of	   the	   HSCs	   and	  
vasculature.	  The	  shape	  of	  HSCs	  are	  generally	  described	  as	  large	  round	  cells,	  thus	  
a	   NURBS	   sphere	   was	   created	   to	   represent	   the	   HSC.	   For	   the	   vasculature,	   a	  
Subdivision	  cube	  was	  flattened	  to	  resemble	  a	  flat	  square-­‐shaped	  endothelial	  cell.	  
The	   cube	   was	   then	   duplicated	   to	   generate	   a	   long	   rectangular	   sheet	   of	  
“endothelial	  cells”	  to	  create	  a	  full	  (scene	  2)	  or	  half	  (scene	  3)	  of	  a	  vessel	  using	  the	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Nonlinear	   Bend	   Deformer.	   For	   the	   red	   cells	   circulating	   through	   the	   vessel,	   a	  
NURBS	  sphere	  was	  adjusted	  to	  look	  like	  a	  human	  red	  cell	  but	  more	  oval	  in	  shape	  
as	  zebrafish	  red	  cells	  are.	  
	   For	   the	   fifth	   scene,	   which	   involves	   a	   lower	   magnification	   view	   of	   the	  
zebrafish	   kidney	   region,	   a	   Polygon	   cube	   was	   used	   to	   generate	   objects	  
representing	   the	  kidney,	   including	   two	   randomly	  extruded	  cubes	  placed	   inside	  
the	  kidney	  to	  emulate	  the	  nephrons.	  Circles	  were	  used	  to	  extrude	  from	  a	  Curve	  
to	   generate	   three	   large	   vessels	   that	   run	   through	   the	   region.	   One	   object	  
representing	   the	   swim	   bladder	   was	   placed	   next	   to	   the	   kidney	   and	   a	   large	  
randomly	   shaped	   object	   was	   placed	   behind	   these	   structures	   to	   fill	   in	  
surrounding	  space.	  
	  
Texturing	  and	  Lighting	  
	   The	   zebrafish	   embryo	   is	   transparent,	   thus	   very	   little	   texturing	   was	  
required.	   A	  Blinn	   shade	   and	   transparency	  was	   used	   for	   all	   texturing.	   The	   yolk	  
was	   tinted	  yellow,	  and	  a	   	  of	  Bump	  mapping	  using	  an	   image	  of	   the	  yolk	  surface	  
was	  applied	  to	  simulate	  the	  appearance	  of	  globular	  yolk	  cells.	  For	  the	  embryo,	  a	  
Rock	   texture	   was	   colored	   off-­‐white	   and	   Bump	   mapping	   was	   created	   using	  
Brownian	  noise	  to	  give	  a	  cellular	  look	  to	  the	  surface	  of	  the	  embryo.	  An	  image	  of	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the	  zebrafish	  eye	  was	  used	  to	  texture	  the	  eyes.	  A	   light	  color	  was	  applied	  to	  the	  
neural	   tube	   to	   help	  make	   it	  more	   visible	   through	   the	   other	   objects	   covering	   it	  
(Figure	  5-­‐1B).	  The	  same	  textures	  were	  applied	  to	  the	  5	  day	  embryo	  model.	  	  
	   Since	   blood	   is	   associated	  with	   red	   color,	   the	   HSC,	   red	   cells,	   and	   kidney	  
were	  textured	  in	  that	  shade,	  with	  the	  red	  cell	  being	  lighter	  and	  HSC	  darker	  and	  
the	  kidney	   in	  between.	  Brownian	  noise	  was	  used	  again	   for	  bump	  mapping	  and	  
for	  the	  transparency	  attribute	  of	  the	  HSC	  texture.	  A	  camel	  color	  was	  used	  for	  the	  
endothelial	  cells.	  Brownian	  noise	  was	  also	  applied	  to	  the	  transparency	  attribute	  
and	  leather	  was	  used	  for	  bump	  mapping	  create	  a	  more	  textured	  surface.	  	  
	   Directional	  light	  was	  used	  in	  every	  scene.	  Spot	  lights	  or	  Point	  lights	  were	  
added	  where	  needed.	  Every	  scene	  was	  enclosed	  inside	  a	  large	  sphere	  for	  lighting	  
purposes.	  The	  sphere	  was	  textured	  white,	  and	  a	  hint	  of	  yellow	  was	  added	  to	  the	  




	   To	   create	   circulating	   blood	   cells,	   a	   Curve	   Flow	   was	   created	   from	   the	  
Dynamics	  effects	  in	  which	  particles	  flow	  from	  one	  end	  of	  the	  Curve	  to	  the	  other	  
with	  their	  movement	  constrained	  by	  circles	  placed	  along	  the	  length	  of	  the	  curve.	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The	   Curve	  was	   drawn	   following	   the	  models	   of	   the	   vessels	   or	   embryo,	   and	   the	  
scale	  and	  location	  of	  the	  circles	  were	  adjusted	  to	  fit	  inside	  these	  objects.	  Next,	  the	  
model	   of	   the	   red	   cell	   was	   Instanced	   onto	   the	   flow	   particles	   to	   create	   the	  
circulating	  red	  cells	  (Figure	  5-­‐1C).	  Finally,	   the	  number	  of	  particles	  emitted	  was	  
adjusted	  to	  the	  appropriate	  number	  to	  fill	  the	  vessel.	  
	   	  
Animation	  
	   Simple	   animation	   was	   used	   to	   model	   the	   migration	   of	   the	   HSCs.	   This	  
involves	   moving	   the	   HSC	   sphere	   and	   setting	   key	   frames	   at	   each	   position.	   To	  
animate	  the	  HSCs	  squeezing	  through	  a	  vessel,	  a	  Lattice	  deformer	  was	  placed	  at	  
the	  site	  of	  extrusion.	  To	  animate	  the	  budding	  of	  the	  HSC	  from	  the	  endothelium,	  3	  
objects	   were	   created	   to	   model	   the	   different	   shapes	   of	   the	   HSC	   during	   the	  
budding	  process	  and	  blended	   together	  using	   the	  Blend	   shape	  deformer.	  At	   the	  
final	  stage,	  the	  endothelial	  cell	  was	  removed	  by	  applying	  full	  transparency	  to	  its	  
texture	  and	  replaced	  with	  a	  NURBS	  sphere	  representing	  the	  HSC	  that	  enters	  into	  
the	  circulation.	  The	  Blend	  shape	  deformer	  was	  also	  used	  to	  animate	  the	  beating	  
heart	  of	  the	  5	  day	  embryo.	  
In	   the	   final	   scene	  when	   the	   embryo	   swims	   off	   the	   scene,	   the	   embryo	  was	  
animated	  using	  key	  frames,	  and	  a	  Bend	  deformer	  was	  applied	  to	  the	  tail	  so	  that	  it	  
 119 
can	  flip	  back	  and	  forth	  in	  a	  swimming	  motion.	  Cameras	  were	  also	  key	  framed	  to	  
zoom	  in,	  zoom	  out,	  and	  follow	  the	  migration	  of	  the	  HSCs.	  	  
	  
Rendering	  and	  Compositing	  
	   Each	   scene	   was	   batch	   rendered	   into	   an	   image	   sequence.	   Scenes	   were	  
rendered	   in	  multiple	  parts	  when	  necessary.	   For	   example,	   to	   avoid	  overlapping	  
multiple	  curve	  flows	  in	  a	  scene	  such	  as	  the	  CHT,	  each	  curve	  flow	  was	  rendered	  
separately.	  All	   image	  sequences	  were	  subsequently	  composited	   in	  After	  Effects	  
(Figure	  5-­‐1D).	  Title,	  wording,	  and	  scene	  transitions	  were	  added	  at	  this	  step.	  The	  
selected	   music	   was	   cropped	   to	   match	   the	   duration	   of	   the	   animation	   in	  




	   The	   animated	   video	   presentation	   of	   the	   ontogeny	   of	   HSCs	   during	  
hematopoietic	   development	   provides	   a	   concise	   review	   of	   this	   process	   that	   is	  
easily	   understood.	   Developmental	   hematopoiesis	   is	   a	   dynamic	   process	   that	   is	  
spatiotemporally	  regulated.	  Studies	  of	  embryonic	  hematopoiesis	  involve	  whole-­‐
mount	  in	  situ	  hybridization	  (WISH)	  or	  imaging	  of	  fluorescent	  transgenic	  lines	  of	  
various	   blood	   markers	   at	   different	   stages	   of	   development	   to	   examine	   the	  
formation	   of	   erythroid,	   myeloid,	   or	   lymphoid	   cells,	   all	   of	   which	   develop	   at	  
distinct	   anatomical	   sites	   throughout	   the	   embryo.	   This	   animation	   provides	   the	  
audience	  with	  a	  clear	  depiction	  of	  the	  zebrafish	  embryo	  and	  the	  key	  anatomical	  
sites	  that	  would	  facilitate	  the	  understanding	  of	  the	   in	  situ	  data	  being	  presented	  
during	  a	  scientific	  talk	  (Figure	  5-­‐2).	  	  
The	  first	  version	  of	  the	  movie,	  titled	  “Induction	  of	  hematopoietic	  stem	  cells	  
in	  zebrafish,”	  was	  submitted	  as	  an	  introduction	  to	  a	  Cell	  article	  that	  can	  now	  be	  
found	   in	   Cell	   Press	   journal’s	   YouTube	   channel	  
(www.youtube.com/watch?v=tngFCgcrZ74)	  (Goessling	  et	  al	  2009).	  Given	  that	  a	  
wide	  audience	  was	  targeted,	  short	  sentences	  were	  added	  to	  the	  composition	  to	  
summarize	  the	  process	  animated	  in	  each	  scene,	  a	  very	  quick	  and	  easy	  task.	  Over	  
8,500	   views	   of	   the	   animation	   have	   occurred	   over	   the	   course	   of	   two	   years,	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supporting	   the	   usefulness	   of	   such	   visualizations.	   New	   evidence	   regarding	   the	  
budding	  process	  of	  HSCs	  from	  the	  endothelium	  has	  emerged	  since	  the	  creation	  of	  
the	  movie,	  and	  the	  animation	  was	  updated	  by	  adding	  a	  new	  AGM	  scene,	  using	  the	  
same	  techniques	  as	  before.	  Thus	  this	  animation	  can	  be	  rapidly	  modified	  to	  show	  
the	  latest	  developments	  in	  our	  understanding	  of	  hematopoiesis	  in	  zebrafish.	  	  
Besides	   creating	   Hollywood	   movies	   or	   TV	   commercials,	   one	   of	   the	   most	  
valuable	  aspects	  about	  3D	  animation	  is	  the	  ability	  to	  incorporate	  real	  data	  into	  it.	  
A	   method	   has	   been	   described	   to	   import	   confocal	   images	   into	   Maya,	   thus	   real	  
AGM	  and	  CHT	  structures,	   for	  example,	  can	  be	  imported	  into	  Maya	  and	  used	  for	  
the	   animation	   (Biological	   Visualization	   Interest	   Group)	   (Figure	   5-­‐3).	   This	   and	  
other	  methods	  of	  animating	  scientific	  data	  are	  more	  prominent	  in	  the	  field	  of	  cell	  
biology	   to	   help	   visualize	   protein	   structures	   or	   chemical	   reactions.	   Because	   the	  
biology	  of	  any	  system	  being	  studied	  can	  be	  complex,	  the	  combined	  presentation	  
of	   experimental	   data	   and	   the	   model	   derived	   from	   the	   data	   facilitates	   our	  
understanding	  of	   the	  science	  being	  presented.	  Thus	  the	  use	  of	  3D	  animation	   in	  




Materials	  and	  Methods	  
Reference	  images	  
	   Reference	   images	   for	   modeling	   were	   taken	   from	   wild-­‐type	   Tüebingen	  
zebrafish	  embryos	  at	  36	  hpf	  and	  5	  days	  using	  a	  Nikon	  stereoscope	  with	  a	  Nikon	  
Coolpix	  4500	  camera.	  Confocal	  imaging	  was	  performed	  on	  a	  Zeiss	  spinning	  disk	  
confocal	  microscope	   of	   a	   double	   36	   hpf	   transgenic	   embryo	   for	  Tg(cd41:EGFP)	  
and	  Tg(kdrl:RFP)	  (Huang	  et	  al	  2005,	  Traver	  et	  al	  2003).	  
	  
Softwares	  and	  music.	  
	   Autodesk	  Maya	  2008	  was	  used	  for	  the	  animation.	  Adobe	  After	  Effects	  CS4	  
was	  used	   for	   compositing.	  Adobe	   Soundbooth	  CS5	  was	  used	   to	   edit	   the	  music.	  
Imaris	  (BitPlane),	  a	  scientific	  visualization	  and	  analysis	  software,	  and	  Blender,	  a	  
3D	   animation	   freeware,	  were	   used	   to	   create	   the	   object	   file	   for	   the	   confocal	   z-­‐
stacks	  of	   the	  AGM	  to	   import	   into	  Maya.	  The	  music	  “Beneath	  the	  Lights”	  by	  The	  








Figure	  5-­1.	  The	  process	  of	  3D	  animation.	  	  (A)	  A	  polygon	  cube	  is	  modeled	  into	  a	  zebrafish	  embryo	  in	  Maya.	  	  (B)	  Textures	  and	  lighting	  applied	  to	  the	  models	  finish	  the	  look.	  	  (C)	   Animation	   of	   the	   embryo	   and	   HSCs	   together	   with	   curve	   flow	   of	   red	   cells	  complete	  the	  scenes	  for	  rendering.	  	  (D)	  All	  scenes	  are	  composited	  together	  in	  After	  Effects.	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Figure	  5-­2.	  Scenes	  for	  the	  animation.	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Figure	  5-­3.	  3D	  reconstruction	  of	  confocal	  data	  in	  Maya.	  	  (A)	   Confocal	   z-­‐stacks	   are	   acquired	   for	   example	   using	   Volocity	   software.	   The	  confocal	  data	  was	  then	  transferred	  to	  Imaris	  in	  which	  3D	  surfaces	  are	  generated.	  The	  surfaces	  were	  imported	  into	  Blender,	  a	  3D	  program,	  to	  convert	  the	  surfaces	  into	  an	  object	  file	  that	  can	  be	  read	  by	  Maya.	  	  (B)	  High	  resolution	  z-­‐stacks	  of	  a	  36	  hpf	  AGM	  in	  a	  double	  transgenic	  embryo	  for	  





















To understand the role of chromatin regulation in hematopoiesis, we 
conducted a reverse genetic screen knocking down most of the known chromatin 
factors in zebrafish embryos searching for factors that could alter hematopoietic gene 
expression during the process of primitive and definitive hematopoiesis. We 
identified a cohort of 47 factors that regulated distinct stages of primitive and 
definitive hematopoiesis, from the induction of the mesoderm to generate erythroid 
cells to the formation of hematopoietic stem and progenitor cells (HSPCs) from the 
hemogenic endothelium. These chromatin factors function in histone methylation, 
histone acetylation, and nucleosome remodeling. Characterization of individual 
factors revealed important tissue specific functions. For example, knockdown of chd7 
resulted in a cell autonomous increase in blood production in both primitive and 
definitive hematopoiesis. Loss of unk and jmjd2b reduced definitive hematopoiesis 
but they were also required for the development of the central nervous system and 
initiation of zygotic transcription during mid-blastula transition (MBT) stage, 
respectively. Collectively, these results demonstrate the important role of chromatin 
factors in establishing the programs of gene expression for specification and 
differentiation in hematopoiesis and other tissues. 
 
Morpholinos as a powerful tool for studying epigenetics. 
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 Morpholinos have been used widely to knockdown expression of specific 
genes and have been a valuable tool for developmental studies in zebrafish. They 
inhibit gene expression by steric blocking of translation initiation or of exon splicing. 
Delivery can be easily accomplished via microinjection into single cell embryos, and 
the concentration of the morpholinos can be adjusted to achieve different levels of 
knockdown in the injected embryos, or morphants, similar to an allelic series. Using 
our screening method of analyzing morphant phenotypes at three different doses for 
each morpholino, we were able to elucidate hematopoietic specific phenotypes, if any, 
for the knockdown of each chromatin factor. Because knockdown of some chromatin 
factors result in severe developmental abnormalities, which would subsequently affect 
blood development, we were able to adjust the dosing to reduce these morphological 
defects in order to determine whether the particular chromatin factor plays a role in 
blood formation. This is best exemplified by knockdown of jmjd2b. The histone 
demethylase jmjd2b is a critical factor for MBT, but at lower levels of knockdown, 
the embryo is able to develop relatively normally except for the formation of HSPCs 
at 36 hpf, revealing a requirement for jmjd2b in hematopoiesis. This type of 
manipulation is currently difficult to do for developmental studies in other organisms 
such as mice. All knockout models would result in complete knockdown of the gene 
of interest. Furthermore, the development of zebrafish embryos ex utero allows for 
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visualization of developmental processes otherwise difficult in mammalian systems. 
Defects in morphogenic movements, anterior-posterior patterning, or organ formation 
can all be scored just by looking at the embryos. Putative factors involved in cardiac 
function, such as smarcd2, and melanocyte development, such as suv39h1, have been 
uncovered in the chromatin factor screen. As a result, zebrafish will continue to be a 
valuable model for the study of epigenetics in development. 
 
Non-redundant roles of chromatin factors in modulating hematopoietic gene 
expression. 
 Chromatin modifying factors are needed to recognize and interpret the various 
chromatin modifications in order to execute the epigenetic program. With over 11 
post-translational modifications that can occur at 60 different histone residues, a 
reasonably large number of chromatin modifying factors would be needed. We 
curated a list of 425 chromatin factors encompassing most of the known chromatin 
factors to screen for epigenetic regulators of hematopoiesis. Perhaps because of the 
variety of histone methylation marks, with each one having differential functions 
depending on the chromatin context, a large number of chromatin modifying factors 
in our gene list are associated with methylation, with nearly 60 SET domain 
methyltransferases that catalyze the methylation reaction, about 30 demethylases that 
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can remove the mark, and over 60 binding factors that can be recruited by a methyl 
mark in zebrafish.  
Although there are a large number of related chromatin factors, we observed 
that loss of individual chromatin factors results in a noticeable hematopoietic 
phenotype. This implies that they have very tissue specific functions that cannot be 
compensated by other members of the same family. For example, within the SET 
domain family, the mixed-lineage leukemia (mll) gene and other family members 
mll3a, mll4a, and mll4b are all expressed ubiquitously in the early embryo, yet only 
knockdown of mll in the screen resulted in a loss of c-myb and runx1 expression in 
definitive HSPCs (Sun et al 2008). Mll is part of the trithorax proteins that catalyze 
and maintain the methylation of H3K4 and has been shown to be essential for HSC 
self-renewal, consistent with our screen results (Jude et al 2007, Macmahon et al 
2007). Thus the function of individual chromatin factors in vivo is largely distinct, 
even when they have overlapping expression patterns.  
There is also tissue specificity in terms of the level of knockdown required to 
change the expression of the hematopoietic transcription factors. Because of the three 
dose screening method, we were able to observe and distinguish between gross 
developmental phenotypes and blood specific phenotypes. High levels of smarca1 
knockdown resulted in developmental delay, but at lower doses, when the 
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developmental delay was milder, primitive erythroid cell formation was completely 
inhibited as shown by lack of scl+, gata1+ and β-globin e3+ cells in morphant 
embryos. At much lower doses, when embryos developed relatively normally until 36 
hpf, we could observe the loss of c-myb+ and runx1+ cells in the morphants. Thus the 
blood cells are more sensitive to levels of smarca1 compared to other tissues within 
the embryo. In comparing between the primitive and definitive screens, the 14 hpf 
embryos seemed to tolerate much higher doses of morpholinos than 36 hpf embryos. 
It may be because of residual maternal RNA remaining at the earlier timepoint or 
because the defects arise slightly later in development, but it could also be because of 
different sensitivities between primitive erythroid cells and definitive HSPCs. Due to 
the variety of factors that could contribute to the blood phenotype in the morphants, 
the morpholino dose curve allowed us to distinguish more hematopoietic specific 
defects by comparing the changes in blood phenotype with respect to the changes in 
embryonic development.  
 
Differential requirement of chromatin factors in hematopoietic development. 
Tissue differentiation is thought to be largely an instructive process directed 
by lineage specific transcription factors. The concept that gene repression plays an 
important role in lineage determination has also been proposed with some evidence to 
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support it. DNA methyltransferase 1 (Dnmt1) catalyzes DNA methylation, which is 
usually associated with gene repression. Loss of Dnmt1 not only resulted in loss of 
HSC self-renewal but also skewing towards the myeloid lineage (Bröske et al 2009, 
Trowbridge et al 2009). Bmi1, a component of the Polycomb repressive complex, was 
found to be required for repression of the B cell lineage regulators Ebf1 and Pax5 in 
HSCs, which were activated prematurely in Bmi1 knockout mice (Oguro et al 2010). 
Our screen results support both models in which chromatin factors participate in 
lineage specification and differentiation through activating and inhibitory functions. 
Based on the primitive screen, depletion of one chromatin factor is sufficient 
to alter gene expression of scl, gata1, and β-globin e3, which subsequently disrupts 
normal development of erythroid cells. Reduced scl  expression always coincided 
with loss of gata1 andβ-globin e3 expression. Even though scl expression was not 
fully abrogated in morphant embryos, it was sufficient to impair the formation of red 
cells, demonstrating the critical role that chromatin factors have in maintaining proper 
gene expression levels that in turn affect cell fate decisions. 
In analyzing the screen hits to determine which chromatin modifications were 
important for the regulation of hematopoietic genes, mainly chromatin factors 
involved in the processes of histone methylation, histone acetylation, and nucleosome 
remodeling were found. Based on whole genome mapping of histone modifications, 
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histone acetylation is generally associated with active transcription. In contrast, the 
effect of histone methylation depends on the residue that is modified. H3K4 
methylation is relatively specific to active gene promoters and H3K36 methylation 
marks chromatin domains that are actively transcribed. Methylation of H3K9 and 
H3K27, on the other hand, generally correlate with repression. Finally, nucleosome 
remodeling is important for mobilizing nucleosomes to make the DNA accessible to 
transcription factors and other cellular proteins (Bernstein et al 2007).  
 Overall, the chromatin factor hits from the definitive screen support the model 
in which activating marks promote HSPC formation. The 29 definitive chromatin 
factors that were characterized are involved in the processes of H3K4 methylation, 
H3K9 methylation, H3K36 methylation, and histone acetylation, suggesting that these 
modifications are important for the induction of HSPCs. Loss of setd1ba, ash2l, 
cxxc1l, rbbp4, and rbbp7, components of the SET1 complex known to methylate 
H3K4, resulted in loss of HSPC formation. Knockdown of jmjd1ca, which 
demethylates H3K9, also resulted in loss of HSPCs. Thus these chromatin factors are 
needed presumably to activate genes required for the formation of HSPCs, including 
c-myb and runx1, via methylation of H3K4 and demethylation of H3K9. However, 
loss of some other factors, such as the H3K36 demethylase jhdm1bb, also resulted in 
loss c-myb or runx1 expression in the AGM even though retention of active marks 
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should have enhanced c-myb and runx1 expression instead. This indicates that 
repression also plays a role during lineage specification. 
 Consistent with this idea, we observed increased erythroid differentiation in 
morphants that had more overall transcriptional repression. Knockdown of two thirds 
of the 18 chromatin factors characterized in the primitive screen resulted in increased 
globin expression and not a reduction. Depletion of these chromatin factors should 
have resulted in an accumulation of repressive marks, thus supporting the model that 
gene repression is critical for differentiation. Loss of ash2l would reduce levels of 
active H3K4 methylation, whereas loss of jhdm1f and jmjd3 would each result in 
preservation of repressive H3K9 and H3K27 methylation, respectively. Furthermore, 
loss of ing5b, which participates in a histone acetyltransferase complex, should lead 
to reduced acetylation levels, promoting a more repressive environment. Generally, 
repressive histone marks inhibit transcription and therefore should have inhibited scl 
and gata1 expression in the morphants, but our screen results suggest that this is not 
the case. These observations could mean that repression is required to suppress gene 
expression of the earlier cell fate or alternative cell fates, especially since scl+ cells in 
the posterior lateral mesoderm also give rise to angioblasts, and perturbing this 
balance is what results in increased primitive hematopoiesis. Another possible 
explanation is that the function of either the histone marks or the chromatin factors in 
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vivo are more diverse than currently thought. One example is the Tip60 
acetyltransferase, which in ES cells has been found to repress target genes when in 
complex with p400 (Fazzio et al 2008). Thus the cellular context is an important 
determining factor in how the epigenetic code is deciphered.  
One method to characterize the effects of these chromatin factors on lineage 
decisions in hematopoiesis is to study the gene expression changes in the morphants. 
The primary screen provides a targeted list of chromatin factors that can be re-
screened for lineage skewing either by WISH or by expression array to identify 
additional hematopoietic genes that are affected. The primary hit list could then be 
subdivided into groups that regulate different lineages. For example, neutrophils and 
thrombocytes are among other lineages that are produced in concert with erythrocytes 
during the primitive wave, and loss of gata1 converts erythropoiesis to myelopoiesis 
(Galloway et al 2005, Warga et al 2009). Taken together, our screen results are 
consistent with the overall concept that both positive and negative regulation is 
required for proper specification and differentiation of hematopoietic cells. 
 
Stages of chromatin modification in hematopoietic development. 
Based	  on	  the	  characterization	  of	  the	  screen	  hits,	  a	  map	  can	  be	  generated	  
delineating	   the	   chromatin	  modifications	   important	   for	   different	   steps	   of	   blood	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development.	   The	   screen	   results	   suggest	   that	   ISWI	   chromatin	   remodeling	   is	  
among	  the	  first	  steps	  required	  to	  initiate	  the	  blood	  program	  given	  the	  severity	  of	  
the	  scl	  phenotype.	  Subsequently,	  Polycomb	  and	  NuRD	  factors	  are	  important	  for	  
the	   formation	   of	   gata1+	   progenitors	   given	   that	   only	   gata1	   and	  β-­globin	   e3	  
expression	  are	  affected	  in	  the	  cbx8	  and	  chd4	  morphants,	  respectively.	  Then,	  the	  
NuA4	  acetyltransferase	   is	   required	  during	   the	  differentiation	  of	   erythroid	   cells	  
since	  onlyβ-­globin	  e3	  expression	  was	  reduced	  in	  kat5	  morphants.	  Furthermore,	  
histone	  modifications	  exist	   in	   combinatorial	  patterns	   (Latham	  and	  Dent	  2007),	  
and	  our	  screen	  results	  indicate	  the	  possibility	  that	  patterns	  of	  H3K4,	  H3K9,	  and	  
H3K27	  methylation	  plays	  a	  role	  in	  the	  transition	  between	  the	  stages	  of	  primitive	  
blood	   formation.	   It	  may	  be	  possible	   to	  use	   transgenic	   fish	  expressing	  draculin-­
GFP,	  which	  is	  expressed	  in	  primitive	  blood	  precursors	  in	  the	  lateral	  mesoderm	  at	  
11	  hpf	  all	  the	  way	  to	  maturing	  erythroid	  cells	  at	  24	  hpf,	  to	  sort	  GFP-­‐positive	  cells	  
for	   mapping	   these	   histone	   marks	   across	   the	   different	   stages	   of	   erythroid	  
development	  (Herbomel	  et	  al	  1999).	  Our	  screen	  complements	  other	  efforts	  such	  
as	   the	   characterization	  of	  histone	  marks	   in	  mouse	   fetal	   liver	   erythropoiesis	  by	  
providing	  a	   list	  of	  chromatin	  factors	  and	  chromatin	  modifications	   implicated	  at	  
these	  different	  stages	  of	  blood	  development	  (Wong	  et	  al	  2011).	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Primitive and definitive hematopoiesis utilize the same chromatin complexes. 
 Many of the primitive and definitive screen hits can be organized into known 
chromatin complexes, including SWI/SNF, SET1, Sin3A/HDAC, HBO/NuA4/HAT, 
and PRC1. The SWI/SNF, SET1, and HBO/HAT complexes are important for both 
primitive and definitive blood formation while Sin3A/HDAC, NuA4/HAT, and PRC1 
are required more for definitive blood formation. Despite the large overlap in 
complexes utilized, fewer components of each complex were needed in the primitive 
wave. This may reflect the more complex regulation of HSCs, in which they must 
balance self-renewal with differentiation, whereas primitive blood progenitors only 
need to produce red cells.  
 One of the mechanisms by which chromatin factors are believed to achieve 
tissue specificity is through combinatorial assembly of chromatin modifying 
complexes. Given that primitive and definitive complexes overlap in terms of their 
function, the individual components that makeup these complexes are largely distinct. 
Thus the subunits likely provide tissue and stage specificity for these overlapping 
chromatin complexes. It would be valuable to test whether screen hits within the same 
category in various combinations with each other can all enhance the hematopoietic 
phenotype. This can be tested by injecting combinations of morpholinos at suboptimal 
doses to determine whether they phenocopy the individual morphants. This was the 
 138 
case for the combined knockdown of the ISWI related factors smarca1, chrac1, and 
rsf1b and the PBAF associated factors chd7 and arid4b. Whether this indicates that 
these chromatin factors participate in the same chromatin complexes or function in 
parallel pathways would require protein interaction assays such as co-
immunoprecipitations or protein pulldowns to distinguish between the two 
possibilities. A recent study comparing the localization of 29 chromatin factors 
between embryonic stem (ES) and K562 cells revealed that the association between 
groups of chromatin regulators appear to be preserved between the two different cell 
types, suggesting that chromatin complex associations discovered in our screen could 
be conserved in other tissues as well (Ram et al 2011). 
 One interesting observation from the screen was that both enzymes, i.e. 
‘writers’ and ‘erasers,’ and binding factors, i.e. ‘readers,’ were found to be equally 
important for regulating hematopoiesis. Counting the 47 chromatin factors having the 
greatest decrease or increase blood phenotypes characterized in the screen, the 
number of enzymes and binding factors in the primitive and definitive lists were 
roughly equal. Within the enzymatic group, there was even representation of ‘writers’ 
and ‘erasers.’ Thus all three processes are important for maintaining the proper 
balance of gene expression pattern in the embryo, regardless of whether they form a 
chromatin complex together or not.  
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Screen resource for the future. 
 In order to record the wealth of phenotypes observed in the screen, a database 
was created to catalog all the results and facilitate future studies of chromatin factor 
regulation in hematopoiesis and other developmental biology. The database contains 
all the zebrafish and human annotations for the 425 chromatin factors screened, all the 
experimental details including methods, all the in situ data results for each chromatin 
factor screened, and is searchable by gene of interest. Most importantly, it provides a 
collection of morpholino sequences that result in an embryonic phenotype, which will 
be of interest to the broader community.  
 The database can be used to identify putative chromatin regulators of a 
specific developmental process other than hematopoiesis. In zebrafish, histone 
methylation of H3K4, H3K36, and H3K27 occurs only after the onset of zygotic 
transcription during MBT stage (Sun et al 2008, Vastenhouw et al 2010). Multiple 
histone methyltransferases, demethylases, and methyl mark binding proteins might be 
required at this time, and some of these chromatin factors were probably included in 
our screen. phf3 and phf6, PHD domain containing factors that can bind methylated 
histone marks, and prdm1a, setd4, setd6, and setdb1b, SET domain 
methyltransferases, are all potential regulators given their early developmental 
defects. 
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The mechanisms of chromatin regulation in embryonic development remains 
largely unknown. The majority of the studies focused on histone modifications have 
been on the N-terminal tail modifications, yet histones can also be modified within 
their globular domain. With advances in the development of new antibodies and 
improvements in mass spectrometry, new histone modifications are being discovered. 
Most recently, over 67 novel histone modifications were identified, and lysine 
crotonylation was discovered as a new mark that correlates strongly with active 
promoters like H3K4 methylation (Tan et al 2011). Thus the identification of new 
protein domains that can catalyze the crotonylation of histone proteins are likely in 
progress. Whether these domains will be uncovered in a new class of histone 
modifying factors or as additional domains in currently known chromatin factors 
remains to be determined. Even within our current list of 425 chromatin factors, the 
function of many of those factors containing chromatin modifying domains is 
unknown. Consequently, our screen database will continue to serve as a valuable 
resource for the study of chromatin factors and their effects on development.   
 
Individual chromatin factors have essential developmental and tissue specific 
roles. 
 Characterization of individual chromatin factors, e.g. chd7, from the screen 
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has already provided insights into the mechanisms of how each regulates 
development and provides additional clues about how tissue specificity is achieved. 
Expanding the analysis to other individual factors should yield such insights. unk, a 
radical SAM domain containing protein, not only regulates HSPC formation but is 
also required for central nervous system development. jmjd2b, a histone demethylase, 
is required for both the initiation of zygotic transcription and induction of HSPCs 
later in development. One of the factors with the most robust phenotype identified 
from the screen was chd7.  
Although expressed ubiquitiously, knockdown of chd7 resulted in a specific 
enhancement of primitive and definitive hematopoiesis. The expression of scl marks 
one of the first steps in developmental hematopoiesis, the induction of the lateral 
mesoderm. By the 5 somite stage (ss), roughly 11.6 hpf, the scl+ cells in the posterior 
tail have already started to expand in chd7 morphants, and by 24 hpf, primitive 
erythroid and myeloid lineages are also increased. The same pattern is observed with 
the formation of definitive c-myb+ and runx1+ HSPCs in the aorta gonad 
mesonephros (AGM) region at 36 hpf and in the erythroid, thrombocytic, and myeloid 
lineages in the caudal hematopoietic tissue (CHT) at 5 days. It was surprising to see 
the phenotype persist this long because the morpholinos generally lose their effect by 
5 days as they have already been diluted in the embryo through so many cell 
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divisions. More importantly, the blood expansion is cell autonomous as determined 
by blastula transplantation experiments. Collectively, these results suggest that chd7 
is as a potent repressor of embryonic hematopoiesis.  
 
Elucidating the molecular mechanism of Chd7 in blood. 
 One of the major future directions resulting from the chromatin factor screen 
is to elucidate the mechanism by which the chromatin factors identified regulate 
hematopoiesis, and chd7 is a great candidate for initiating such studies. The blood 
expansion observed in chd7 morphants could be the result of several mechanisms. 
One possible model is that hematopoietic transcription factors such as scl, c-myb, and 
runx1 are transcriptional targets of chd7, which can be assayed by chromatin 
immunoprecipitation (ChIP) followed by sequencing to map Chd7 binding sites 
across the genome. ChIP-seq data of CHD7 in K562 cells, a human erythroleukemic 
cell line, is available, and initial analysis revealed CHD7 binding at important 
hematopoietic genes such as SCL, RUNX1, and MYB (Ram et al 2011). This is 
consistent with an interesting observation in zebrafish embryos in which knockdown 
of chd7 in Tg(cmyb:EGFP), Tg(lmo2:dsRed), and Tg(cd41:gfp) embryos not only 
increased the number of fluorescently labeled blood cells but the intensity of the 
fluorescence was also significantly higher, indicating direct repression by Chd7 at 
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these hematopoietic promoters. Correlating the CHD7 ChIP binding sites to genome-
wide histone marks from the ENCODE database and expression data from K562 cells 
will help determine whether CHD7 binding associates with repression or not in this 
context. With the exception of one study so far, CHD7 is generally associated with 
transcriptional activation, and thus the role for chd7 in blood appears to be opposite of 
its function in other tissues, with preliminary evidence to support the case discussed 
later in this chapter. 
  A MYB motif was identified from a subset of the CHD7 binding sites, 
suggesting a potential interaction between CHD7 and MYB. Previous work has 
shown the essential role for cMyb in regulating multipotent progenitors. 
Overexpression of c-Myb in ES cells increased multilineage colony formation and 
self-renewal in culture whereas conditional knockout of the gene in mouse bone 
marrow resulted in defective self-renewal and multilineage differentiation of adult 
HSCs (Dai et al 2006, Lieu and Reddy 2009). Thus overexpression of c-myb in the 
context of chd7 knockdown may be the cause of increased stem cell and blood 
formation. To determine whether CHD7 and MYB bind to the same set of target 
genes, ChIP-seq of MYB in K562 cells were initiated. CHD7 can also be knocked 
down in the K562 cells to determine whether MYB binding changes. If CHD7 
inhibits MYB by competing for MYB binding sites, then under normal conditions, 
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target genes may be occupied by CHD7 whereas in the CHD7 knockdown, MYB 
would occupy those same sites. If MYB binding was independent of CHD7, then 
knockdown of CHD7 will probably not cause any changes in MYB binding. The only 
difference would be in the expression of the target genes. In the presence of CHD7, 
there would be low to no expression of MYB targets whereas their expression should 
increase upon depletion of CHD7. Thus analyzing the expression of MYB target 
genes in the presence or absence of CHD7 will help determine the role of CHD7 in 
regulating MYB function. 
Given that chd7 is widely expressed but has hematopoietic specific functions, 
a protein pulldown with mass spectrometry of CHD7 in blood cells will help identify 
its hematopoietic specific interacting factors. Co-elution of MYB and CHD7 from 
K562 gel filtration analysis indicated a potential interaction between the two factors, 
thus the pulldown will also help verify whether MYB and CHD7 interact in the same 
complex given that a direct interaction was not detected by co-immunoprecipitation. 
Since multiple hematopoietic genes are affected by chd7 knockdown, additional 
hematopoietic transcription factors may be identified in the pulldown. Subunits of 
repressive chromatin complexes such as SETDB1 may also be pulled down with 
CHD7 given its negative regulatory function on hematopoietic gene expression. One 
previous study revealed that SETDB1 can recruit CHD7 to repress target genes in 
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mesenchymal stem cells (Takada et al 2007). Although expressed at low levels in 
K562 cells, a direct interaction has been shown for RUNX1 and CHD7 via the 
transactivation domain of RUNX1 in T cells (see Chapter 3, note added in proof). 
Runx1 is required for the induction of HSCs from the AGM and differentiation of 
certain adult lineages, which may also account for the expansion of stem and 
progenitor cells in chd7 morphants (Li et al 2006, Okuda et al 1996). Thus identifying 
the interacting proteins of CHD7 will be important for understanding its function in 
blood cells.  
The next question would be which protein domains of Chd7 are important for 
its function in hematopoiesis. Mutational truncation analysis to identify the MYB or 
RUNX1 interacting domains of CHD7 will help determine whether CHD7 represses 
both MYB and RUNX1 together via two different interacting domains or by 
competition for the same binding site. In the latter case, a possible model for CHD7 
function is that binding to RUNX1 renders it inactive or inefficient in transcriptional 
activation, but when CHD7 is knocked down, RUNX1 activity is regained and can 
activate downstream hematopoietic genes such as MYB. Furthermore, it would be 
interesting to determine whether the chromatin modifying domains of CHD7 are 
required for suppression of MYB and RUNX1. In a preliminary experiment, 
overexpression of human CHD7 suppressed formation of c-myb+ cells in 
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Tg(cmyb:EGFP) embryos, and a catalytic mutant CHD7K998R can be tested to 
determine whether suppression of c-myb+ cells is lost. Overall, understanding the 
mechanism of CHD7 function will provide much insight into the regulation of 
hematopoiesis.  
 Genetic interaction between chd7 and other proteins identified from the 
pulldown can be verified in zebrafish. Double morpholino knockdown of chd7 and 
the candidate factors can be done to test whether chd7 morphants are rescued to 
identify regulators of Chd7 function. Mutants for c-myb and runx1 are available and 
can be used to test for interaction with chd7.  The cmybt25127 allele results in an amino 
acid substitution that abrogates its DNA binding domain, and homozygous mutant 
embryos progressively lose definitive hematopoietic cells after 24 hpf (Soza-Reid et 
al 2010). However, c-myb transcripts accumulate in the ICM of 24 hpf mutants as 
seen by WISH and then gradually disappear. It is unknown at this point whether 
runx1 expression is affected in the mutants. On the other hand homozygous runx1hg1 
mutants lose all c-myb expression in the AGM and in the CHT. The mutant allele 
results in a truncation of the protein starting from within the runt domain (Jin et al 
2009). chd7 morpholino can be injected into embryos from an incross of cmybt25127 or 
runx1hg1 heterozygous fish to determine whether increased c-myb or runx1 expression 
is retained in the homozygous mutant embryos. If chd7 works through c-myb and 
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runx1, mutation of either gene should suppress the expansion of blood induced by 
loss of chd7. One potential caveat to the c-myb experiment is that there may be 
compensation by b-myb, thus a double knockdown of b-myb and chd7 may be 
required to see the suppression. Collectively, these experiments will help elucidate a 
mechanism for CHD7 function by identifying interacting partners and the target genes 
that regulate blood development.  
 
Identifying signaling pathways that interact with chd7.  
Various transgenic fish expressing activators or inhibitors of known signaling 
pathways important for blood development could be used to rapidly screen for 
upstream regulators of chd7. Heat-shock lines overexpressing activators and 
inhibitors of Wnt, BMP, and Notch can be injected with chd7 morpholinos to 
determine whether c-myb or runx1 expression is affected. Enhancement of bone 
morphogenic protein (BMP) signaling pathway by overexpressing bmp2b increased 
posterior blood island formation, demonstrating a role for BMP signaling in the 
induction of primitive hematopoietic cells (Lengerke et al 2008). To test whether 
inhibition of BMP signaling could suppress the blood expansion of chd7 morphants, 
chd7 morpholino was injected into embryos expressing the BMP inhibitor chordin 
under the control of a heat-shock promoter, Tg(hsp70l:chd). Embryos were 
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heatshocked briefly after the onset of gastrulation and developed until 36 hpf to 
examine c-myb and runx1 expression in the AGM. It was interesting to observe that 
chd7 overall synergized with BMP pathway because heat-shocked chordin chd7 
morphants displayed a more severe phenotype than uninjected chordin embryos, 
consistent with previous studies (Hurd et al 2010, Layman et al 2009, Patten et al 
2012). For example, the tail of the morphants was much shorter, and heart 
development was severely inhibited. However, chordin chd7 morphants still had more 
c-myb+/runx1+ cells in the trunk compared to uninjected controls, thus chd7 does not 
appear to interact with the BMP pathway in blood, further supporting the differential 
role of Chd7 in hematopoiesis distinct from other tissues. 
  
chd7 regulation in adult hematopoiesis. 
Given that knockdown of chd7 increased most of the hematopoietic lineages 
tested, one of the questions that arises is whether chd7 is also required for the 
differentiation of individual hematopoietic lineages. Specific knockouts of chd7 in 
each hematopoietic lineage would have to be generated in order to address this 
question, which is possible in mice by breeding existing Chd7flox lines to tissue 
specific Cre recombinase lines. In one initial study, Vav-Cre driven knockout of Chd7 
in all hematopoietic lineages in the mouse embryo did not result in specific lineage 
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defects, but there was an expansion of T cells after competitive transplantation, 
consistent with the zebrafish phenotype and suggesting functional conservation of 
CHD7 in mice (see Chapter 3, note added in proof). The role of Chd7 in adult 
hematopoietic cells can be studied by conitionally deleting Chd7 using Mx1-Cre. 
In addition to embryonic hematopoiesis, chd7 may also have a role in adult 
hematopoiesis. To date, a zebrafish mutant for chd7 has not been identified, but a 
mutant can be generated relatively quickly using engineered zinc finger nucleases 
(ZFN). Zinc finger nucleases are chimeric proteins containing zinc finger proteins, 
which provide DNA binding specificity, fused to a FokI endonuclease domain. 
Dimerization of zinc finger nucleases is required for endonuclease activity, which 
ultimately results in the introduction of mutations during the repair of double stranded 
DNA breaks induced at the target sites (Meng et al 2008). Using the context-
dependent assembly (CoDA) program, sequences within chd7 suitable for zinc finger 
targeting can be rapidly identified (Sander et al 2008). Recently, I have generated 
three pairs of zinc fingers that target the coding regions of chd7, of which two appear 
to have activity in vivo. Screening is in progress to identify founder fish harboring 
mutations in chd7. Although homozygous mutant fish may not survive to adulthood 
given the crucial role of chd7 in development, they may still be able to survive to the 
larval stages to allow for additional blood analysis. The study of globin switching 
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would be possible with such a mutant. Although still in the process of being analyzed, 
the microarray results showed an increase in adult globin expression in chd7 
morphants at 36 hpf. Any changes in embryonic or adult globin expression can be 
assayed by quantitative PCR for the specific globin genes. 
With a viable zebrafish chd7 mutant, the effects of losing chd7 in the 
development and maintenance of adult kidney marrow blood populations could be 
studied. Even the loss of one allele may result in a phenotype given that human 
CHARGE patients are haploinsufficient for CHD7. Fluorescence activated cell 
sorting (FACS) can be used to visualize the lymphoid, myeloid, and precursor 
populations in the kidney marrow. Based on the embryonic phenotype, there may be a 
higher percentage of blood populations in chd7 deficient marrow compared to wild-
type. Skewing towards the myeloid lineage is possible given the strong upregulation 
of c-myb in the embryo.  
Whether upregulation of hematopoietic genes in chd7 deficient cells correlates 
with improved regenerative functions can be tested by kidney marrow irradiation and 
transplantation assays. For the irradiation recovery assay, chd7 mutant, heterozygous, 
and wild-type adult zebrafish are sublethaly irradiated, and recovery of lymphoid, 
myeloid, and precursor populations is measured by FACS over a time course 
(Trompouki et al 2011). Competitive kidney marrow transplantation experiments can 
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be performed to determine whether loss of chd7 improves the transplantability of 
marrow cells using FACS again to measure marrow populations after transplantation. 
Some hematopoietic genes have been found to improve self-renewal and engraftment 
ability of HSCs, notably HoxB4, thus chd7 deficient cells may also show improved 
reconstitution given the broad upregulation of hematopoietic genes. These 
experiments will also help determine whether Chd7 is valuable as a therapeutic target 
(Antonchuck et al 2001).  
Some evidence in mice already suggests a function for chd7 in adulthood. 
Chd7 is expressed at low levels in bone marrow HSCs but at very high levels in 
monocytes and granulocytes of the myeloid lineage and B and T cells of the lymphoid 
lineage, among others (Beerman et al 2010). Consistent with the high expression in 
lymphoid cells, Chd7 deficient bone marrow showed a competitive advantage in T 
cell reconstitution (see Chapter 3, note added in proof). These experiments can be 
extended to secondary and tertiary transplants to determine whether chd7 deficient 
stem cells show enhanced self-renewal capabilities. Collectively, the use of zebrafish 
mutants and conditional mice will help elucidate the function of Chd7 in regulating 
adult hematopoiesis. 
 
CHD7 as a therapeutic target. 
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If indeed the inhibition of CHD7 results in activation of the entire 
hematopoietic program, it would be a valuable target to manipulate for ex vivo 
generation of blood cells or for therapies such as cord blood transplantation that 
require cells to reconstitute the entire hematopoietic system. A transgenic fish line 
expressing GFP under the chd7 promoter can be generated and used for chemical 
screening for factors that suppress chd7. Any upstream signaling pathway found to 
interact with chd7 can be verified with chemicals as part of the screen. The 
fluorescent readout should be robust given the high levels of ubiquitous expression of 
chd7 in the early embryo as determined by whole mount in situ hybridization 
(WISH). As this is not a tissue specific assay, any potential candidates can be retested 
in Tg(cmyb:EGFP) embryos or by WISH for various blood markers. 
Chemicals that regulate chd7 can then be tested for their ability to enhance 
blood formation in therapeutic cell types such as human embryonic stem (ES) cells 
and mobilized bone marrow CD34+ cells. Knockdown of CHD7 will have to be 
tested first to characterize its function in these systems. Given that CD34+ cells are 
hematopoietic, we would expect that depletion of CHD7 would expand these cells. 
Transplantation into mice can be used to determine if it enhances engraftment or 
transplantability. ES cells are pluripotent cell types that can be instructed to form 
various adult tissue types. Reduction of CHD7 may relieve repression of 
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hematopoietic transcription factors and improve directed differentiation of ES cells 
into blood ex vivo. Various efforts are underway to uncover epigenetic drugs that alter 
the epigenetic state of cells for therapeutic uses. With the use of zebrafish genetics, 
we have identified chd7 and other chromatin factors as a putative therapeutic targets 
for hematopoietic reconstitution in humans. 
 
Concluding remarks. 
 The work described in this thesis provides a platform for understanding the 
epigenetic code that directs the specification and differentiation of hematopoietic 
cells. The hematopoietic system has been used widely to study the molecular 
mechanism regulating developmental processes. Earlier studies focused on the role of 
transcription factors in determining cell fate, and current efforts are focused on the 
epigenetic contributions to this process. Our chromatin factor screen identified a non-
redundant and tissue specific role for chromatin factors regulating various stages of 
developmental hematopoiesis in vivo using zebrafish. The workup of chd7 supports a 
possible model in which chromatin factors act as gatekeepers of lineage commitment 
and differentiation given as disruption of chd7 and other chromatin factors 
characterized in this thesis appear to regulate development of an entire organ. 
Elucidating the function of chd7 and other chromatin factors identified from the 
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screen will likely reveal new mechanisms into how changes in chromatin structure 



































	  	  	  
Supplementary	   Figure	   2-­1.	   Screen	   hits	   with	   morphological	   defects.	   Blue	  downward	   arrows	   represent	   reduced	   expression	   of	   the	   marker,	   with	   three	  arrows	  representing	  the	  strongest	  reduction.	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Supplementary	  Figure	  2-­2.	  smarca1	  is	  required	  for	  primitive	  and	  definitive	  




















Supplementary	   Figure	   2-­3.	   Combinatorial	   loss	   of	   chromatin	   factors	  
enhances	  hematopoiesis.	  Knockdown	  of	  arid4b	  results	  in	  increased	  c-­myb	  and	  


























Supplementary	  Table	  2.	  Definitive	  strong	  decrease	  and	  increase	  hits.	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Addendum	  
	   To	  further	  categorize	  and	  analyze	  our	  dataset,	  we	  are	  generating	  a	  protein-­‐
protein	  interaction	  map	  of	  all	  425	  chromatin	  factors	  screened	  and	  mapping	  our	  
screen	   hits	   with	   no	   morphological	   defects	   onto	   this	   network	   to	   help	   identify	  
additional	  complexes	  or	  subunits	  important	  for	  blood	  development.	  This	  work	  is	  
being	  done	  in	  collaboration	  with	  the	  Winston	  Hide	  lab.	  	  
We	   are	   also	   developing	   Fluidigm	   technology	   of	   high-­‐throughput	   qPCR	   to	  
analyze	  changes	  in	  gene	  expression	  in	  blood	  and	  other	  tissues,	  including	  vessel,	  
heart,	  kidney,	  liver,	  eye,	  skin,	  pancreas,	  muscle,	  and	  nervous	  system,	  to	  verify	  the	  
blood	  defects	  of	  the	  morphants	  and	  to	  provide	  clues	  about	  the	  function	  of	  these	  
chromatin	   factors	   during	   development.	   RNA	   was	   collected	   from	   all	   47	  
morphants	  that	  were	  characterized	  with	  additional	  markers,	  and	  we	  have	  run	  1	  
plate	   of	   each	   primitive	   and	   definitive	   samples	   through	   Fluidigm.	   We	   are	  
currently	   analyzing	   the	   results	   to	   determine	   the	   proper	   normalization	  method	  






















	   To	   investigate	   the	   mechanism	   by	   which	   knockdown	   of	   chd7	   causes	   a	  
hematopoietic	  expansion	  phenotype,	  a	  BrDU	  remains	  to	  be	  tested	  at	  the	  earlier	  
stages	   to	  verify	   this	  phenotype	  microarray	  was	  recently	  performed	   to	  examine	  
global	  changes	  in	  gene	  expression.	  RNA	  was	  collected	  from	  wild-­‐type	  uninjected	  
controls	   and	   chd7	   morpholino	   injected	   embryos	   at	   5	   ss	   (12	   hpf),	   the	   earliest	  
timepoint	  at	  which	  scl	  expression	  was	  increased,	  and	  at	  36	  hpf,	  when	  definitive	  
HSPCs	  have	  formed	  in	  the	  AGM.	  The	  experiment	  was	  conducted	  in	  triplicate,	  and	  
samples	   were	   hybridized	   to	   an	   Affymetrix	   zebrafish	   chip.	   500	   genes	   were	  
significantly	   up-­‐	   or	   downregulated	   at	   the	   36	   hpf	   timepoint.	   Among	   the	  
hematopoietic	   genes	   identified	   from	   these	   arrays	   are	   nfe2	   and	   β-­globin	   a1.	  
However,	   the	   zebrafish	   annotations	   must	   be	   converted	   to	   human	   gene	  
annotations	   for	   further	   analysis,	   such	   as	   conducting	   an	   Integrated	   Pathway	  
Analysis	   (IPA)	   to	   identify	   biological	   processes	   potentially	   involved	   in	   the	  
mechanism	  of	  chd7	  function	  in	  blood.	  This	  will	  be	  done	  after	  my	  thesis	  defense.	  
	   chd7	  morpholinos	  were	  re-­‐injected	  into	  embryos	  derived	  from	  genotyped	  
cmybt25127	   heterozygous	  mutant	   fish	   and	   collected	   at	  36	  hpf	   for	  WISH	  of	   runx1	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I	  performed	  all	  the	  zebrafish	  experiments	  presented	  in	  this	  article.	  I	  
designed	  morpholinos	  to	  knock	  down	  runx1,	  bmi1,	  bmi1b,	  and	  ring1b.	  I	  did	  
microinjections,	  performed	  WISH,	  and	  confocal	  imaging.	  Katie	  Kathrein	  helped	  
with	  microinjections	  and	  confocal	  imaging.	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